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by

SHINGO ESAKI

Under the Direction of Gregory M. K. Poon, PhD

ABSTRACT
The ETS family of transcription factors bind to site-specific DNA via DNA-binding
domains called the ETS domains. The ETS domains are structurally homologous but divergent in
primary sequences. PU.1 is an essential transcription factor and its biological activity is primarily
controlled by up- and down-regulation of its expression. Aside from down-regulated expression,
only a few inhibitory mechanisms are known for PU.1. The most understood one involves PU.1
forming a heterodimer with other protein partners, such as GATA-1. However, unlike autoinhibited ETS-family members whose activity is regulated by autoinhibitory elements that
reduce the net affinity of binding to specific DNA, PU.1 has no such regulatory mechanism at
the protein-DNA level. We report here that PU.1, unlike its auto-inhibited paralog Ets-1, forms a

2:1 complex with site-specific DNA (>10 bp) in a negatively cooperative manner. We also
detected potential interface (193DKDK196) of the PU.1 dimer by using heteronuclear single
quantum correlation (HSQC) NMR. Self-titration of PU.1 is a negative feedback mechanism at
the protein-DNA level. Following these findings, our group found the presence of the IDRs
flanking the ETS domain does not change the DNA binding modes of the PU.1 ETS domain, yet
the PEST domain modifies DNA recognition by the ETS domain through changing DNA
binding affinities. We successfully assigned ~90% or more backbone amide resonances in the
1

H-15N HSQC spectra of hPU.1 constructs with and without IDRs, in the absence and presence

(1:1 complex) of DNA. Using the fully assigned HSQC spectra, we studied fast (ps to ns) time
scale internal dynamics of PU.1 protein. Spin relaxation rates and heteronuclear 1H{15N}-NOE
were acquired for the hPU.1 proteins with and without DNA by NMR. We demonstrated that the
PEST domain remains disordered but becomes more dynamic upon specific DNA binding. In
terms of DNA recognition, the presence of the PEST domain increases the affinity of 1:1
complex of the ETS domain with cognate DNA, without perturbing the structure or changing the
fast time scale backbone motions of the ETS domain.

INDEX WORDS: Transcription factors, ETS family, PU.1, Ets-1, autoinhibition, Dimer,
Dimeric interface, Protein-protein interactions, Nucleic acids, Site-specific DNA, Nonspecific
DNA, Nuclear magnetic resonance, Protein dynamics
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1
1.1

INTRODUCTION

Eukaryotic gene transcription overview
RNA polymerase needs to bind to a promoter sequence, and transcription factors need to

bind to enhancer sequences for the initiation of transcription on an opened chromatin template
(1). Transcription factors are the proteins necessary for the initiation of transcription but not a
part of RNA polymerase. Many roles of transcription factors are known: recognition of (i) cisacting elements of DNA, (ii) other transcription factors, and (iii) RNA polymerase, by forming
an initiation complex (1). The mechanism of transcription in eukaryotes is quite different from
that in prokaryotes. Prokaryotic transcription occurs on a DNA template, while eukaryotic
transcription occurs on a chromatin template (1). Prokaryotic RNA polymerase reads DNA
sequences and binds to promoters, but eukaryotic RNA polymerase cannot do the same (1). This
is the reason why many eukaryotic transcription factors need to bind to cis-acting sites before
RNA polymerase binds to DNA. These transcription factors are called basal transcription factors
and form a DNA complex, to which RNA polymerase binds to initiate transcription (1).
Only a single RNA polymerase is known for prokaryotes, but three types of RNA
polymerase occur in eukaryotes: (i) RNA polymerase I that transcribes 18S/28S rRNA, (ii) RNA
polymerase II that transcribes mRNA and a few small RNAs, and (iii) RNA polymerase III that
transcribes tRNA, 5S ribosomal RNA, and some small RNAs (1). Basal transcription factors
form a complex with DNA at promoters for all three types of RNA polymerase. The structure of
the transcription factor/DNA complexes for RNA polymerase I and III is simple, but the one for
RNA polymerase II is huge (1). The structure formed by basal transcription factors and RNA
polymerase are called basal transcription apparatus (1). The promoters typically lie upstream of
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the start point for RNA polymerases I and II, while they are located downstream of the start point
for most of RNA polymerase III (1).
RNA polymerases and thousands of proteins, including basal and general transcription
factors (TFs), are responsible for gene activation and repression (1). Transcription reactions
proceed through three stages: initiation, elongation, and termination. Binding of TFIID to the
TATA box or Inr is the first step in initiation (Fig. 1.1). Other TFs subsequently bind to the
initiation complex in a defined order. When RNA polymerase II binds to the complex, it initiates
transcription. Binding of TFIIE and TFIIH enables to melt DNA and allow polymerase
movement. Initiation is followed by promoter clearance and elongation, which requires
phosphorylation of the carboxy-terminal domain (CTD). During termination, synthesized mRNA
is released, and RNA polymerase II dissociates from the template DNA.
1.2

Interactions that contribute to DNA recognition by transcription factors
Proteins use similar strategies to recognize nucleic acids (2). The general principles to

recognize cognate sites by transcription factors are the same: it is based on the sequence and
structure (2). One of the forces that are involved in noncovalent protein-nucleic acid complex
formation and contribute most is electrostatic one (2). Nucleic acids are polyanions, and DNA
binding domains of transcription factors are typically positively charged due to an abundance of
lysine and arginine residues in them (2). Many other weak forces for interactions are also
involved in the protein-nucleic acid complex formation, such as hydrophobic and polar ones
(direct and water-mediated hydrogen bonds) (3). Therefore, the sum of weak interactions drives
complex formation (3).
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1.3

helix-turn-helix and winged helix-turn-helix transcription factors
The helix-turn-helix (HTH) is a common motif for DNA recognition in prokaryotes and

bacteriophage (2). DNA binding proteins such as bacteriophage λ-repressor and bacterial Trp
repressor were the first HTH transcription factors (TFs) that were characterized biologically and
structurally in prokaryotes and bacteriophage (2). Interestingly, HTH TFs in prokaryotes and
bacteriophage are homodimers in general, while eukaryotic HTH TFs are monomeric (2). HTH
motif is typically comprised of three core helices that form a right-handed bundle with a tight
turn between helix #2 and #3 (so-called H2 and H3) (Fig. 1.2 A). A hydrophobic core at the
interface of the three helices stabilizes the overall structure as well as serves to present the DNA
recognition helix (helix #3; H3). Upon specific DNA binding, the DNA recognition helix is
inserted into the DNA major groove, where the H3 sidechains specifically contact both
nucleotide bases and sugar-phosphate backbone. Helix #1 (so-called H1) and the turn between
H2 and H3 also contact DNA. A variety of orientations of H3 with the DNA major groove are
known among HTH TFs, thereby different regions of the DNA recognition helix serve for
specific DNA binding (2).
Winged helix-turn-helix (wHTH) motif is a variant of the HTH motif and belongs to
Winged helix DNA-binding domain superfamily (EBI entry: IPR036390) (2). The wHTH
motif/domain contains one or two wings (W1-2), three α-helices (H1-3), and three β-sheets (S13). A typical wHTH domain consists of the three helices bundled from the HTH motif and an
additional antiparallel β-sheet located adjacent to the HTH motif and over the DNA minor
groove (Fig. 1.2 B). This β-sheet makes an additional DNA backbone contact. Many proteins in
this superfamily contain a second wing which is comprised of the turn between H2 and H3 or
resides by N- or C-terminal extensions to the wHTH domain (2).
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The prototypical wHTH motif is seen in HNF-3 protein (2). The structure of 1:1 bound
HNF-3γ/DNA complex shows that α-helix #3 (H3) fits well into the major groove of B-form
DNA, which mediates sequence-specific DNA contacts, and that two wings (the loop between
S1 and S2; the loop after S3 to the C-terminus) mediates DNA backbone contacts to the flanking
minor grooves (2).
1.4

ETS Transcription factors
1.4.1

ETS Transcription factors overview

The ETS (E twenty-six) family of transcription factors were originally identified as Ets
and Myb genes transduced by E26 virus (4). They are found from sponges to humans (i.e.,
throughout Metazoa), and 28 human genes are known (5). All family members bind to sitespecific DNA via structurally conserved DNA-binding domain called “ETS domain” that
consists of ~85 amino acids and exhibits the winged helix-turn-helix (wHTH) motif. ETS TFs
bind to specific purine-rich DNA sequences with a consensus sequence (core motif: 5’GGA(A/T)-3’) for ETS proteins (6). And further specificities for each family member are given
by the flanking sequences of the 5’-GGA(A/T)-3’ core. The ETS domains are structurally similar
to each other, but their primary sequences are highly different from one another.
1.4.2

Combinational regulation of ETS Transcription factors

ETS proteins form heterodimers with other transcriptional regulators either through the
ETS domain or through regions outside the ETS domain. The dimer formation reinforces sitespecific binding to DNA due to so-called combinational regulation (cf. Chapter 1.8.1 for details).
The ETS family members SAP-1 and Elk-1 cooperatively bind to the c-fos promoter with
the MADS-box serum response factor (SRF) (7). Both SAP-1 and Elk-1 have a sequence of 20
amino acids called B-box, which is required for interaction with SRF (7). The cooperativity of
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SAP and Elk-1 requires an interaction between the B-box and the DNA binding domain of SRF
(7). Direct interactions of the SAP/Elk-1 DNA binding domain with the SRF are also required
for DNA recognition by the complex (7). SAP-1 binds to c-fos sites efficiently in the absence of
SRF, whereas Elk-1 does not. Then, SRF is thought to modify the DNA binding properties of
Elf-1. The structure of the ternary SAP-1/SRF/DNA complex was solved (PDB 1HBX; Fig. 1.3
A) (8). A direct interaction between the DNA recognition helices of SRF and SAP-1 is visible in
this structure. Tyr65 that is conserved in almost all the ETS family plays a key role in mediating
the extensive interaction (8). SRF reorients the Tyr65 residue of SAP-1 for optimal DNA contacts
to the GGAA core sequence. Structural comparison of the SAP-1/SRF/DNA complex with sitespecific 1:1 Elk-1/DNA complex revealed that the conserved Tyr residue is oriented to prevent
interactions with the GGAA consensus sequence. This explains why nascent Elk-1 cannot bind
to c-fos promoter sites in the absence of SRF (9). Modeling studies of Elk-1/SRF complex with a
c-fos promoter site further suggested that the conserved Tyr residue in Elk-1 is reoriented to
make similar interactions with SAP-1: namely, interactions between Elk-1 and SRF, unless
otherwise it is a low-affinity DNA site for Elk-1 (10).
Another example of combinational regulation in the ETS family is the ternary Ets1/Pax5/DNA complex (PDB 1K78; Fig. 1.3 B) (11). The affinity of Ets-1 for the mb-1 promoter
is low in the absence of Pax5, and Pax5 selectively recruits Ets-1 to the promoter. The structure
of the Ets-1/Pax5/DNA complex has been compared with that of site-specific 1:1 Ets-1/DNA
complex. Then, the side-chain interactions at the Ets-1/Pax5 interface have been found to
reorient a conserved Tyr residue (Tyr395) in the DNA recognition helix for optimal DNA
contacts. Taken together, a conserved feature of such ternary complexes in the ETS family is the
reorientation of residue(s) in the DNA binding domain for optimal DNA contacts.
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1.5

Biological roles of ETS Transcription factors
1.5.1

Overview of biological roles of ETS proteins

ETS proteins transcriptionally regulate many viral and cellular genes (12). ETS TFs
control gene expression which is important for biological processes such as cellular proliferation
and differentiation, cell cycle regulation, cell signaling, hematopoiesis, apoptosis, and metastasis
(12). ETS proteins are an important family of transcription factors, thereby aberrant activity of
ETS TFs has been found to be associated with a lot of diseases. One of those diseases is cancer
that results from the loss of cellular homeostasis, i.e., the balance between cellular proliferation
and cell death. And many oncogenes are regulated by ETS target genes (13). Human cancer
associated with the activity of ETS TFs includes breast cancer, prostate cancer,
leukemia/lymphoma, and Ewing’s sarcoma, etc. (13).
1.5.2

Biological roles of PU.1

The transcription factor PU.1 was discovered by Moreau-Gachelin et al. in 1988 (14).
They reported it is the product of an upregulated gene in murine erythroleukemia, due to proviral
integration of the spleen focus forming virus (SFFV) (14). This gene was named SFFV proviral
integration site 1 (Sfpi1) in mice and SPI1 in humans. Klemsz et al. isolated the cDNA of the
gene coding for an ETS transcription factor and named it PU box binding-1 (PU.1) (9).
PU.1 is an essential transcription factor, and its main biological role is the development
of hematopoietic stem cells (HSCs) in the immune system (15). PU.1 is a central transcriptional
regulator of HSCs differentiation into lymphocytes and myelocytes, B and T cell development,
and HSCs maintenance (16). This function spans from early to late stages of progression in a
lineage- and cell type-specific manner; thus, it controls proliferation, terminal differentiation, and
maintenance of HSCs (17). Therefore, PU.1 is a key transcriptional regulator within the
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hematopoietic system and plays critical roles in both the innate and adaptive immune systems by
controlling cell differentiation.
Many target genes of PU.1 have been described since its discovery. Turkistany et al.
studied the identity of target genes from the published literature (18). Because PU.1’s primary
role is transcriptional activation, they sorted PU.1 target genes into four criteria. (i) The genes are
activated by PU.1 as seen by the changes in mRNA levels in response to PU.1 expression. (ii)
The genes have at least one PU.1 binding site that contains the consensus sequence 5’-GGAA-3’
(with the exception of 5’-AGAA-3’). (iii) Transient transfection experiments in vitro and/or
mutational studies of the predicted binding site(s) can demonstrate that the genes are
transcriptionally activated by PU.1. (iv) Site-specific PU.1 binding demonstrated by EMSA
and/or ChIP. Thus, they identified 110 PU.1-activated genes based on these criteria. They also
found the subcellular location of the 110 target gene products by subsequent bioinformatics
analysis (18): 22 in the nucleus; 21 in the cytoplasm; 44 in the plasma membrane; and 23 in
extracellular space. Thus, 61% (67 of 110) of the gene products regulated by PU.1 reside in the
plasma membrane or are secreted. Therefore, PU.1 plays an important role in regulating cellular
communication. Several cytoplasmic proteins regulated by PU.1 also mediate intracellular
signaling downstream of plasma membrane proteins such as BTK. Most PU.1-activated nuclear
proteins such as GATA-1 and IRF4 are important transcription factors. Thus, PU.1 possibly
controls downstream gene networks.
Furthermore, PU.1 activates transcription of genes coding for antibodies, antibody
receptors, cytokines such as interleukin 3 (IL-3), cytokine receptors, chemokines, chemokine
receptors, and integrins (18).
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1.5.3

PU.1 protein and diseases

Deregulation of PU.1 activity has been linked to at least three human diseases:
rheumatism, Alzheimer’s disease, and hematologic cancers. Thus, PU.1 not only works as an
indispensable regulator of normal HSCs but also has pathogenic functions in the hematopoietic
immune system. Genome-wide analysis of epigenomic elements by Dozmorov et al. provided
statistical evidence for PU.1 as a transcriptional regulator of genes associated with rheumatism
(19). Gjoneska et al. recently reported the upregulation of PU.1 expression in Alzheimer’s
disease (20).
PU.1 is known as a tumor suppressor in myeloid cells. Inactivating mutations of the SPI1
gene, which codes for PU.1, have been identified in patients of acute myeloid leukemia (AML)
(21). Also, the expression of PU.1 is often suppressed in AML (22). Recent studies have shown
that minimal PU.1 expression reduction (35%) is sufficient to induce preleukemic stem cells,
which leads to transformation to AML (23). The downregulation of PU.1 expression is also
associated with myeloma and classical Hodgkin disease (24,25).
1.6

Structures of PU.1 ETS domain
ETS subfamily belongs to the winged helix-turn-helix (wHTH) superfamily as mentioned

above. The ETS domain (DNA binding domain) is the only ordered region for PU.1 protein (Fig.
1.4). Therefore, PU.1 is a Type I transcription factor. Two structures have been determined for
the PU.1 ETS domain. One is a co-crystal structure of PU.1 ETS domain and 16-bp high-affinity
DNA (PDB: 1PUE) (26). The other is a solution NMR structure of PU.1 ETS domain and all the
C-terminal residues, in the absence of DNA (PDB: 5W3G). Interestingly, these structures are
almost identical to one another (Fig. 1.5, A-C). ETS domains in their family are structurally
similar to each other, although their primary sequences are mutually far different. For example,
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the tertiary structure of the ETS domain of Ets-1 (PDB: 1K79) is superimposable with that of
PU.1 (Fig. 1.5 D). However, Ets-1 and PU.1 belong to individual family members which are
physiologically quite far from each other (27).
As mentioned above, Kodandapani et al. solved a co-crystal structure of murine PU.1
ETS domain (171-258 a.a.) and 16-bp DNA (5’-AAAAAGGGGAAGTGGG-3’) at 2.3 Å
resolution (PDB: 1PUE) (26). The PU.1 ETS domain has a globular structure (33 × 34 × 38 Å3)
that consists of three α-helices (H1, H2, and H3) and four antiparallel β-sheets (S1, S2, S3, and
S4). The structure is typical of a winged helix-turn-helix (HTH) family, consisting of H2-loopH3 as HTH and another loop between S3 and S4 as a wing. Thus, the ETS domain of PU.1 and
other family members have a loop-helix-loop motif.
The DNA-binding site of the ETS domains has four strictly conserved residues: K219,
R232, R235, and K245 in murine PU.1. R232 and R235 in H3 directly contact the bases of
GGAA (the consensus sequence of the ETS family) in the major groove. These arginine residues
also make water-mediated contacts with the bases of the GGAA core. K245 contacts phosphate
backbone of the GGAA strand in the minor groove, and K219 contacts phosphate backbone of
the other strand. It is notable that R81 and R84 of Fli-1, which correspond to R232 and R235 of
PU.1, respectively, do not contact DNA directly. However, intermolecular NOE has been
observed between the arginine residues and DNA by NMR (28).
1.7

Regulation/control of PU. 1 activity in the cell
1.7.1

Regulatory mechanisms of PU.1 activity

The biological activity of PU.1, as an essential transcription factor, is primarily controlled
by up- and down-regulation of its expression. In addition to downregulation in expression, a few
other inhibitory mechanisms for PU.1 are known: formation of a heterodimer with other protein
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partners such as GATA-1 (29). Auto-inhibited ETS-family members are regulated by inhibitory
helices packing against their DNA-binding domain in the unbound state. However, PU.1 has no
such regulatory mechanism.
1.7.2

Roles and functions of autoinhibition for ETS transcription factors

Autoinhibition is a control mechanism of protein activity, whereby inhibitory module or
domain of a protein interacts with another part of the protein so that it works for negative
regulation (30). Many protein regulation mechanisms are known to proceed through
autoinhibition (30). For example, alternative splicing or proteolysis would remove the
autoinhibitory module (30). Post-translational modifications (PTM) or protein-protein
interactions (PPI) in response to cellular signaling would relieve or reinforce autoinhibition and
enable the protein to control downstream events (31).
Autoinhibition has been described as a key regulatory mechanism for ETS transcription
factors at the protein/DNA level (30). Most of the 28 paralogs of ETS family in humans, except
a few members including PU.1, have been described to possess autoinhibition (31). They
typically have a common mechanism in which autoinhibitory elements, typically helices (α- or
310-helix), adjacent to the ETS domain, make DNA binding unfavorable. Thus, one can
determine if an ETS protein is autoinhibited or not by detecting reduced affinity for site-specific
DNA of a full-length protein (or a construct harboring both ETS domain and adjacent
autoinhibitory elements) by comparison with an isolated ETS domain.
One way to classify the ETS family members is based on the number of autoinhibitory
helices on both sides of the ETS domain (31). Ets-1 and Ets-2 have two helices on both sides of
the ETS domain (N-terminal HI-1 and HI-2; C-terminal H4 and H5). GABPA and ETV6 have
only C-terminal helices (H4 and H5). ELK4 has only one inhibitory helix (H4) at the C-terminal
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side of the ETS domain. And several members, including PU.1, FLI1, SPDEF, ELF3, ELF5,
ELK1, ELK3, and ELK4, have no autoinhibitory helices adjacent to the ETS domain (31).
Among the ETS family members, Ets-1 has been most characterized about autoinhibition.
The autoinhibitory module of Ets-1 consists of the four helices (HI-1, HI-2, H4, and H5) and the
interfaces with H1 of the ETS domain (Fig. 1.6, A and B). Early work on Ets-1 demonstrated that
HI-1 unfolds upon binding to a specific DNA. Thus, the autoinhibition is thought to give an
energetic penalty to the protein on DNA binding and to reduce net affinity (32). Recent dynamics
studies by NMR revealed that both HI-1 and HI-2 unfolds upon binding to both specific and
nonspecific DNA (33). Structural data of Ets-1 gives an insight that the inhibitory helices of Ets1 lie on the distal surface from the DNA binding site. This leads to the understanding that
binding to DNA and unfolding of autoinhibitory elements are allosterically coupled (34,35).
In the presence of all the four inhibitory helices, the net affinity of Ets-1 is reduced to a
half (36). And the presence of an intrinsically disordered serine-rich region (SRR), which is
located at the N-terminus of HI-1 and transiently interacts with both the ETS domain and the
inhibitory module, diminishes binding affinity of Ets-1 up to 20-fold (36). Transient interactions
with the SRR are enhanced by promoting multisite phosphorylation levels in response to Ca2+
signaling. Thus, the autoinhibition of Ets-1 is linked with cellular signaling events mediated by
Ca2+-dependent kinases such as CaM kinase II (36). Taken together, Ets-1 autoinhibition is
associated with a conformational equilibrium between transcriptionally inactive and active states.
Upon specific DNA binding, helices HI-1 and HI-2 unfold, and Ets-1 becomes flexible and in an
active state. The inactive state of Ets-1 is favored and therefore stabilized by transient
interactions of the SRR with the ETS domain and the autoinhibitory module (the four inhibitory
helices). These interactions are dependent on multisite phosphorylation of the SRR.
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Various other examples of autoinhibition for ETS proteins have been reported. ETV6 has
two C-terminal helices H4 and H5. H5 sterically blocks the DNA-binding interface of its ETS
domain, which leads to attenuate DNA binding greatly (37). ETV4 and ETV5 in the PEA3
subfamily have non-helical autoinhibitory elements (sequences) on both sides of their ETS
domains (38,39). The cooperative binding of USF-1, a binding partner of ETV4, has been
reported to enhance the DNA-binding affinity of ETV4 by interacting with the inhibitory
elements (38). The autoinhibitory element of ELF3 is an ordered coil sequence, immediately C
terminal to S4 of its ETS domain (31).
The autoinhibited ETS proteins mentioned above have autoinhibitory element(s)
appended to both sides of or only C-terminal to the ETS domain, whereas distant sequences from
the ETS domain autoinhibit two subfamilies (ESE and TCF) of ETS proteins. In the case of ESE
subfamily, ELF3 (ESE-1) is autoinhibited by the transactivation domain at the center of the
protein, thereby disruption of the transactivation domain enhances specific DNA binding (40).
On the other hand, ELF5 (ESE-2) is autoinhibited by the N-terminal sequences of the protein
(41). In the case of TCF subfamily, the autoinhibition of ELK1, ELK3, and ELK4 involves
interactions between the B-box, the transactivation domain, and the NET inhibitory domain
(31,42-44). Intramolecular and intermolecular interactions with the helix-loop-helix Id proteins
are also part of the autoinhibition of TCF subfamily (45). Moreover, phosphorylation of the
transactivation domain of the TCF subfamily by MAP kinases enhances specific DNA binding
(46).
Various autoinhibitory mechanisms have been presented for the ETS TFs. Thus, an
interesting question worth discussing is whether common features in the autoinhibition occur in
the ETS family. DNA-binding domains for TFs are in general conformationally dynamic, which
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is necessary for TFs to search for specific binding sites in a majority of nonspecific DNA, with
DNA-scanning quenched upon specific DNA binding (47,48). DNA-binding interfaces in the
ETS domains of Ets-1 and ETV6 are also conformationally dynamic as probed by NMR and
HDX experiments (33,37), and this feature is likely to be common for ETS domains.
Furthermore, such flexibility of the DNA-binding site presumably explains why Ets-1 protein
shares the same binding interface for specific and nonspecific DNA binding (33). Collectively,
diverse autoinhibitory elements adjacent to the ETS domain presumably reduce these dynamic
properties of the ETS family, like the autoinhibitory helices of Ets-1 regulate its DNA-scanning
motions.
1.8

Protein-protein interactions (PPIs) of ETS domains
1.8.1

Classification of protein-protein complexes

Classification of protein association into functionally and structurally related classes is
important. Both the function and performance of the protein complex need to be considered for
classification. Nooren and Thornton defined protein complexes as (i) either obligate or nonobligate and as (ii) either permanent or transient (49). An obligate protein complex is defined as
one in which each subunit is too unstable to be found in vivo. A non-obligate protein complex is
defined as one in which each subunit is stable and can be found in vivo. The terms permanent
and transient classify protein complexes based on their lifetime. A permanent protein complex is
defined as very stable associations. A transient protein complex is defined as one in which each
subunit associates and dissociates in vivo. Notably, an obligate protein complex is the only
permanent one in this definition, while a non-obligate protein complex can be either permanent
or transient. In the literature, each of the two terms in each group (group (i) and (ii) above) is not
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used to discriminate one from the other (50). They are considered to be interchangeable in
protein-protein complexes (51).
While there have been many reports about protein oligomerization, our understanding of
its supramolecular assembly and function is still limited compared to our knowledge of tertiary
protein structures (52). One way to characterize the relationship between protein quaternary
structure and function is to engineer or mutate a protein into a different oligomeric state, as we
have studied here. Self-association of proteins is a common feature in the cells, and it has been
estimated that 70-80% of cellular proteins are tetramers composed of four monomers associated
noncovalently to function as oligomeric proteins (53,54). Various other oligomeric forms of
proteins occur from a simple dimer to a complex form composed of many subunits, but the
majority of them are either homo-dimers or homo-tetramers (55).
Oligomeric proteins consist of either homo- (identical) or hetero- (non-identical)
subunits. Homo-oligomers associate either in an isologous or heterologous manner (52). An
isologous association is symmetric and uses the same contact surfaces (residues), while a
heterologous association is asymmetric and uses non-identical contact surfaces (52). Heterooligomers form only a heterologous assembly by their nature. This classification applies to
protein oligomers except for some oligomeric interactions such as domain swapping, which is
discussed below. Oligomeric protein structures are also classified into two groups: an obligate or
non-obligate interaction (49). Obligate oligomers are usually very stable and exist as oligomers,
thus their monomeric components are unstable and not found in vivo. On the other hand, nonobligate oligomers associate and dissociate in vivo. These protein oligomers can be further
classified. Dynamic oligomeric orders (equilibrium) and transient interactions are produced by
weak interactions and altered by molecular or physiological triggers. Such an equilibrium in the
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oligomeric state can be important in protein function. The interfaces of non-obligate oligomers
are typically smaller and less hydrophobic than those of obligate oligomers, probably to meet
folding and solubility requirements for monomers in non-obligate oligomers (49).
1.8.2

Heterodimers of ETS domains and binding partners

PPIs regulate many eukaryotic transcription factors through their DNA-binding domains
or additional subunits to function, typically as non-covalent dimers (56). For ETS transcription
factors, dimers can be formed through ETS domains or other domains such as the PNT domain
that approximately one-third of ETS family have, for both homodimerization and
heterodimerization (31). Heterodimerization enables precise control of tissue-specific
transcriptional regulation for the ETS family (57). Thus far, several structures of heterodimers of
the ETS domain in (ternary) complex with DNA have been determined: GABPα/β (58), Ets1/Pax-5 (11), ELK4 (SAP-1)/SRF (59), and PU.1/IRF4 (60).
The heterodimeric structure of the ETS domain of the GABPα subunit in a complex with
GABPβ subunit at 2.15 Å resolution (PDB: 1AWC) was reported in 1998 (58). The total buried
surface area of the dimerization interface is 1600 Å2, where hydrophobic contacts in the main
part and some water-mediated hydrogen bonds are observed (58). The ankyrin repeats of GABPβ
insert into a depression of GABPα formed by H1, H4, H5, and the loop between H3 and S3.
Even though GABPβ subunit does not have direct DNA contacts, the formation of GABPα/β
heterodimer increases DNA-binding affinity compared to monomeric GABPα, presumably due
to indirect GABPβ-DNA interaction mediated by hydrogen bonding from Lys69 of GABPβ to
Gln321 of GABPα (58).
Heterodimeric Ets-1/PAX5 complex with the mb-1 promoter DNA (PDB: 1K78) has only
180 Å2 dimerization interface area because PAX5 binds to its cognate DNA site located on the
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opposite side from Ets-1 (11). The DNA has variant 5’-GGAG-3’ core. mb-1 promoter has a
low-affinity sequence for Ets-1. Thus, this interaction is critical for binding. It is because the
heterodimeric complex forms optimal DNA contacts of the Tyr395 side chain in H3 (DNArecognition helix) of Ets-1 as well as the further formation of van der Waals and salt bridge
contacts (11). This is a good example to illustrate that the DNA-recognition helix H3 plays a key
role in both protein–DNA and protein-protein interactions.
The interface of the Ets-1/PAX5 complex is similar to that of ELK4 (SAP1)/SRF
complex with DNA (PDB: 1K6O (59)). Note that optimal DNA contacts like Ets-1/PAX5 are
formed once SRF binds to its cognate DNA and ELK4 protein. In the heterodimeric complex of
ELK4/SRF with DNA, further contacts between ELV4 and DNA are formed by reorientation of
conserved Tyr and Arg residues of ELK4, after a small hydrophobic pocket in ELK4 H3
accommodates Leu155 of SRF (59).
PU.1 forms a heterodimer with the interferon regulatory family transcription factor IRF4
in the presence of immunoglobulin light-chain gene (λB) enhancer DNA (60). Low-affinity
DNA binding of IRF4 increases co-operativity 20- to 40-fold, presumably because PU.1 forms a
salt bridge with IRF4 and gains binding energy (60). Thus, in the cases of Ets-1, ELK4, and
PU.1, dynamic co-operativity upon binding to their heterodimeric binding partners in the
presence of DNA are observed either by optimizing binding to low-affinity DNA sequences or
by gaining binding energy.
A number of other binding partners of PU.1 have been identified for each domain of
PU.1 (61). Proteins such as TFIID, TBP, GATA-1, and GATA-2 interacts with the
transactivation domain (N-terminus). PU.1 interacting partner (PIP) and ICSBP are known to
interact with the central PEST domain, and phosphorylation of Ser148 residue in murine PU.1
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plays an essential role in this protein-protein interaction (62). Proteins including c-Jun, c-Myb,
GATA-1, GATA-2, and NF-IL6 interact with the C-terminal ETS domain.
In the case of binding through the ETS domain of PU.1, a critical PU.1 coactivator c-Jun
interacts with the ‘wing’ of the winged HTH motif (the S3/S4 region), which is also the binding
site for GATA TFs (GATA-1 and GATA-2), and therefore they compete to bind. Through these
events, transactivation of both PU.1 and GATA TFs is repressed (63). Interestingly, a
structurally homologous ETS family member ERG also binds to the Jun basic domain via its
ETS domain, but the ‘wing’ is not the dimerization interface, which reflects functional diversity
of the ETS domain (64). Instead, Arg367 and Tyr371 in H3 of ERG are critical for the interaction
(64). PU.1 also interacts with NF-IL6 via two regions: the ‘wing’ (the same interface as binding
to c-Jun and GATA) and the S2-H2-H3 region (65).
1.8.3

Homodimers of ETS domains in the presence of DNA

In addition to transcriptionally active 1:1 protein/DNA complex, homodimerization of
many ETS family members has been reported including Ets-1, Elk-1, ETV1, ETV6, FEV, ERG,
and PU.1 (66-70). Here, it is noteworthy that all of these ETS domain homodimers are 2:2
protein/DNA complex except for an example of 2:1 protein/DNA complex of Ets-1 in a nonreducing environment, where two Cys residues from each subunit are likely to form a disulfide
bond (71). Among the ETS proteins capable of homo-dimerizing, Ets-1 has been studied most
extensively. For example, positively co-operative binding of Ets-1 at 2:2 protein/DNA
stoichiometry is observed at repeated (palindromic) specific DNA sites such as stromelysin-1
promoter (72). Such a positively cooperative DNA binding of Ets-1 is known to counteract its
autoinhibition (73). Three homodimeric structures of Ets-1 have been determined by
crystallization (PDB: 2NNY, 3MFK, and 3RI4) (Fig. 1.7) (72,74,75).
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Ets-1 has two dimerization interfaces for its homodimerization. For the structures 2NNY
and 3MFK, the binding mode is head-to-head on palindromic specific sites, with HI-2 and the
loop between HI-2 and H1 contacting the loop between H2 and H3 reciprocally. For the
structures 3MFK and 3RI4, the binding mode is also head-to-head on palindromic specific sites,
with HI-1 reciprocally contacting H4, HI-2, and the loop between HI-1 and HI-2. It is notable
that 3MFK has two dimerization interfaces.
In the case of Elk-1 (PDB: 1DUX), the homodimer (2:2 protein/DNA complex) has a
reciprocal interface involving H1 and the H1/S1 loop of each subunit. The dimerization interface
of Elk-1 is similar to that of Ets-1, except that Elk-1 does not have autoinhibitory helices
appended to the ETS domain. In the 2:2 complex structure of Elk-1, the DNA-binding site
locates on the almost opposite side of the dimerization interface, which is different from Ets-1
that forms head-to-head 2:2 complex. Furthermore, both ETV1 (PDB: 4AVP) and FEV (PDB:
2YPR) structures have a dimerization interface at H1, H4, and the S1/S2 loop, involving an
intermolecular disulfide bond, although their orientations and surface positions are different from
each other.
1.8.4

Homodimerization of ETS proteins in the absence of DNA

The ETS domain of Elk-1 is known to mediate homodimerization of Elk-1, and the
resulting homodimer is given cytoplasmic stability to resist proteasomal degradation as well as
localization to the nucleus (68). In the same report, PU.1 in the nucleus forms homodimer(s) in
the absence of DNA but is monomeric upon binding to high-affinity DNA (68). This report
suggests the biological relevance of PU.1 homodimerization mediated by the ETS domain and
also arises a new question of whether PU.1 can dimerize in the presence of DNA.
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1.8.5

Potential for dimerization of PU.1 at a single cognate site of DNA

In our previous work, we observed the potential for the ETS domain of PU.1 to dimerize
at a single specific site by ITC titration experiments in 2012 (76). When a forward titration was
performed by adding PU.1 protein to site-specific DNA, initially stable titration heats (ΔH°)
started increasing beyond the 1:1 protein:DNA ratio and returned to baseline after a second
equivalence point. Thus, two distinct phases (Fα and Fβ) were observed. Next, when a reverse
titration was performed by adding DNA to PU.1 protein, two distinct transitions of ΔH° were
observed. Negative ΔΔH° transition (Rα) from the beginning of titration to the first equivalence
point (1:1 protein:DNA ratio) and positive ΔΔH° transition (Rβ) from the first to the second
equivalence point were observed. It is noteworthy that the magnitudes and signs of the ΔH° are
different between the forward and reverse titrations. Collectively, we observed the potential of
two distinct DNA binding modes (1:1 and 2:1 protein:DNA ratio) for PU.1. Also, the negative to
positive transition in the reverse titration (Rα and Rβ) implies that a 2:1 (PU.1:DNA) complex is
formed in a negatively cooperative manner.
1.8.6

Free energy landscape of PU.1 ETS domain in solution

The free energy of the four states of PU.1 (i.e., monomeric and dimeric PU.1 in the
absence or presence of site-specific DNA) were further analyzed under standard state conditions,
in the same study (76). Among the four states of PU.1, the unbound PU.1 monomer is most
unstable, and the 1:1 DNA-bound complex is most stable. Furthermore, taking the free energy
between these two monomeric states into account, the DNA-free dimer is less stable than the
DNA-bound dimer (i.e., 2:1 PU.1/DNA complex) although the magnitudes of ΔG° between
DNA-free and -bound dimer significantly depends on the flanking sequences of the core DNAbinding motif of PU.1 (76). Taken together, the free energy (G°) gradient of the PU.1 ETS
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domain is as follows: unbound monomer > PU.1 dimer in the absence of DNA > 2:1 DNAbound complex > 1:1 DNA-bound complex.
1.9

Intrinsically disordered regions (IDRs) of ETS domains
1.9.1

Intrinsically disordered proteins (IDPs) and regions (IDRs)

A large fraction of any eukaryotic proteomes consists of polypeptides that are unlikely to
form well-defined, three-dimensional structures (77). Recent studies support that such protein
segments can be functional even in the absence of stable and globular tertiary structures (78-80);
these protein segments are referred to as intrinsically disordered regions (IDRs) now. Biased
amino acid composition and low sequence complexity are characteristic of IDRs. IDRs cannot
form the hydrophobic core necessary for making up fixed tertiary structures due to low
proportions of bulky hydrophobic amino acids (81). Proteins that are composed of only
disordered sequences and thus have no tertiary structures are called intrinsically disordered
proteins (IDPs) (77). However, the majority of eukaryotic proteins consist of both IDRs and
structured regions (77).
1.9.2

Emerging roles of IDRs for transcription factors

IDRs are known to be functional since the mid-1990s (82), and the reports on IDRs have
changed the classic paradigm of protein structure-function relationship. IDRs are unable to make
stable and well-defined tertiary structures. Instead, their disorder is dynamic, and therefore, they
can rapidly form a range of conformations (81). Thus, IDRs can display various binding affinity
and kinetics due to their dynamic properties (81).
TFs have many advantages with the disorder, which facilitate their function and
regulation, such as conformational plasticity and binding promiscuity (81). TFs with disorder can
adopt different conformations and interact with multiple binding/interaction partners, which in
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turn promotes the assembly of macromolecule complexes (81). This explains why eukaryotic
TFs exhibit a significantly higher degree of disorder than prokaryotic ones (83).
1.9.3

IDRs of transcription factors and diseases

IDRs can cause diseases either through dysregulation or aggregation of proteins (84).
Diseases associated with TFs that contain IDRs include multiple types of cancer (85-87),
neurodegenerative diseases (88-90), cardiovascular diseases (91), and type 2 diabetes (92). One
of the ETS family members FLI1 can be a cause of Ewing’s sarcoma by generating an oncogenic
fusion protein EWS-FLI1 (86). This is an example of cancer that IDRs drive through
dysregulation (chromosomal translocation in this case). Aberrant oligomers of IDRs can
assemble into pathological aggregates (amyloids). TFs with IDRs can be dysfunctional as such
and cause neurodegenerative diseases such as Alzheimer’s disease (93).
1.9.4

PEST sequences

A protein region that destabilizes a protein and its half-life by >100-folds was identified
using computational methods in the 1980s (94). This small region is enriched in Pro (P), Glu (E),
Ser (S), and Thr (T) and forms a degradation signal, thus it was named the PEST region after the
four representative amino acids (95,96). PEST region is hydrophilic and consists of at least 12
amino acids, flanked by positively charged amino acids – Lys, Arg, and His (94). About 10% of
proteins have such a sequence, and interestingly, proteins with a shorter life span have higher
populations of PEST sequences. Various regulatory proteins such as p53, Jun, Fos, Myc, and
protein kinases and phosphatases have PEST sequences (94). Proteins with the PEST sequence
get degraded by the proteasome, but the mechanism is still not clear yet (94).
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1.9.5

Difficulties in NMR spectral assignment of IDRs

While IDPs are hard to study by crystallography because of their inherent structural
flexibility, NMR is a powerful tool to study protein structure, dynamic properties, interactions,
and so on. A 2D 1H-15N HSQC spectra can be considered as a protein “fingerprint” since it
contains well-dispersed peaks of all backbone amide resonances except Pro residues that do not
appear in 1H-15N HSQC spectra. However, residues in IDRs display severe spectral overlap (97).
Unfortunately, Pro residues are highly abundant in IDRs, which makes sequential backbone
assignment of IDPs even more difficult than we analyze ordered proteins (97).
To overcome such difficulties, measurements at low temperatures and pH are often used
for the backbone assignment of IDPs (97). Improved instrumental sensitivities have been
achieved for the following reasons (97). (i) Non-uniform sampling technologies allow for highdimensionality experiments. (ii) Faster acquisition of NMR experiments using cryoprobe allows
longitudinal relaxation experiments and direct detection of heteronuclei (13C). The latter has also
helped overcome line broadening problems. Signal overlap problems require the future
development of NMR techniques (97).
1.9.6

Gaining structures in IDPs

IDPs are sensitive to chemical environments such as pH, temperature, and ligand binding.
In a recent study, some IDPs gained more compact structures with higher α-helical content under
acidic conditions because electrostatic repulsion of negatively charged residues reduced (98).
Thus, IDPs are suggested to be stabilized by favorable electrostatic interactions.

23

Figure 1.1 Assembly of the preinitiation complex (PIC) in the initiation step of eukaryotic
transcription.
In eukaryotes, each gene has its own promoter near and upstream of the gene. RNA polymerase
II binds to a promoter sequence of DNA. For promoters that contain TATA box, TBP (TATA
box binding protein) binds to the TATA box and initiates transcription complex assembly.
Activation signals from mediators and coactivators are sent to transcription activators. The
chromatin remodeling complex and coactivators activate chromatin. Subsequently, PIC is
assembled by RNA polymerase II, using five general transcription factors (TFIIA, IIB, IIE, IIF,
and IIH).
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Figure 1.2 Helix-turn-helix and Winged helix-turn-helix transcription factors.
A, a solution NMR structure of the Trp repressor and DNA complex (PDB: 1RCS). The protein
subunits are shown in green, with the helix-turn-helix (HTH) domain highlighted in red. B, a 1:1
complex of HNF-3 (shown in green) and DNA (PDB: 2HDC). The winged-helix-turn-helix
(wHTH) domain and the second wing are highlighted in red.
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Figure 1.3 Combinational transcriptional regulatory complexes in the ETS family.
A, a crystal structure of ternary SAP-1/SRF/specific DNA complex (PDB: 1HBX). The ETS
domain of Sap-1 is shown in green. The MADS-box DNA binding domains of SRF (SRF-d and
SRF-p) are in blue and magenta. B, a crystal structure of ternary Ets-1/Pax5/specific DNA
complex (PDB: 1K78). The ETS domain of Ets-1 is shown in green and Pax-5 is in blue.
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Figure 1.4 Nomenclature and domain organization of hPU.1 protein.
In PU.1 protein, the ETS domain is the only ordered region. hPU.1 protein mainly consists of
four parts. N-terminal transactivation domain (1-116), PEST domain (117-164), ETS domain
(165-258), and C-terminal disordered residues (259-270). Therefore, the ETS domain is flanked
by IDRs.
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Figure 1.5 PU.1 structures in the presence and absence of DNA, an overlay of PU.1 in
the presence and absence of DNA, and an overlay of PU.1 and Ets-1.
A, a crystal structure of PU.1/specific DNA complex (PDB: 1PUE). The ETS domain of PU.1 is
shown in green. B, a solution NMR structure of unbound PU.1 ETS domain (PDB: 5W3G). The
ETS domain of PU.1 including C-terminal IDR is shown in magenta. C, an overlay of PU.1 in
the presence (green) and absence (magenta) of cognate DNA. D, an overlay of PU.1 (green) and
Ets-1 (yellow; PDB: 1K79) in the presence of cognate DNA.
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Figure 1.6 Autoinhibitory module of Ets-1.
A, The autoinhibitory elements of Ets-1 flank both termini of the ETS domain. B, the autoinhibitory module of Ets-1 consists of the four helices (HI-1, HI-2, H4, and H5) and the
interfaces with H1 of the ETS domain (PDB: 1R36).
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Figure 1.7 2:2 Ets-1/DNA complex.
A crystal structure of (Ets-1)2/2DNA quaternary complex (PDB: 3RI4), where head-to-head
binding between ETS domains on palindromic cognate DNA sites are observed. Two ETS
domains of Ets-1 are shown in cyan and magenta. The helices HI-2, H4, and H5 are involved in
docking of HI-1 from the other Ets-1 subunit.
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2

MULTIPLE DNA-BINDING MODES FOR THE ETS FAMILY TRANSCRIPTION
FACTOR PU.1

2.1

Preface
The content in this chapter is based on a peer-reviewed paper: Multiple DNA-binding

modes for the ETS family transcription factor PU.1. Esaki S, Evich MG, Erlitzki N, Germann
MW, Poon GMK. Journal of Biological Chemistry. 2017 Sep 29;292(39):16044-16054 (99). I
prepared the protein and DNA samples in this work. I conducted the SNS-dye binding assays and
NMR experiments. NMR experiments and analysis were in collaboration with Drs. Markus
Germann and Marina Evich. This work was supported by National Science Foundation Grant
MCB 15451600 and National Institutes of Health Grant R21 HL129063.
2.2

Abstract
The eponymous DNA-binding domain of ETS (E26 transformation-specific) transcription

factors binds a single sequence-specific site as a monomer over a single helical turn. Following
our previous observation by titration calorimetry that the ETS member PU.1 dimerizes
sequentially at a single sequence-specific DNA-binding site to form a 2:1 complex, we have
carried out an extensive spectroscopic and biochemical characterization of site-specific PU.1
ETS complexes. Whereas 10 bp of DNA was sufficient to support PU.1 binding as a monomer,
additional flanking bases were required to invoke sequential dimerization of the bound protein.
NMR spectroscopy revealed a marked loss of signal intensity in the 2:1 complex, and mutational
analysis implicated the distal surface away from the bound DNA as the dimerization interface.
Hydroxyl radical DNA footprinting indicated that the site-specifically bound PU.1 dimers
occupied an extended DNA interface downstream from the 5’-GGAA-3’ core consensus relative
to its 1:1 counterpart, thus explaining the apparent site size requirement for sequential
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dimerization. The site-specifically bound PU.1 dimer resisted competition from nonspecific
DNA and showed affinities similar to other functionally significant PU.1 interactions. As
sequential dimerization did not occur with the ETS domain of Ets-1, a close structural homolog
of PU.1, 2:1 complex formation may represent an alternative autoinhibitory mechanism in the
ETS family at the protein-DNA level
2.3

Introduction
The differentiation of distinct lineages of blood cells from a single progenitor species

occurs in a multistep process, termed hematopoiesis, that is intricately controlled at the
transcriptional level. The ETS family transcription factor PU.1 ranks among the most essential
hematopoietic regulators in ensuring the continued self-renewal of this progenitor, the
hematopoietic stem cell (17). PU.1 is also essential for directing correct differentiation of the
hematopoietic stem cell to various cell lineages. Crucially, PU.1 governs cell fate specification
and functions in a transient, dosage- and cell stage-dependent manner (100). In mature cells,
graded PU.1 activity is also required for key cellular processes and the specialization of mature
cells into function-specific subtypes. Aberrant PU.1 activity is linked to a spectrum of diseases,
including rheumatism (19), hematologic cancers (24,25,101), and Alzheimer’s disease (102).
Clearly, knowledge of the regulatory mechanisms of PU.1 is essential to an understanding of its
role in normal biology and in disease.
Biological modulation of PU.1 activity is generally attributed to up- or down-regulation
at the level of expression. With a metabolic half-life of ~50 h, a period that spans the entire cell
cycle (103), the cellular persistence of PU.1 means that downregulation of its own expression
cannot alone provide a complete description of PU.1 regulation, as additional dampening
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mechanisms are required to prevent open-ended escalation of PU.1 activity during its lifetime in
the cell.
Outside of down-regulated expression, few inhibitory mechanisms have been described
for PU.1. The best understood is the mutual antagonism between PU.1 and the zinc finger
transcription factor GATA-1, wherein each protein inhibits DNA binding by the other during
myelopoiesis (29). In addition, PU.1 is one of only a few ETS family members that lack socalled autoinhibition, a regulatory mechanism in which helices adjacent to the ETS DNAbinding domain allosterically reduce DNA-binding affinity (Fig. 2.1 A) (104). In the case of Ets1, the archetypal autoinhibited ETS paralog, interactions with partner proteins, such as Pax5
(105) and AML1/RUNX1/CBFα2 (73), relieve autoinhibition and restore high-affinity binding.
Thus, in the absence of lineage-specific inhibitory partners such as GATA-1 or some intrinsic
regulatory alternative to autoinhibition, PU.1 would be continuously poised in a functionally
uncontrolled, transcriptionally permissive state.
In previous work, we have observed in calorimetric titrations the potential for the
eponymous DNA-binding domain of PU.1 to dimerize at a single cognate DNA-binding site
(76). Whereas dimerization of ETS domains of other ETS family homologs bound to two sites
(i.e. 2:2 complexes) has been reported (74,106-109), self-association at a single site is poorly
understood. We have carried out an extensive series of spectroscopic and biochemical
experiments to directly characterize the variable binding modes of PU.1 as a function of DNA
sequence and site size. The results show a site-specific 2:1 complex in exchange between free
PU.1 on the one hand and the 1:1 site-specifically bound state on the other, while contacting the
DNA over an extended interface beyond the single helical turn observed in the 1:1 co-crystal
structure. Sequential dimerization imposes the dual requirements of specific DNA as well as a
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site size longer than 10 bp. Nonspecific DNA forms oligomeric but not 1:1 complexes at
equilibrium. Sequential dimerization of site-specifically bound PU.1, which sequesters excess
circulating PU.1 from accessible DNA target sites, suggests itself as a potential mechanism of
negative feedback in the absence of inhibitory binding partners.
2.4

Materials and methods
2.4.1

Proteins

Recombinant constructs representing the ETS domain of murine PU.1 (residues 167–272,
designated PU.1∆N167) and Ets-1 (residues 331–440, designated Ets-1∆N331) were cloned with
a thrombin-cleavable C-terminal His6 tag as described (110). A similarly tagged construct for
autoinhibited Ets-1 (residues 280–440, Ets-1∆N280) was a gift from Dr. Lawrence P. McIntosh
(University of British Columbia). Unlabeled constructs were overexpressed in Escherichia coli
in LB medium. Uniformly 15N-labeled PU.1∆N167 was expressed from 5-ml starter cultures in
LB broth grown at 37 °C for ~8 h. All of the culture was inoculated into 250 ml of LB broth,
grown at 37 °C for ~16 h, and harvested. The cell pellet was resuspended in standard M9
medium containing 15NH4Cl, MgSO4, CaCl2, trace metals, minimal essential medium vitamins,
and glucose. Protein expression was induced with 0.5 mM isopropyl 1-thio-β-Dgalactopyranoside overnight at 25 °C. Both unlabeled and isotopically labeled constructs were
purified as described (111). In brief, cleared lysate was first purified by immobilized metal
affinity chromatography, cleaved with thrombin, dialyzed against 10 mM NaH2PO4/Na2HPO4
(pH 7.4) containing 0.5 M NaCl, and polished on Sepharose SP (GE Healthcare). Buffers used
with Ets-1 constructs, which harbored reduced cysteines, additionally contained 0.5 mM tris(2carboxyethyl)phosphine-HCl. Protein concentrations were determined by UV absorption at 280
nm using the following extinction coefficients (in M-1 cm-1): 22,460 (PU.1∆N167), 32,430 (Ets-
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1∆N331), and 39,880 (Ets-1∆N280). The labeling efficiency of 15N-labeledconstructs was >98%,
as judged by mass spectrometry (Fig. S1).
2.4.2

Nucleic acids

Synthetic DNA oligonucleotides were purchased from Integrated DNA Technologies
(Coralville, IA) and annealed to form duplex binding sites harboring the high-affinity 5’AGCGGAAGTG- 3’, low-affinity 5’-AAAGGAATGG-3’, or nonspecific 5’-AGCGAGAGTG3’ DNA sequence (ETS-specific core consensus in boldface type). Fluorescent DNA probes were
constructed by annealing a Cy3-labeled oligonucleotide with excess unlabeled complementary
strand as described (112).
2.4.3

Fluorescence polarization titrations

ETS protein binding to fluorescently labeled DNA sites was measured using a Molecular
Devices Paradigm plate reader as described (113). In brief, DNA probe (0.5 nM) was incubated
to equilibrium with graded concentrations of purified PU.1∆N167 in a total volume of 30 μl of
10 mM Tris-HCl (pH 7.4) containing 150 mM total Na and 0.1 mg/ml bovine serum albumin.
Steady-state fluorescence parallel and perpendicular to the incident polarized light was acquired
at 595/35 nm upon excitation at 535/25 nm. Each data point represents the mean ± S.E. of five
consecutive measurements as an indication of instrumental noise. Anisotropy data were fitted
with a 1:1 or sequential binding model (112) to directly estimate the dissociation constants of the
PU.1/DNA 1:1 and 2:1 complexes.
2.4.4

Pulsed field gradient diffusion-ordered NMR (DOSY)

NMR experiments were performed on Bruker Avance 500 and 600 MHz spectrometers,
equipped with a 5 mm TBI and QXI probe, respectively (Bruker). Purified PU.1ΔN167 (~250 µM)
and DNA (~600 µM high-affinity, low-affinity and non-specific duplexes) were extensively co-
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dialyzed against 10 mM NaH2PO4/Na2HPO4 (pH 7.4) containing 150 mM NaCl, lyophilized, and
re-dissolved to their previous volumes with 99.996% D2O. The pH* (meter reading) of the
reconstituted samples was 7.6. Protein was titrated with DNA to the indicated ratios in the text. In
the case of low-affinity and nonspecific DNA, turbidity was observed at ratios below DNA:protein
= 1:3 immediately after titration that resolved overnight at room temperature. A 1D pre-saturation
(zgpr) spectrum was measured for each titration prior to diffusion measurements. Diffusion
experiment parameters (Δ, δ and gradient strength) were first optimized by running 1D diffusion
experiments (stebpgp1sd) at 2 and 95% gradient strengths with 100 ms and 5 ms, Δ and δ diffusion
times, respectively for ~10% signal retention. Using these parameters, a pseudo-2D DOSY
experiment using stimulated echo with bipolar gradient pulses (stebpgp1s) was acquired with 16k
× 20 data points with a spoil gradient of 1.1 ms and 4.0 s relaxation delay from 2 to 95% gradient
strength with a linear ramp. Data was processed with Bruker Topspin T1/T2 software using manual
peak picking. Care was taken to avoid NMR peaks that potentially overlap with free DNA at 1:1
(protein:DNA) and excess DNA titrations. The intensity I of each picked peak was fitted to the
following equation as a function of field gradient strength g:

I ( g ) = I 0e− DQg

2

(E1)

where I0 is the reference (unattenuated) intensity, D the diffusion coefficient, and Q is a
constant consisting of fixed parameters specific to the experimental configuration.
2.4.5

2D 1H-15N HSQC NMR

Purified [15N] PU.1∆N167 (~0.5 mM) was extensively dialyzed together with various
duplex DNA constructs (~2 mM) in separate dialysis tubings against 11 mM
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NaH2PO4/Na2HPO4, pH 7.6, 167 mM NaCl, and 0.1% NaN3 and adjusted to 10% D2O. DNA
was titrated into protein to achieve the desired DNA/protein ratios. 1H-15N correlated
measurements were made using a phase-sensitive, double inept transfer with a GARP decoupling
sequence, and solvent suppression (hsqcf3gpph19). Spectra were acquired with 1024 × 144 data
points and zero-filled to 4096 × 4096.
2.4.6

ANS fluorescence

ANS (ammonium salt, Alfa Aesar) was prepared at 2 mM in 10 mM NaH2PO4/Na2HPO4
(pH 7.4) buffer containing 150 mM NaCl and stored in the dark at 4 °C. Triplicate samples of
PU.1 with or without 16-bp high-affinity DNA plus various controls were prepared in the same
buffer before the addition of ANS to 200 μM. Final concentrations of PU.1 and DNA were as
indicated under “Results.” After incubation for 30 min, the fluorescence intensity of each sample
was read at 370/530 nm or scanned from 400 to 750 nm with a Paradigm plate reader.
2.4.7

Hydroxyl radical DNA footprinting

A 130-bp DNA fragment harboring a copy of the high-affinity PU.1-binding site 5’AGCGGAAGTG-3’ was generated by PCR using two primers, of which the one encoding the
5’-CACTTCCGCT-3’ strand had been 5’-end–labeled with [32P]ATP. After purification by
agarose gel electrophoresis, the radiolabeled fragment (<1 nM) was incubated to equilibrium
with graded concentrations of PU.1∆N167. Each sample was digested with hydroxyl radical,
purified, resolved by denaturing polyacrylamide gel electrophoresis, and digitized by
phosphorimagery as described (114). Lane traces were constructed, and bands were indexed
using a C ± T chemical sequencing reaction. Peaks were fitted as a superposition of Gaussian
distributions, numerically integrated, and normalized to a band outside of the binding site to
quantify fractional protection relative to the unbound sample.
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2.4.8

Structure-based calculations

Self-diffusion constants for unbound and 1:1 DNA-bound PU.1∆N167 were computed
using the software HydroPRO (115). DNA-bound and unbound PU.1 structures were templated
from the co-crystal structure with DNA (PDB code 1PUE) (26), appended with additional
residues present in PU.1∆N167, and relaxed by all-atom molecular dynamics simulation for 200
ns following our established protocol (113). Computations were carried out using volumetric
values for D2O at 25 °C, namely a density of 1.107 g/ml, viscosity of 1.25 centipoises, and
partial specific volume of 0.70 ml/g.
Continuum electrostatics of PU.1 in the co-crystal structure were computed using APBS
(116). Calculations were performed for an aqueous solution containing 0.15 M NaCl at 25 °C
and rendered on the solvent-accessible surface from -1 to +1 kT/e.
2.4.9

ITC

Purified PU.1 or Ets-1 was dialyzed extensively together with 23-bp DNA harboring the
protein’s respective optimal target (5’-AGCGGAAGTG-3’ for PU.1; 5’-GCCGGAAGTG-3’ for
Ets-1) in separate compartments, against 50 mM NaH2PO4/Na2HPO4, pH 7.4, 150 mM total Na+,
0.1 mM EDTA, and 1 mM dithiothreitol. Titrations were performed by injecting DNA (initial
concentration ~500 μM) into protein (~50 μM) in a Nano ITC instrument (TA Instruments). Data
fitting to empirical 1:1 and cooperative models was performed as described (117) only to
demonstrate the models qualitatively, not for quantitative estimation of the binding affinities, due
to the very strong dissociation constant of the 1:1 complex (10-9 M). To compare the calorimetric
enthalpies for DNA binding by PU.1 with those for Ets-1, which exhibited strictly 1:1 behavior,
the calorimetric enthalpies for PU.1/DNA binding were decomposed as follows to extract the
enthalpy changes for the 1:1 complex. Whereas PU.1∆N167 dimerizes in both unligated and
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DNA-bound states, the former occurs at considerably higher concentrations (near 10-3 M)
(76,118) than those used in the “reverse” DNA-into-protein titrations shown in Fig. 2.1 (A and
B). Under these conditions, the biphasic profile arises from the 1:1 complex being strongly
favored and yielding a 2:1 complex only in excess protein at the initial phase (Rα) of the titration
as shown in Scheme 1, where P and D represent PU.1∆N167 and site-specific DNA in their
various free and bound states. The two phases Rα and Rβ are marked in the reverse titration
shown in Fig. 2.1B. Because the transition from the 1:1 to 2:1 PU.1/DNA complex occurs
sequentially, both phases are well-defined and extracted according to the technique of “total
association at partial saturation” (119).

To compare the enthalpy changes meaningfully with the manifestly 1:1 binding for Ets-1
in Fig. 2.1 (C–F), the complex heats in the reverse titrations are dissected to account for the
thermodynamics of coupled dimerization and dissociation of PU.1 as shown in Scheme 2. The
calorimetric enthalpy marked Fβ has been measured previously for PU.1∆N167 under the same
solutions (76). Based on ∆HRβ = -44.2 ± 1.4 kJ/mol (cf. Fig. 2.1B) and ∆HFβ = 17.1 ± 0.7 kJ/mol
(76) at 25 °C, the enthalpy change for the formation of the canonical 1:1 complex was -27.1 ±
1.6 kJ/mol. Thus, the enthalpy change for formation of the 1:1 complex from unbound
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constituents was larger in magnitude than that for minimal (∆H1:1 = -12.0 ± 0.4 kJ/mol) and
autoinhibited Ets-1 (∆H1:1 = -8.1 ± 0.4 kJ/mol) at 25 °C.
2.5

Results
A1:1 protein/DNA site stoichiometry is universally observed in co-crystal structures of

ETS family transcription factors, including PU.1 (27,30) (Fig. 2.1 A). Nevertheless, calorimetric
measurements of DNA binding by the PU.1 ETS domain (encoded by the C-terminal fragment,
PU.1∆N167) showed that PU.1 bound site-specific targets with non-1:1 stoichiometry (76).
When site-specific DNA was titrated into PU.1∆N167, the protein bound the DNA in a
negatively cooperative manner (Fig. 2.1, B and C). Dimerization was strictly noncovalent, as
PU.1∆N167 harbored no cysteine residue. To broaden our observations and determine whether
2:1 binding was a class property of ETS domains, we measured high-affinity site-specific
binding by the ETS domain of Ets-1 (encoded by the C-terminal fragment Ets-1∆N331), which
contained two free cysteines. Although PU.1∆N167 and Ets-1∆N331 represent sequencedivergent ETS members, their backbones are superimposable in their DNA-bound states (120).
At comparable concentrations as PU.1∆N167 (~40 μM) and under reducing but otherwise
identical conditions, Ets-1∆N331 bound site-specific DNA at strictly 1:1 stoichiometry (Fig. 2.1,
D and E). Moreover, the inclusion of flanking elements known to autoinhibit Ets-1 (Ets-1∆N280)
did not affect the binding stoichiometry (Fig. 2.1, F and G). Thus, dimerization at a single site
was not shared by Ets-1 but was particular to PU.1 and possibly other sequence-similar ETS
homologs.
Although the ITC titrations could be fitted empirically with model-dependent profiles, the
high concentrations (>10-5 M) required for the experiments precluded an accurate quantitative
determination of binding affinities due to the strong dissociation constant of the 1:1 complex (10-
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M). We therefore titrated a 20-bp Cy3-labeled duplex oligonucleotide harboring the same high-

affinity site as used in the ITC experiments and measured binding from changes in fluorescence
polarization of the DNA probe (Fig. 2.2 A). The binding data yielded a biphasic profile to which
a sequential binding model (111) was fitted with dissociation constants of 7.0 ± 1.3 nM and (1.2
± 0.8) × 103 nM, or a (negative) cooperativity parameter of ~170. Constraining the model to 1:1
binding significantly compromised the fit to the data (green curve in Fig. 2.2 A). To determine
whether a single helical turn of contact interface, as observed in the co-crystal PU.1/DNA
structure (26), was sufficient to support sequential binding of PU.1, we repeated the titration with
a DNA construct in which only the core 10 bp of the cognate site (5’-AGCGGAAGTG-3’) was
duplex. Binding to the 10-bp duplex exhibited monophasic binding that was well-described by a
1:1 model with a ~2-fold reduction in dissociation constant (12 ± 2 nM). To further determine
whether the excess binding to the 23-bp construct represented nonspecific interactions, we
measured PU.1∆N167 binding to an isomer of the 20-bp DNA in which the core 5’-GGAA-3’
consensus was mutated to 5’- GAGA-3’. In contrast with the specific site, binding to the
nonspecific site was >100-fold weaker (2.1 ± 0.2 μM) than either site-specific DNA and yielded
a Hill coefficient of well above unity, indicative of concerted binding of two or more equivalents
of PU.1∆N167 (Fig. 2.2 B). The titrations therefore showed that sequential dimerization of the
PU.1 ETS domain, wherein excess protein self-titrated the canonical 1:1 PU.1/DNA complex to
form a 2:1 complex, was exclusive to site-specific DNA longer than 10 bp. Although nonspecific
DNA bound PU.1 in multiple equivalents, it did not form a 1:1 complex at equilibrium (Fig. 2.2
B).
To evaluate site-specific PU.1 dimerization in the presence of excess nonspecific DNA,
as would be encountered under genomic conditions, we titrated a 209-bp fragment harboring a
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single high-affinity PU.1-binding site with PU.1∆N167. Resolution of the DNA by native gel
electrophoresis (Fig. 2.2 C) showed a PU.1-bound band that transitioned to a less mobile band at
~100-fold excess protein with respect to the specific site (1 nM), in agreement with the
sequential site-specific dimer observed in the fluorescence polarization titrations. The low
mobility and broadness of the dimer peak suggested that this complex was interconverting
between free and bound states at rates comparable with electrophoretic separation of the two
complexes (121). The dimeric peak occurred in advance of a final nonspecific complex that was
not detected in the gel. The latter state was verified with an isomeric nonspecific DNA fragment
that failed to yield PU.1∆N167 at any defined stoichiometry (Fig. 2.2 D). Thus, the
electrophoretic data showed that the sequential dimerization of PU.1 at a single embedded
cognate site effectively resisted competition from excess nonspecific DNA.
2.5.1

Hydrodynamic characterization of PU.1/DNA complexes by NMR spectroscopy

To characterize the solution behavior of the PU.1/DNA complex directly, we interrogated
PU.1∆N167 with site-specific and nonspecific DNA oligonucleotides hydrodynamically by
diffusion-ordered NMR spectroscopy (see “Materials and methods”). At 250 μM protein, we
measured a self-diffusion coefficient of (9.1 ± 0.1) × 10-11 m2/s for unbound PU.1∆N167 (13.0
kDa) in D2O at 25 °C. Comparison with a computed value (115) under equivalent conditions for
a PU.1∆N167 monomer derived from the co-crystal structure of the 1:1 PU.1 ETS/DNA
complex (see “Materials and methods”) found good agreement (8.8 × 10-11 m2/s). An unbound
PU.1 dimer modeled as a pair of rigid spheres would exhibit a diffusion coefficient at 75% of the
monomer (122), or ~7 × 10-11 m2/s. Thus, although unbound PU.1 was known to dimerize at very
high concentrations (76,118) in vitro, PU.1∆N167 was monomeric under the conditions of the
DOSY experiments.
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We tracked the self-diffusion coefficients of PU.1∆N167 at graded stoichiometric ratios
of DNA (Figs. S2.2 and S2.3; parametric values in Table 1). Titration with 16-bp high- or lowaffinity site-specific DNA lowered the apparent diffusion coefficient to a minimum of (5.9 ± 0.1)
× 10-11 m2/s at, within experimental uncertainty, a DNA/PU.1 ratio of 0.5 (i.e. PU.1/DNA 2:1).
The subsequent addition of site-specific DNA past this point increased the diffusion coefficient
to a stable value of (7.5 ± 0.2) × 10-11 m2/s at 1:1 equivalence and beyond (Fig. S2.3 A). This
biphasic behavior was consistent with the other titration data by ITC, fluorescence polarization,
and gel mobility shift. This change in DOSY intensity was not due to simple contributions from
added DNA because we had carefully avoided peaks that overlapped with DNA (Fig. S2.2). The
measured diffusion coefficient upon reaching molar equivalence also agreed with a computed
value (115) of 7.3 × 10-11 m2/s based on the 1:1 PU.1/DNA co-crystal structure. Finally, the
sequential transitions in diffusion coefficients at half and unit molar equivalence were
incompatible with a 2:2 complex. Thus, the DOSY titrations indicated that PU.1 formed
exclusively a 2:1 complex with site-specific DNA at PU.1/DNA up to 2:1, followed by a 1:1
complex at molar equivalence and above.
In contrast with site-specific DNA, nonspecific binding by PU.1∆N167 showed
qualitatively different behavior (Fig. S2.3 C). Specifically, titration of PU.1∆N167 with 16-bp
nonspecific DNA yielded only a single inflection point at a DNA/PU.1 ratio of 0.5 and a stable
diffusion coefficient of (6.6 ± 0.2) × 10-11 m2/s, between the site-specific 1:1 and 2:1 complexes.
Thus, the DOSY titration data pointed to the exclusive formation of a defined dimeric
nonspecific 16-bp complex. An alternative scenario in which PU.1∆N167 formed a mixture of
2:1 and 1:1 complexes was not likely, as the apparent diffusion coefficient would be
composition-dependent and change upon continued titration of DNA.
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As the fluorescence polarization titration showed that the 10 bp of site-specific DNA
bound PU.1∆N167 in a 1:1 complex but was insufficient to invoke sequential dimerization, we
repeated the DOSY titrations with a 10-bp duplexes. In stark contrast with their 16-bp parents,
all of the 10-bp complexes regardless of sequence gave indistinguishable hydrodynamic profiles
showing single inflections (Fig. S2.3, D–F). If the site-specific 10-bp 1:1 complexes maintained
the structure observed in the co-crystal structure, their computed (115) diffusion coefficient
would be 7.9 × 10-11 m2/s under the present experimental conditions. Thus, the measured
diffusion coefficients of the 10-bp complexes (~6.5 × 10-11 m2/s), which were significantly lower
even than their 16-bp 1:1 counterpart, were unexpected for a 10-bp 1:1 complex. We confirmed
the 1:1 stoichiometry of the 10-bp PU.1/DNA complexes by examining the 1H spectra of the 10bp high-affinity DNA in the imino region at graded PU.1∆N167 concentration. Resonances
corresponding to free DNA were exhausted by unit molar protein/ DNA ratio (Fig. S2.4). Thus,
PU.1 bound 10-bp DNA exclusively as monomers even at excess concentrations, and sequential
dimerization of PU.1 was limited to site-specific DNA longer than 10 bp. Moreover, the data
implied that the protein underwent significant conformational changes to hydrodynamically
larger structures than the same protein bound to 16-bp site-specific DNA.
2.5.2

Structural properties of the site-specific PU.1 ETS dimer

We recorded 1H-15N HSQC spectra of uniformly 15N-labeled PU.1∆N167, which showed
a structured protein with well-dispersed cross-peaks in the absence of DNA (Fig. 2.3A). Upon
the addition of 16-bp high-affinity DNA (Fig. 2.3, B–D) to a DNA/PU.1 ratio of 1:2, we
observed the immediate disappearance of ~80% of the NH resonances and a marked loss of
chemical shift dispersion, but no sign of precipitation even after prolonged incubation (~24 h).
The addition of a second half-equivalent of DNA to DNA/PU.1 1:1 promptly restored the NH
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resonances, with significant chemical shift perturbations compared with the free protein. The
further addition of excess DNA produced no further changes to the HSQC spectrum.
When we repeated the HSQC titration using the same high-affinity 10-bp construct as in
the DOSY experiments, we observed a progressive disappearance of resonances past the halfequivalence point and no further change past the 1:1 equivalence point (Fig. 2.3, E–H). The
monotonic transition for the 10-bp DNA tracked the changes in diffusion coefficient (Fig. 2.3,
E–H), in contrast with the sharply biphasic behavior of the 16-bp site.
To better understand the effect of binding site size on the bound protein’s conformation,
we probed DNA-bound PU.1∆N167 with 8-anilino-1-naphthalenesulfonate (ANS), an indicator
dye of solvent-exposed hydrophobic moieties. Unbound PU.1 at 50 μM induced strong blueshifted ANS fluorescence associated with a significant number of untitrated basic residues,
which paired with the anionic dye (123), in the absence of DNA (Fig. 2.4 A). DNA alone
induced a negligible effect on ANS fluorescence. After subtraction of a dye-only control, ANS
fluorescence of PU.1 was reduced about 3-fold upon binding a half-equivalent of the 16-bp sitespecific DNA (2:1 complex), and another 8-fold at unit equivalence (1:1 complex) (Fig. 2.4 B).
The higher sensitivity to ANS, together with the NMR DOSY data, suggest that the DNA-bound
PU.1 dimer may be less structured than in the 1:1 complex.
2.5.3

Topology of the site-specifically bound PU.1 dimer

The attenuation in NMR signal from the 2:1 complex suggests intermediate exchange
between these two states. As a result, although the disappearance of 80% of cross-peaks in the
DNA-bound PU.1 dimer (cf. Fig. 2.3 B) precluded a direct identification of the residues involved
in 2:1 complex formation, the remaining resonances still provided valuable clues to the location
of the dimerization interface. We overlaid the HSQC spectra for free and bound PU.1 to 16-bp
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DNA and identified resonances that showed strong overlap throughout the titration (Fig. 2.5, A–
E). Using a reported 1H-15NHSQCassignment of the PU.1 residues 167–260 (118), which applied
well to PU.1∆N167 (Fig. S2.5), we identified well-resolved, well-overlapped resonances for
Arg173, Ala210, Lys224, Gly238, Gly241, Lys247, and Ser255. Resolvable resonances that overlapped
only in the free and 1:1-bound states (i.e. no detectable signal in the 2:1 state), including Ser184,
Trp192, Trp193, Asp197, and Thr200, mapped to solvent-exposed surfaces away from the DNA (Fig.
2.5 F). Thus, the HSQC data implicated the distal surface of PU.1∆N167 opposite the DNAbinding site as a major part of the dimerization interface of the site-specific 2:1 complex.
To further understand how the distal surface of the PU.1 ETS domain was involved in
dimerization, we examined the amino acids that mapped to that surface and noticed a sequence
of four alternately charged residues, 195DKDK198, that comprise part of a β-pleated sheet. These
residues include (Asp197) or are proximal to residues (Trp192, Trp193, and Thr200) whose
resonances became reversibly undetectable in the 2:1 complex (Fig. 2.5, A and D). The
195

DKDK198 sequence gave rise to a charge distribution that suggested an electrostatically

complementary interface for dimerization (Fig. 2.5 G). This hypothesis was further motivated by
the low level of sequence conservation in Ets-1 (357TGDG360) and within the ETS family in
general (113). We therefore cloned a PU.1∆N167 mutant harboring 195NINI198, which abrogated
the charges but maintained similar side-chain structures and secondary structure propensities
(124). In fluorescence polarization and gel mobility shift experiments, the mutant gave titration
profiles that showed a single binding mode at up to 10 μM, a concentration at which DNA-bound
wild-type PU.1 had undergone two binding transitions (Fig. 2.5 H; cf. Fig. 2.2). The anisotropy
and electrophoretic mobility of the bound mutant corresponded to the 1:1 complex formed by
wild-type protein. Thus, the 195NINI198 mutant confirmed that the distal surface was involved in
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PU.1 dimerization. In addition, the mutant bound DNA ~10-fold more weakly (88 ± 11 nM) than
wild-type PU.1∆N167, suggesting coupling between DNA binding and dimerization of the
bound state.
2.5.4

The 2:1 site-specific PU.1/DNA complex occupies an expanded DNA-binding

site
To define the contact interface of the 2:1 PU.1/DNA complex, we carried out hydroxyl
radical (•OH) footprinting titration of a 130-bp radiolabeled DNA fragment harboring the same
high-affinity binding site used in the other experiments. Previous footprinting studies of the 1:1
site-specific PU.1/DNA complex by our group (76,114) and others (125,126) have established
that two spaced clusters of minor-groove contacts flanking the 5’-GGAA-3’ core consensus
generate a highly characteristic •OH footprint on the 5’-TTCC-3’ strand. We therefore used this
biochemical signature to track changes in the DNA-binding site at graded concentration of wildtype PU.1∆N167 (Fig. 2.6 A). Upon reaching PU.1∆N167 concentrations of ~10-7 M that
saturated 1:1 complex (marked P1 and P2 in Fig. 2.6 B), additional PU.1∆N167 gave rise to
protected positions near P2 (marked P*). In total, the footprint of the 2:1 complex spanned ~20
bp of DNA. Quantitation of the protection from •OH at the protected bases as a function of PU.1
concentration clearly recapitulated the sequential formation of the 1:1 followed by the 2:1
complex observed in the other experiments (Fig. 2.6 C). In addition, the hypersensitive positions
between P1 and P2, which is also diagnostic of site-specific 1:1 binding, was preserved in the 2:1
complex and tracked the titration profiles produced by fluorescence anisotropy (cf. Fig. 2.2 A).
Thus, the •OH footprints showed, at single-nucleotide resolution, that the site-specific
PU.1∆N167 dimer made extended contacts with the DNA minor groove although the
dimerization interface was distal from the DNA. The extended footprint exerted by the 2:1
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complex also explained the 10-bp specific site’s apparent incompatibility with PU.1
dimerization, which required several more flanking bases downstream of the 5’-GGAA-3’ core
consensus, although its affinity for the 1:1 complex was only modestly compromised relative to
longer DNA (cf. Fig. 2.2 A).
2.6

Discussion
When bound to sufficiently long site-specific DNA, the ETS domain of PU.1 self-

associates sequentially to a defined dimer, a behavior that is heretofore unknown for ETS
transcription factors (19). The reversibility of dimerization is demonstrated by its independence
on directionality. In gel mobility shift, fluorescence anisotropy, or DNA footprinting titrations in
which excess protein was titrated into site-specific DNA, the 2:1 complex was produced
subsequently to the canonical 1:1 complex. When the titration was reversed (DNA into protein),
as was the case in the NMR and ITC studies, limiting concentrations of DNA directly yielded the
2:1 complex. Impressively, the NMR titrations showed that even after prolonged co-incubation,
the further addition of site-specific DNA converted the 2:1 complex rapidly and quantitatively
into its 1:1 counterpart. Structurally, the identification of the solvent-exposed surface distal from
the DNA as the dimerization interface on the one hand, and the expansion of the DNA footprint
of the 2:1 complex on the other, suggested an allosteric coupling between the PU.1 dimers and
their bound DNA.
Although many DNA-binding domains are known to self-associate when they bind to
site-specific DNA (127), this behavior is associated with systems in which the protein protomers
bind multiple DNA subsites independently, such as the Trp repressor (128), or with positive
cooperativity, such as the p53 core domain (129). Ets-1 and several other non-PU.1 ETS
members can also bind as homodimers, but only to two tandem DNA sites (74,106-109). To our
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knowledge, negatively cooperative binding to a single DNA site, as the PU.1 ETS domain is able
to execute, has not been reported previously.
2.6.1

Flanking sequence length as a specificity determinant of PU.1/DNA binding

We tested a range of DNA lengths to define the site size requirements for PU.1
dimerization in the bound state and to probe the relevance of dimerization in the presence of
excess nonspecific DNA. We observed that the binding modes accessible to the ETS domain of
PU.1 depended on a threshold length of bases flanking the core 10-bp binding site. Within the
range of DNA lengths tested in the various experiments, 16-bp and longer DNA invoked
sequential dimerization of bound PU.1. In stark contrast, in the absence of flanking bases, the 10bp DNA bound PU.1∆N167 exclusively with 1:1 stoichiometry (Figs. 2.2 B and 2.3). Thus, 10
bp of site-specific DNA was insufficient to elicit the full site-specific behavior of the PU.1 ETS
domain. Available evidence indicates that flanking sequence identity is not a determinant
because we had observed two other site-specific DNA sequences yielding the same ITC profiles
for PU.1∆N167 (76).
The 10-bp complex represented a distinct binding mode as the bound PU.1 monomer was
structurally different from its 16-bp counterpart as judged by their HSQC spectra (Fig. 2.3). This
observation was unexpected, given the single turn of contacted double helical DNA in the cocrystal structure of the high-affinity PU.1/DNA complex (26) and ETS/DNA structures more
generally. Of relevance is the report that DNA with staggered ends was absolutely required for
diffraction-quality crystals of the PU.1/DNA complex (130). The overhangs, which paired endto-end between asymmetric units, would result in essentially continuous DNA in the crystal.
Additional interactions with flanking bases that are not part of the core sequence therefore
stabilize the bound protein, and without this stabilization, dimerization becomes prohibitive. In
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summary, flanking sequence length represents an essential additional determinant to fully specify
cognate binding by PU.1 in solution.
2.6.2

Functional relevance of self-titration as a potential negative feedback

mechanism for PU.1 transactivation
PU.1 is a highly inducible protein, ranging from <10 to >200 copies of mRNA per cell in
murine bone marrow progenitors, depending on the stage of hematopoietic development (131).
Under physiologic induction, PU.1 mRNA levels matching and even exceeding that of
glyceraldehyde 3-phosphate dehydrogenase, an abundant glycolytic housekeeping enzyme, have
been measured in cultured (132) and primary (133) human cells. This inducible expression
profile suggests that interactions spanning a large range in affinity are likely to be biologically
relevant. For instance, NMR characterization of the functionally essential PU.1/GATA-1
interaction estimated its dissociation constant to be no stronger than 10-4 M in vitro (134) and did
not appear to involve (as judged by chemical shift changes) the dimerization interface of PU.1.
Many ETS family transcription factors, such as Ets-1, ERG, and members of the ETV
subfamily, are regulated at the protein/ DNA level by inhibitory helices that pack against their
DNA-binding domain in the unbound state (Fig. 2.1 A). Perturbing these helices imposes an
energetic penalty on DNA-binding that maintains, by default, an autoinhibited state. Binding
partners that disrupt the autoinhibitory interactions thus induce a transcriptionally permissive
state (30). ETS paralogs, such as PU.1, that lack this mechanism would therefore be locked in a
permissive state in the absence of some mechanism for negative regulation. Whereas
functionally antagonistic binding partners, such as GATA-1, would serve such an inhibitory role,
their expression profiles only partially overlap with that of PU.1 (the common myeloid
progenitor in the case of GATA-1, 135). An intrinsic negative feedback mechanism is hitherto
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unknown in PU.1. Our observation that PU.1 forms a reversible, negatively cooperative 2:1
complex with site-specific DNA suggests “self-titration” as a potential mechanism of negative
feedback: even if the 2:1 complex retains the functional activity of the 1:1 complex, removal of
circulating PU.1 alone would attenuate transactivation of target genes. Consistent with this
notion, we observed self-titration only with site-specific DNA and not nonspecific DNA.
Moreover, we did not observe dimer formation with the structural homolog Ets-1, with or
without its autoinhibition helices, when its cysteines were maintained in a reduced state (Fig. 2.1,
D–G). Interestingly, a 2:1 Ets-1/DNA complex was reported under non-reducing conditions (71),
reflecting the strong propensity for its two cysteine residues (which are not present in the PU.1
ETS domain) to form nonnative disulfide linkages.
The dissociation constant for binding to oligomeric nonspecific sites (~10-6 M) (114),
such as that used in our NMR experiments, is only ~10-fold higher than the sequential affinity of
the second equivalent of PU.1∆N167. It might therefore appear that the abundance of
nonspecific DNA relative to specific sites would overwhelm self-titration of specific complexes.
Our gel mobility data on binding to polymeric DNA (cf. Fig. 2.2 C) provide a useful insight into
this question. Compared with titration of oligomeric site-specific DNA, formation of the 2:1
complex at an embedded binding site flanked by substantial nonspecific DNA (~100 bp on each
side) occurred at ~10-fold lower concentration (~10-7 M) and clearly preceded any nonspecific
binding. The footprinting data showed the same behavior at a shorter (~130-bp) DNA fragment.
This difference reflected the favorable contribution to reaching an embedded site from linear
diffusion that was absent for an isolated counterpart. Thus, a complete description of the effect of
excess nonspecific flanking DNA (as would be expected under genomic conditions) includes a
competitive effect that is more than offset by favorable contributions from linear diffusion.
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2.6.3

Nonspecifically bound PU.1 is oligomeric

The 16-bp nonspecific site, involving only the isomeric reversal of two adjacent positions
in the core consensus (5’- GGAA-3’ to 5’-GAGA-3’), forced the exclusive formation of a
dimeric complex. No 1:1 complex was detectable at equilibrium. In the context of self-titration
as a potential negative regulatory mechanism, this behavior suggests that the role of site-specific
DNA (i.e. sequences harboring the core consensus) is not only to provide a much higher-affinity
binding site for PU.1 but, perhaps more importantly, to “unlock” the transcriptionally active 1:1
conformation. It may therefore be more appropriate to consider dimeric PU.1, as the default
autoinhibited state, which becomes activated, by a coupled dissociation/order transition, upon
encountering a specific DNA site at permissively low protein concentrations.
2.7

Conclusion
We report, for the first time, a 2:1 complex formed by PU.1 with a single cognate binding

site. This complex forms negatively cooperatively with respect to the canonical, transcriptionally
active 1:1 complex and resists competition from nonspecific DNA. It is kinetically stable (on the
order of many hours) and interconverts efficiently with the 1:1 complex (within minutes) upon
the addition of DNA. These biophysical properties of self-titration of PU.1 at site-specific DNA
are biologically compatible and, indeed, physiologically appropriate given the significant
accumulation of PU.1 under induction (>10-6 M), when negative feedback would be most
required to dampen its transcriptional response. Self-titration therefore represents a potential
buffering mechanism for self-regulation in ETS paralogs, such as PU.1, that lack autoinhibitory
elements in their structures.
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Table 2.1 Apparent translational self-diffusion coefficients of PU.1/DNA complexes.
Diffusion coefficients (×10-11 m2 s-1), as plotted in Figure 2.3 in the main text, of PU.1ΔN167 alone
and in complex with 16-bp and 10-bp high-affinity (5’-GCAAGCGGAAGTGAGC-3’), lowaffinity
(5’-GCAAAAGGAATGGAGC-3’),
and
nonspecific
DNA
(5’GCAAGCGAGAGTGAGC-3’). The 10-bp DNA sites consist only of the underlined core
sequences.
DNA to

16-bp

PU.1
molar

highaffinity

ratio

16-bp
low-

16-bp

10-bp

nonspecific

highaffinity

affinity

0

9.11±0.17

9.00±0.15

9.40±0.13

1

8.15±0.25

7.80±0.25

7.73±0.15

1

1

1

2

3

5

6

3

7.27±0.15

6.68±0.11

6.50±0.21

2

6.21±0.18

5.84±0.16

6.60±0.22

3

5.90±0.11

5.92±0.11

6.70±0.22

1

11

6

11

11

13

2

6.56±0.13

6.59±0.14

7.00±0.14

7.38±0.12

6.70±0.10

7.72±0.27

2

7.75±0.06

7.53±0.23

8.90±0.59

8.03±0.45

7.11±0.13

7.54±0.32

7.08±0.23

6.80±0.14

6.69±0.19

6.49±0.25
6.27±0.10

6.68±0.18

6.88±0.18

6.64±0.14

6.43±0.19

7.02±0.10

6.30±0.14

6.62±0.16

7.00±0.18

6.51±0.17

7.79±0.08

6.81±0.10

4

7.56±0.10

9.29±0.24

6.46±0.27

4

3

11

6.53±0.14

nonspecific

affinity

7.68±0.08

6.72±0.06

4

low-

10-bp

8.26±0.33

8.30±0.24

4

6

9.08±0.17

10-bp

7.84±0.15

6.59±0.28
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Figure 2.1 Dimerization at a single cognate binding site is intrinsic to the ETS domain of
PU.1, but not its structural homolog Ets-1.
A, the co-crystal structures of PU.1 (gold; PDB code 1PUE) and Ets-1 (green), the latter with
(1MDM) or without (1K79) part of its autoinhibitory domain (blue). All three structures show
the canonical 1:1 binding stoichiometry with oligomeric DNA harboring a core 5’-GGAX-3’
consensus (red), as labeled. Note that the cognate DNA sequences in the co-crystal structures are
not sequence-identical to the experimental sequences in this study. B, D, and F, representative
ITC thermograms at 25 °C of DNA-into-protein titrations for the ETS domains of PU.1 (B) and
Ets-1 (minimal ∆N331 (D); autoinhibited ∆N280 (F)). The ordinate is baseline-subtracted and
normalized to the amount of DNA delivered per injection to aid comparison; exothermic
response is upward. C, E, and G, the titration data for PU.1∆N167 was empirically fitted as a
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negatively cooperative interaction. The two phases in the PU.1 titration (marked Rα and Rβ in C)
represent the successive formation of a protein/DNA 2:1 complex (protein in excess) followed
by the 1:1 complex. For Ets-1∆N331 (E) and Ets- 1∆N280 (G), a 1:1 model was empirically
fitted to the data. The stronger and more complex apparent heats associated with the PU.1∆N167
titrations included the dimerization and binding of PU.1∆N167 as a 2:1 complex, which
dissociates to two 1:1 complexes as DNA reached molar equivalence, in addition to more
enthalpically driven 1:1 binding than Ets-1. The details of the thermodynamic deconvolution are
provided under “Materials and methods.”
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Figure 2.2 Sequence and site size requirements for sequential dimerization of the specific
DNA-bound ETS domain of PU.1.

Fluorescence polarization titration of Cy3-labeled 20-bp (open symbols) and 10-bp (gray) DNA
probes (0.5 nM) harboring the high-affinity site 5’-AGCGGAAGTG-3’ (A) and its isomeric
nonspecific variant 5’-AGCGAGAGTG-3’ (B) with PU.1ΔN167. Curves represent a least-square
fit of the data from triplicate experiments to a sequential 2:1 binding model (red) or a constrained
to a 1:1 model (green). The latter afforded a poor fit of the data (p < 1 × 10-4, Fisher’s F-test on
sums of squares). The nonspecific data was fitted with the Hill equation (black). C, Native
electrophoretic mobility shift titration of a 209-bp DNA fragment (1 nM, marked “0”) harboring
the same high-affinity site with PU.1ΔN167. Following formation of the 1:1 complex (marked
“1”), a discrete, low-mobility species was present at 0.1 µM protein (marked “2”). At 1 µM protein
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(103-fold excess), a nonspecific complex finally forms, which did not enter the gel, as confirmed
with a fragment harboring the nonspecific sequence (D). The shadows lining the wells in Panel C
represent an irregular imaging artefact of the stained gel, not protein-DNA complex, as it was
observed even in the negative-control lane containing no PU.1 (marked “N”).
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Figure 2.3 1H-15N HSQC NMR spectroscopy of PU.1/DNA complexes.
Uniformly 15N-labeled PU.1ΔN167 was titrated with a 16- (A to D) or 10-bp (E to H) unlabeled
high-affinity DNA at the indicated molar ratios. Each series of spectra was acquired with the same
sample and intensity adjusted to the same noise level.
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Figure 2.4 Biochemical characterization of PU.1/DNA complex conformation.
A, fluorescence spectra of 50 µM PU.1ΔN167 alone or with 0.5, 1.0, or 2.0 molar eq of 16-bp sitespecific DNA after mixing with 200 µM ANS. Samples were excited at 375 nm. B, fluorescence
intensity at 530 nm of PU.1ΔN167 with or without 16-bp DNA after subtraction of an ANS-only
control, shown as average ± S.D. (error bars) of triplicate experiments.
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Figure 2.5 Mapping the dimerization interface of the site-specific 2:1 complex.
A, Overlay of 1H-15N HSQC spectra in the absence (green) or presence of 16-bp site-specific DNA
at 0.5 (red) and 1.0 (blue) molar ratios. Peaks labeled in orange that showed strong overlap among
all three states (blue/red/green) were taken to represent residues not involved in site-specific
dimerization. Peaks labeled in purple that overlapped only in the unbound and 1:1-bound states
(blue/green) were taken to represent residues involved in dimerization. Assigned resonances were
as reported for residues 167 to 260 by Jia et al. (118). Boxes indicate regions that are magnified in
Panels B to E. F, Mapping of the (purple) residues implicated in PU.1 dimerization to the 1:1 cocrystal structure (PDB: 1PUE). G, continuum electrostatic surface potential of PU.1 in the cocrystal structure. The residues 195DKDK198 are shown as spheres. H, DNA-binding profiles of a
195
NINI198 mutant of PU.1∆N167 by fluorescence polarization (20 bp) and gel mobility shift (209
bp) under the same experimental conditions as in Fig. 2.2. Symbols represent replicate
experiments; the curve represents a 1:1 fit to the data. Error bars, S.E.

60

Figure 2.6 Dynamics Expansion of the DNA contact interface in the 2:1 PU.1/DNA
complex.
A singly end-radiolabeled DNA fragment was titrated at equilibrium with PU.1ΔN167 and
digested with •OH under single-hit conditions. A C+T reaction was included to index the
digested DNA following denaturing electrophoresis. A, Image of the sequencing gel. N and U
denote DNA digested without protein and undigested DNA, respectively. A second footprint was
observed at a cryptic binding site (5’-ATGGGAATTC-3’) encoded by pUC19 vector further
downstream from the cloned high-affinity site. The lower affinity of this site (136) meant that it
did not generate the sequential 2:1 complex beyond the 1:1 footprint at the maximum PU.1
concentration used. B, Traces of the indicated lanes. Brackets and red dots denote protected and
hyper-sensitive positions at the indicated and higher protein concentrations, respectively, relative
to a distal control peak marked with a hollow dot (○). C, Titration of the summed integrated
intensities of the protected bases marked P1 and P2 (□) associated with the 1:1 complex, and P*
(■) produced by the 2:1 complex in Panel B, normalized to the control peak intensity and scaled
to [0,1]. Curves represent empirical fits to the Hill equation. D, Titration of the summed
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integrated intensities of the hyper-sensitive peaks (●), scaled to [0,1] but normalized to the
intensity at the highest PU.1ΔN167 concentration tested. The curve represents a fit by a
sequential 2:1 binding model.

62

2.8

Supplemental information

A
12846

intensity [a.u.]

5000
4000
3000
2000
1000

6423

0
5000

10000

15000

20000

m/z

B
2500
13016

intensity [a.u.]

2000
1500
1000
500
6508
0
5000

10000

15000

20000

m/z

Figure S 2.1 MALDI-ToF spectra of unlabeled and 15N-labeled PU.1ΔN167.
The expected MW for the unlabeled (A) and 15N-labeled (B) constructs were 12,847 and 13,018
(assuming 99% enrichment), respectively. Both the +1 and +2 ions were detected.
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Figure S 2.2 Diffusion ordered NMR (DOSY) spectra of PU.1 ETS domain, target DNA,
and their complexes.
Self-diffusion of unlabeled PU.1ΔN167, 16-bp high-affinity DNA, and mixtures of the two at 1:1
and 2:1 molar ratios was determined in solution using pulsed field gradients. Protein
concentrations were 250 µM (C), 204 µM (E), and 173 µM (G), and the DNA concentrations were
562 µM (A), 102 µM (E), and 173 µM (G). At each gradient strength, the labeled peaks were
individually fitted to Eq. (E1) to estimate the diffusion coefficient and then averaged. Fitted curves
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of intensity decay for representative peaks at the indicated chemical shifts are shown in Panels B,
D, F, and H.
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Figure S 2.3 DOSY titrations reveal site requirements for dimerization of DNA-bound
PU.1 in solution.
Translational self-diffusion coefficients of PU.1ΔN167 alone and bound to a 16-bp high-affinity
(A, 5’-GCAAGCGGAAGTGAGC-3’), low-affinity (B, 5’-GCAAAAGGAATGGAGC-3’), or
nonspecific DNA sequence (C, 5’-GCAAGCGAGAGTGAGC-3’). Measurements were repeated
using 10-bp duplex sites harboring only the underlined sequences under the same solution
conditions (D to F). Lines represent linear fits of the data in the indicated ranges. The diffusion
coefficients of the 16- and 10-bp DNA alone were (10 ± 1) and (14 ± 1) × 10-11 m2 s-1, respectively.
Error bars, S.D.
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Figure S 2.4 NMR spectroscopic changes to 10-bp site-specific DNA upon titration by
the ETS domain of PU.1.
Chemical shift perturbations of imino 1H resonances were monitored upon titration with 250 µM
PU.1ΔN167 at the indicated molar ratios at 20°C using 1-1 Jump and Return pulse sequence (600
MHz) (137). Each spectrum was referenced and normalized in intensity to DSS. Since the DOSY
titration showed a single transition, resonances from unbound DNA would be expected to be
persist up to the stoichiometric ratio of the complex. For the 10-bp high-affinity DNA, the
observable imino 1H peaks in the unbound 10-bp high-affinity DNA were fully exhausted by unit
molar equivalence.
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Figure S 2.5 1H-15N HSQC spectra of unbound murine PU.1(167-260) and PU.1ΔN167.
A truncated PU.1 ETS construct without the final 12 residues in the PU.1ΔN167 used in the
experiments described in the main text was cloned and over-expressed as a uniformly 15N-labeled
protein in E. coli similarly as PU.1ΔN167, and purified on Sepharose SP. The 1H-15N HSQC of
PU.1(167-260) (A) closely matched a previously reported spectrum of Jia et al. (118) which in turn
allowed assignment of many resonances in PU.1ΔN167 (B).
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3

CHARACTERIZATION OF INTRINSICALLY DISORDERED REGIONS ON
INTERNAL DYNAMICS OF THE ETS DOMAIN OF PU.1

3.1

Preface
The objective of the study in this chapter is to characterize the effects of intrinsically

disordered regions (IDRs; N-terminal PEST domain and C-terminal 12 residues) flanking the
ETS domain on backbone dynamics of PU.1 using NMR. I prepared the protein and DNA
samples in this study. I conducted all the NMR experiments with Dr. Markus Germann, except
for the hydrogen-deuterium exchange (HDX) experiment. The HDX experiment was in
collaboration with Dr. Marina Evich. Our collaborator, Dr. James Aramini at the City University
of New York Advanced Science Research Center (CUNY ASRC), assigned the residues of
hPU.1 ETS domain (residues 165-258) in the 1:1 complex with 16-bp site-specific DNA. This
work was supported by NSF grant MCB 15451600 and NIH grant R21 HL129063.
3.2

Abstract
The presence of the IDRs flanking the ETS domain does not change the DNA binding

modes of the PU.1 ETS domain (cf. Chapter 2), yet the N-terminal IDR (PEST domain) modifies
DNA recognition by the ETS domain through changing DNA binding affinities. We used 3D
NMR (HNCO, HN(CA)CO, HNCA, HNCACB, and HN(CO)CACB) to analyze the 1H-15N
HSQC spectra of hPU.1 constructs with and without IDRs, and also in the absence and presence
(1:1 complex) of DNA. Thus, we successfully assigned ~90% or more backbone amide
resonances of hPU.1. Using the fully assigned HSQC spectra, we studied fast (ps to ns) time
scale internal dynamics of PU.1 protein. Whole sets of 15N R1 and R2 relaxation rates and
heteronuclear 1H{15N}-NOE were acquired for all the hPU.1 constructs with and without DNA.
We found the PEST domain upon specific DNA binding becomes more dynamic in a disordered
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structure. In terms of DNA recognition, the presence of the PEST domain increases the affinity
of 1:1 complex of the ETS domain with cognate DNA, without perturbing the structure or
changing the fast time scale backbone motions of the ETS domain.
3.3

Introduction
In Chapter 2, we found the ETS domain of PU.1 dimerizes at a single cognate site of

DNA in a negatively cooperative manner via the ETS domain, while some ETS family members,
including Ets-1, are unable to form a 2:1 complex in physiological conditions (99). This is the
first direct demonstration of a 2:1 complex formation with site-specific DNA by an ETS family
member to sequester excess protein of its own. Since PU.1 is one of a few members that lack
autoinhibition, we proposed that this is a self-regulating and negative feedback mechanism of
PU.1 protein instead of autoinhibition. We also detected the dimerization interface of PU.1 in the
2:1 PU.1/DNA complex: the site distal to the DNA-binding interface, including the loop between
S1 and S2 where four consecutive charged residues 193DKDK196 reside (99).
Following what we discovered in Chapter 2, we planned to investigate the conformations
and interactions that the PU.1 dimer displays upon binding with site-specific DNA. However, as
we observed in Chapter 2, ~80% of the 1H-15N HSQC resonances disappear in 2:1 PU.1/DNA
complex (Fig. 2.3, B), which unfortunately prevented us from direct observation of the DNAbound PU.1 dimer. On the other hand, both unbound PU.1 and 1:1 PU.1/DNA complex (Fig. 2.3,
A and C) show well-dispersed HSQC peaks. Thus, we have decided to study internal dynamics
of unbound and 1:1 DNA-bound PU.1 at atomic resolution by NMR, instead of directly
examining the 2:1 PU.1/DNA complex.
Moreover, the study in this chapter follows our recent studies of the roles of IDRs on
DNA-free PU.1 homodimerization, which was previously observed in vivo by Evans et al. (68)
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(138). The PU.1 dimers in the absence and presence of DNA antagonize to each other, and IDRs
flanking the ETS domain play key roles for this phenomenon (138). We also found that DNA
recognition by the ETS domain of PU.1 is modified by the presence of IDR. The N-terminal
PEST domain is intrinsically disordered, and this nature is important because it facilitates the 1:1
DNA complex formation. However, the affinity of the 2:1 PU.1/DNA complex is reduced by the
disordered PEST (138). The DNA recognition of the ETS domain is not affected by the absence
of C-terminal IDR. By contrast, PU.1 is unable to form a DNA-free dimer without C-terminal
IDR (138).
Thus, to study how the PEST domain modifies DNA recognition of PU.1, we tested
whether or not the PEST domain changes the internal dynamics of the ETS domain using NMR,
in this chapter. We, therefore, prepared three constructs of hPU.1 protein that consist of only the
ETS domain (sΔN165), ETS domain and C-terminal IDR (ΔN165), and ETS domain and both
N- and C-terminal IDRs (ΔN117), respectively (Fig. 3.2 A). As a first step, we worked on
backbone assignment of PU.1 proteins consisting of the ETS domain and/or flanking IDRs (Nterminal PEST domain and C-terminal 12 residues) in the absence and presence of cognate DNA
because these backbone assignments give us opportunities to further investigate the
hydrodynamic properties of hPU.1 protein at the residue-by-residue level.
3.4

Materials and methods
3.4.1

Protein and DNA sample preparation

Molecular cloning. DNA fragments of hPU.1ΔN165 (human residues 165–270) and
ΔN117 (human residues 117–270) were purchased from Integrated DNA Technologies
(Midland, IA), and subcloned directly into the NcoI/HindIII sites of pET28b vector. The
hPU.1sΔN165 (human residues 165–258) construct that lacks both N- and C-terminal IDRs
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flanking the ETS domain was subcloned directly into the NcoI/NdeI sites of pET15b. All
constructs were verified by Macrogen (Rockville, MD) using Sanger sequencing.
Protein expression and purification. Three human PU.1 constructs were used in this
study: sΔN165 (ETS domain only), ΔN165 (ETS domain and C-terminal 12 residues), and
ΔN117 (N-terminal PEST domain, ETS domain, and C-terminal 12 residues). Uniformly 15Nlabeled or 15N/13C-labeled hPU.1 proteins were overexpressed in BL21(DE3) (for sΔN165 and
ΔN165) or BL21(DE3) pLysS (for ΔN117) E. coli as previously described (99). In brief, the cell
pellet of starter culture in 50 mL LB was harvested, washed, and resuspended in 1 L M9 minimal
medium containing 15NH4Cl, MgSO4, CaCl2, trace metals, MEM vitamins, and unlabeled or 13Clabeled glucose as required for 15N (or 15N/13C) labeling. Protein expression was induced with
0.5 mM IPTG for 4 h at 30 °C (for sΔN165 and ΔN165) or 25 °C (for ΔN117). Bacterial pellets
were resuspended in 10 mM sodium phosphate (pH 7.4), 500 mM NaCl and 0.1 mM
phenylmethanesulfonyl fluoride, and shear-homogenized (Sonic Dismembrator FB-505, Fisher
Scientific). The lysate was cleared by centrifugation and directly loaded onto a cation exchange
column (HiTrapTM SP HP, GE Healthcare) under the control of a Bio-Rad NGS Quest 10
instrument. After washing out residual impurities, the protein was eluted by a NaCl gradient 0.52 M. Purified proteins were extensively dialyzed against 10 mM sodium phosphate buffer (pH
7.0) containing 50 mM (for sΔN165) or 150 mM (for ΔN165 and ΔN117) total [Na+], 0.5 mM
EDTA, and 0.01% NaN3. Each hPU.1 protein concentration was determined by UV absorption at
280 nm using the extinction coefficients ϵ280 = 22,460 M−1 cm−1 (for sΔN165 and ΔN165) and
23,593 M-1 cm-1 (for ΔN117).
Nucleic acids. Synthetic DNA oligos were purchased from Integrated DNA Technologies
and annealed as described (99). For NMR experiments using PU.1/DNA complex, 16-bp high
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affinity DNA (5’-GCAAGCGGAAGTGAGC- 3’) was co-dialyzed with hPU.1sΔN165 or
ΔN165 against 10 mM sodium phosphate buffer (pH 7.0) containing 50 mM (for sΔN165) or
150 mM (for ΔN165 and ΔN117) total [Na+], 0.5 mM EDTA, and 0.01% NaN3. The 23-bp high
affinity DNA (5’-GCGAATAAGCGGAAGTGAAACCG- 3’) was co-dialyzed with
hPU.1ΔN117 against 10 mM sodium phosphate buffer (pH 7.0) containing 150 mM total [Na+],
0.5 mM EDTA, and 0.01% NaN3.
3.4.2

NMR Spectroscopy

Sequential backbone assignment of hPU.1sΔN165, ΔN165, and ΔN117 constructs in the
absence of DNA. 1H-15N correlated 2D HSQC measurements were made as previously described
(99). NMR experiments for PU.1 backbone NH groups assignment were done using 976 μM
(hPU.1 sΔN165), 682 μM (ΔN165), and 563 μM (ΔN117) protein samples in the absence of
DNA, and 600 μM (ΔN165 and ΔN117) in 1:1 complex with cognate DNA. All NMR
experiments were performed with a Bruker Avance 600 MHz spectrometer, equipped with a 5
mm QXI probe, at 25 °C (298 K). Signals from backbone 1H, 13C, and 15N nuclei were assigned
from five 3D heteronuclear experiments HNCO, HN(CA)CO, HNCA, HNCACB, and
HN(CO)CACB (139). Obtained NMR spectra were processed using a Bruker TopSpin 3.2 or 3.5
pl7, and the data analysis was achieved with NMRFAM-Sparky software (140).
Nuclear spin relaxation measurements. Whole sets of 15N T1, T2, and heteronuclear
1

H{15N}-NOE data were acquired using Bruker Avance 600 MHz spectrometer, equipped with a

5 mm HCN triple resonance probe, at 25 °C (298 K) (139). The hPU.1 protein concentrations
were 870 μM (unbound sΔN165), 690 μM (sΔN165 in 1:1 complex with DNA), 600 μM (both
unbound and 1:1 DNA-bound ΔN165, and 1:1 DNA-bound ΔN117), and 563 μM (unbound
ΔN117). A total of 8 data sets were collected to measure T1 with delay values of: 0.005, 0.05,
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0.125, 0.225, 0.350 0.500, 0.750, and 1.000 seconds for all constructs with and without DNA. A
total of 7 data sets were collected to measure T2 with delay values of: 0.01, 0.02, 0.04, 0.07, 0.09,
0.13, and 0.18 seconds (for sΔN165 with and without DNA), 0.01, 0.025, 0.05, 0.08, 0.1, 0.15,
and 0.2 seconds (for unbound ΔN165 and ΔN117), 0.005, 0.01, 0.0175, 0.025, 0.03, 0.04, 0.05,
0.06, 0.08, 0.1, 0.15, and 0.2 seconds (for 1:1 DNA-bound ΔN165), or 0.005, 0.01, 0.015, 0.02,
0.025, 0.03, 0.04, 0.06, 0.08, 0.14, and 0.2 seconds (for 1:1 DNA-bound ΔN117). Data were
processed with TopSpin 3.2, 3.5 pl7, or 3.6.1 (Bruker) to extract peak intensities and then fit as
single exponential decay with Origin 9.1 (OriginLab). Steady-state heteronuclear 1H{15N}-NOE
was acquired from the difference between spectra acquired with and without 1H saturation and a
total recycle delay of 3s. Heteronuclear 1H{15N}-NOE error was derived by
𝑛𝑜𝑖𝑠𝑒 𝑆𝑎𝑡

|𝑁𝑂𝐸|√{(

𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑆𝑎𝑡

3.5

)2 + (

𝑛𝑜𝑖𝑠𝑒 𝑈𝑛𝑠𝑎𝑡

𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑈𝑛𝑠𝑎𝑡

)2} using backgoround noise level of the spectra.

Results
3.5.1

The presence of the PEST domain does not change DNA binding modes of

PU.1
Our group recently found that the presence of the disordered PEST domain increases the
affinity of 1:1 complex of the structured ETS domain with cognate DNA, while it reduces that of
2:1 complex in physiological conditions (138). Based on this finding, we further studied the roles
of the N-terminal PEST domain on DNA recognition of the ETS domain using NMR.
Translational diffusion constants obtained by DOSY NMR revealed that PU.1 retains its ability
to have multiple DNA binding modes with 23-bp site-specific DNA in the presence of the Nterminal intrinsically disordered PEST domain flanking the ETS domain (hPU.1ΔN117 protein)
(Fig. 3.1 A(a)). The finding is similar to the PU.1 behavior in the absence of the PEST domain
with 16-bp specific DNA (i.e., forming both 2:1 and 1:1 PU.1/DNA complex in direct response
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to the PU.1/DNA molar ratios) (cf. Fig. S 2.3). In contrast, hPU.1ΔN117 titration with 23-bp
specific DNA showed a clear difference from that with 16-bp DNA in binding manners (Fig. 3.1
A(b)). ΔN117 forms a 2:1 PU.1/DNA complex with 16-bp specific DNA in response to the
PU.1/DNA ratio, but 1:1 PU.1/DNA complex formation does not reflect the molar ratio.
Interestingly, the binding behavior of hPU.1ΔN117 to 16-bp DNA is also different from what we
observed for PU.1 ETS domain (mPU.1ΔN167) to 10-bp specific DNA, as described in Chapter
2 (cf. Fig. S 2.3). ΔN117 forms a 2:1 PU.1/DNA complex with 16-bp DNA, but ΔN167 does not
with 10-bp DNA. In Chapter 2, we demonstrated that the DNA contact interface in the 2:1
PU.1/DNA complex is longer than that in the 1:1 complex (cf. Fig. 2.6). The 16-bp DNA is
probably long enough for the PU.1 ETS domain to function fully. Based on the DNA binding
manners of ΔN117 to 23- and 16-bp specific DNA, we can suggest that short (namely, 16 bp or
less) DNA has a negative impact on DNA binding of PU.1 ETS domain in the presence of the
flanking PEST domain.
To monitor the protein “fingerprint” of both the PEST and ETS regions, we tested HSQC
titrations in the same manner as described in Chapter 2. We acquired HSQC spectra of
hPU.1ΔN117 in a titration with 23-bp specific DNA, at PU.1/DNA molar ratios of 0, 0.5, 1, and
2 (Fig. 3.1 B). The ETS crosspeaks that are well-overlapped with our previous HSQC spectrum
of mPU.1ΔN167 (cf. Fig. 2.3) exhibited almost the same trend at each molar ratio. The HSQC
crosspeaks that are not overlapped with the crosspeaks of the ETS residues are most probably the
PEST peaks. Such crosspeaks were clustered at ~8.2 ppm on the proton dimension, and these
HSQC resonances showed little shifts upon specific DNA binding.
Based on the results of the DOSY NMR described above, we further studied the impact
of the DNA length on specific DNA binding of PU.1 ETS domain in the presence of flanking
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PEST domain. We overlaid the HSQC spectrum of hPU.1ΔN117 in 1:1 complex with 16-bp
specific DNA onto that with 23-bp specific DNA. Most of the crosspeaks overlapped well, but
several peaks were found to be shifted. Notably, the peaks of K245-247 showed no overlap
between these spectra (Fig. 3.1 C (a)). These three consecutive Lys residues are located at the
center of the “wing” of PU.1 (Fig. 3.1 C (b)). The “wing” binds upstream of the core GGAA
sequence of DNA. Thus, if the DNA is so short that the terminal base pairs fray in 1:1
PU.1/DNA complex, these positively charged residues would structurally be perturbed due to
charge-charge repulsion with phosphate groups of DNA.
3.5.2

Sequential backbone assignment of three hPU.1 constructs sΔN165, ΔN165,

and ΔN117 in the absence and presence of DNA
To assign 1H-15N HSQC resonances of PU.1 backbone amides, we first focused on five
specific amino acids Gly, Ala, Ser, Thr, and Pro in PU.1 as these amino acids have characteristic
chemical shifts in clear backbone assignment (Fig. 3.2 A). Gly residues do not have beta carbons,
and Ala residues have exceptionally small beta carbon chemical shifts. Ser/Thr residues have
exceptionally large chemical shifts for beta carbons, and Pro residues do not have HSQC peaks
of their own backbone amides. We used these residues for the starting points of the assignment.
For example, the chemical shift of Ser253 beta carbon is much larger than most other beta
carbons, and Gly254 has no beta carbon. Thus, we were able to find these consecutive residues at
the initial stages of the DNA-free hPU.1ΔN165 assignment (Fig. 3.2 B). The N-terminal first
residue is generally not observed in 1H-15N HSQC spectra. This was the case in our studies.
Then we worked on the backbone assignment of the PU.1 protein containing only the
ETS domain (hPU.1sΔN165; residues 165-258) in the absence of DNA. The first three residues
at the N-terminus and residues L172, L180, S203, K204, K221, and K222 were unable to be
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assigned because the corresponding resonances in the 1H-15N correlation spectra were not
observed. The next assignment was done for DNA-free PU.1 protein containing the ETS domain
and C-terminal IDR (hPU.1ΔN165; residues 165-270). L172, L180, S203, K204, and K222 were
unable to be assigned, in the same manner as the hPU.1sΔN165, as described above. Besides, the
assignment of R220 was not achieved. The C-terminal IDR contains two consecutive Pro
residues (P268 and P269) that never appear on 1H-15N HSQC spectra due to the absence of 1H
attached to its 15N in Pro. Moreover, we were unable to unambiguously assign R265.
Likewise, the assignment was done with unbound hPU.1ΔN117 (residues 117-270)
containing N-terminal IDR (PEST domain), the ETS domain, and C-terminal IDR. The same
residues as ΔN165 were assigned in the ETS domain and C-terminal IDR. The PEST domain
(residues 117-164) is disordered and therefore the 1H-15N HSQC resonances are clustered in the
typical amide chemical shift region (~8.2 ppm of 1H). Moreover, this domain contains a lot of
Pro residues (P122, 126, 129, 141, 142, 155, 157, and 161) that cannot be assigned. Thus, the
sequential assignment of the PEST domain was much more difficult than the other part of the
protein. Because N-terminal residues typically exhibit most negative {1H}-15N NOE (described
in detail in 3.5.3 of this chapter), we used the heteronuclear NOE data to distinguish the Nterminal Gly and Ser/Thr residues from the same amino acid residues at other sites. We were
eventually able to assign the PEST residues except for L119, Q120, Y121, L124, Q139, D147,
E149, in addition to all the ETS residues assigned for ΔN165.
Thus, we successfully assigned 88 of 94 backbone amides of hPU.1sΔN165, 94 of 104
resonances of ΔN165, and 126 of 144 residues of ΔN117 (Fig. 3.2 A). Likewise, at least ~90% of
HSQC resonances of the same PU.1 proteins were assigned in 1:1 complex with cognate DNA
(Fig. 3.2 B).
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3.5.3

The PEST domain stays disordered but becomes more dynamic upon specific

DNA binding
Using the 1H-15N HSQC spectra of PU.1 proteins whose resonances were fully resolved,
the well-dispersed crosspeaks of ΔN165 residues were found to be mostly overlapped with
ΔN117 residues. Furthermore, all the residues in the PEST region were clustered at ~8.2 ppm on
the 1H dimension for both unbound and 1:1-DNA bound ΔN117 (Fig. 3.4 A and B). This is
characteristic of structural disorder of proteins in 1H-15N HSQC spectra. The chemical shifts of
these PEST resonances were also similar for both unbound protein and 1:1 complex with specific
DNA binding. Thus, 1H-15N HSQC chemical shifts strongly suggest that the PEST domain stays
similarly disordered upon specific DNA binding in terms of structural perturbation.
We further performed measurements of 15N relaxation parameters (namely, spin-lattice
(R1) and spin-spin (R2) relaxation rate and the steady-state heteronuclear 1H{15N}-NOE) for
hPU.1ΔN165 and ΔN117 residues both in the absence and presence (at 1:1 molar ratio) of 23-bp
specific DNA (Fig. 3.5 A-L and Supplemental Table 3.1-3.4). We excluded those which were
either overlapping or hardly visible. The NOE values were calculated from the intensity ratios of
individual crosspeaks with and without 1H saturation (Fig. 3.5 F and L). The R1 and R2 values of
hPU.1 proteins for both unbound and 1:1 DNA-bound forms were obtained by fitting the
intensity of each crosspeak with a set of relaxation times (Fig. 3.5 A,B,D,E,G,H,J,K).
To evaluate the quality of the spin relaxation data, we obtained the ranges of relative
errors. The relative error ranges of R1, R2 and NOE are as follows. DNA-free ΔN165: 0.5-25.5%,
1.2-7.9%, and 1.6-49.9%, respectively. DNA-free ΔN117: 1.6-62.2%, 1.0-22.6%, and 2.7343.0%, respectively. 1:1 DNA-bound ΔN165: 4.3-84.6%, 3.5-24.9%, and 1.3-25.9%,
respectively. 1:1 DNA-bound ΔN117: 2.6-101.1%, 2.0-31.2%, and 0.8-597.3%, respectively.
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Typical erros in replicated NMR relaxation experiments are 5-10% in the case of Ets-1 from
literature (33), where their group conducted multiple NMR relaxation experiments and obtained
standard errors. In contrast, our errors (standard deviation) were derived from experiments
without replication. Namely, our R1 and R2 errors were derived from fitting and our NOE error
was from signal intensities relative to background noise level. Thus, the high R1 or R2 errors of
some PU.1 residues are attributed to both data fitting and significantly weak HSQC signals, and
the high NOE errors of some PU.1 residues are due to significantly weak signals in the HSQC
specta. We have high errors for some PU.1 residues. Notably, M185 and K245 have high errors
because their HSQC signals are weak (Fig. 3.5 M), which resulted in high errors in the spin
relaxation measurements.
Large NOE values of the ETS residues and much smaller values of the PEST residues
indicate that the ETS domain stays well-ordered, in contrast to the PEST domain which stays
disordered upon specific DNA binding (Fig. 3.5 F and L). Much larger R1 (Fig. 3.5 D and J) and
much smaller R2 (Fig. 3.5 E and K) values of the PEST domain than the corresponding values of
the ETS domain also support this observation. Interestingly, 1H{15N}-NOE of unbound PU.1
PEST domain contains both negative and positive values, and transition from highly negative to
slightly positive is observed as the residues are closer to the well-ordered ETS domain. On the
other hand, 1H{15N}-NOE of the PEST domain of PU.1 in the 1:1 complex is mostly negative,
and no such transition of the degree of disorder is observable. Average NOE values of the PEST
domain in unbound and 1:1 DNA-bound ΔN117 are -0.09 ± 0.04 and -0.30 ± 0.03, respectively.
This suggests that the PEST domain becomes more dynamic upon specific DNA binding.
Collectively, the N-terminal disordered region (PEST domain) flanking the DNA-binding
domain stays disordered upon 1:1 specific DNA binding but becomes more dynamic.
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3.5.4

Effects of the PEST domain on backbone motions of the ETS domain of PU.1

in the absence of DNA and the 1:1 complex with cognate DNA
To examine the effects of the PEST domain on backbone motions of the ETS domain of
DNA-free PU.1, we compared heteronuclear 1H{15N}-NOE of ΔN165 and ΔN117. As our group
reported recently, ΔN165 is monomeric, and ΔN117 is dimeric at the protein concentrations
(~600 μM) used, in the absence of DNA, in physiological conditions (138). We compared the
average NOE values of the ETS domain of DNA-free ΔN165 and ΔN117: 0.80 ± 0.02 and 0.74 ±
0.01, respectively. Smaller average NOE of ΔN117 (than that of ΔN165) suggests that the ETS
domain of PU.1 is overall more dynamic in the presence of the PEST domain, than in the
absence. Furthermore, smaller average R1 (ΔN117: 1.79 ± 0.07 as compared to ΔN165: 2.10 ±
0.05) and larger average R2 (ΔN117: 14.59 ± 0.29 as compared to ΔN165: 10.25 ± 0.15)
relaxation rates of the ETS domain reflect the molecular mass difference (i.e., between ΔN165
and ΔN117) in addition to the difference in dynamics. We subsequently subtracted heteronuclear
NOE values of ΔN117 from ΔN165 in the absence of DNA (Fig. 3.5 N). The ETS domain of
DNA-free PU.1 dimer (ΔN117) is more dynamic than the monomer (ΔN165) because most
residues showed positive ΔNOE values, consistent with average NOE comparison above. We
detected the residues with relatively large |ΔNOE| values (> 0.175). The results clearly show that
three consecutive residues Asp184, Met185, and Lys186, located on the loop between H1 and S1,
show large ΔNOE values, along with some other residues such as Ser202 (highlighted in the
graph). This is consistent with the exchange broadening observed for the amide of Met185 (very
weak correlation peak of Met185) in all the 1H-15N HSQC spectra of DNA-free PU.1. These
characteristics of Met185 residue are consistent with the trends seen in the spin relaxation rates
(anomalously large R2 rate constant) on the picosecond to nanosecond time scale and
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conformational exchange dynamics on the millisecond to microsecond time scale (exceptionally
large Rex value) for the PU.1 ETS domain from literature (118). Thus, Met185 alone or the region
around the residue (the loop between H1 and S1) is in conformational equilibria and presumably
responsible for PU.1 homodimer formation in the absence of DNA, by contributing to
conformational exchange processes between monomer and dimer. On the other hand, the highly
negative ΔNOE value of the Lys245 residue suggests that the residue is less dynamic in the DNAfree dimer than in the DNA-free monomer. Therefore, the residue is probably important for
maintaining the monomeric form of PU.1, which is consistent with our observation that the three
consecutive Lys residues (i.e., Lys245-247) in the “wing” play an important role in DNA
recognition of PU.1, as discussed above (cf. in Chapter 3.5.1).
In order to test whether the PEST domain alters internal dynamics of the ETS domain of
PU.1 upon specific DNA binding, we compared the average NOE values of the ETS domain of
1:1 DNA-bound ΔN165 and ΔN117: 0.79 ± 0.02 and 0.81 ± 0.03, respectively. Thus, no
difference was observed in the average NOE values for ΔN165 and ΔN117, suggesting that the
presence of the PEST domain does not change the net dynamics of the ETS domain.
Subsequently, we subtracted the heteronuclear NOE values of 1:1 DNA-bound ΔN117 from
those of ΔN165 (Fig. 3.5 O), in the same manner as the unbound protein, as described above.
The ΔNOE values were randomly dispersed in both positive and negative directions. This further
suggests that the presence of the PEST domain causes no net change in the internal dynamics of
the ETS domain in the 1:1 complex with cognate DNA. Namely, the ETS domain maintains
similar levels of fast-time scale internal dynamics in total. This result presents a great contrast to
our observation in dimeric (ΔN117) and monomeric (ΔN165) DNA-free PU.1 proteins, as
described above. In the case of DNA-free PU.1, the ETS domain of PU.1, as a whole, is more
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dynamic in ΔN117 than in ΔN165, primarily because the PEST domain facilitates dynamic
homodimer formation of the ETS domain in the absence of DNA.
In summary, the presence of the PEST domain alters the backbone dynamics of the PU.1
ETS domain by facilitating the homodimerization of the ETS domain in the absence of DNA. On
the other hand, in the event of site-specific 1:1 DNA-binding, the PEST domain becomes more
dynamic but does not change backbone motions of the ETS domain. The well-overlapped ETS
domain residues in the 15N-HSQC spectra of ΔN117 and ΔN165 indicate almost no structural
perturbations resulting from the presence of the PEST domain. Thus, the presence of the PEST
domain increases the affinity of 1:1 complex of the ETS domain with cognate DNA, without
perturbing the structure or changing the fast time scale motions of the ETS domain.
3.6

Discussion
3.6.1

Optimal ionic strength and pH for PU.1 backbone assignment

For the backbone assignment of unbound PU.1 ETS domain (hPU.1sΔN165; residues
165-258), we conducted the NMR experiments using a ~0.8 mM protein sample, at 50 mM salt,
at pH 7.0, at 25 °C, using a 600 MHz NMR spectrometer. The PU.1 construct was assigned with
50 mM salt because low salt is known to avoid effectively broadening of signals and to make
shimming of NMR magnet better. The other assignments (ΔN165 and ΔN117) were done in
physiological conditions since no mal-effect by 150 mM salt was found. On the other hand, Jia et
al. previously assigned backbone amides of PU.1 containing almost the same residues (residues
166-258) as our sΔN165, at 2.5 mM protein sample at 400 mM salt, pH 5.5 and 30 °C, using a
500-MHz NMR spectrometer (139). Except for the N-terminal residue that never appears in 1H15

N HSQC spectra and L174, they successfully assigned 91 of 93 residues. L174 was not

detectable in our experiments as well. Furthermore, McIntosh et al. reported an NMR structure
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of unbound murine PU.1 ETS domain (PDB: 5W3G), at 150 mM salt, pH 5.5, and 25 °C, using
an 850-MHz NMR spectrometer. They successfully assigned all the backbone amides with a 0.3
mM protein sample to solve the structure. Their experimental conditions (salt concentration and
temperature) except for pH (5.5) were the same as ours.
We fully assigned the backbone structure of the PU.1 ETS domain with and without
flanking IDRs using protein samples at relatively low concentrations (~0.8 mM or lower) in
physiological conditions (pH 7.0) and with a 600-MHz NMR spectrometer. However, the
experimental conditions of other groups which achieved almost 100% backbone assignments for
PU.1 suggest that lowered pH (5.5) effectively reduces exchange-broadening. The charge of the
hPU.1 ETS domain (residues 165-270) at pH 7.0 and 5.5 are estimated to be 18.9 and 22.3,
respectively (http://protcalc.sourceforge.net/cgi-bin/protcalc). Thus, such a slight increase in the
cationic charge density of the protein probably contributes to the local stability of PU.1, and the
chemical exchange of PU.1 residues is minimized as a result. High salt generally causes line
broadening in NMR, while low salt drives DNA-free homodimerization of the PU.1 ETS
domain. Therefore, 150 mM salt probably provides optimal ionic strength for PU.1. Thus, the
optimal conditions for NMR experiments of PU.1 backbone assignment we selected are 150 mM
salt and pH 5.5.
3.6.2

The presence of the IDR flanking the N-terminus of the ETS domain does not

change the DNA-binding interface or dynamics of the ETS domain upon binding
specific DNA, for both PU.1 and Ets-1
The 1H-15N HSQC spectra of 1:1 specific DNA-bound hPU.1ΔN117 and ΔN165
superimposed very closely (Fig. 3.4 B). This suggests that the PEST domain does not change the
structural interactions of PU.1 with site-specific DNA. Our NMR relaxation experiments also
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revealed that the presence of the PEST domain does not alter the backbone dynamics of the PU.1
ETS domain on the sub-nanosecond time scale upon 1:1 specific DNA binding. The same trend
was reported for the 1:1 complex of Ets-1 and specific DNA by Desjardins et al. (33). The Ets1ΔN279 protein contains the N-terminal intrinsically disordered region (partially truncated
“serine-rich region (SRR)”) as well as the ETS domain with the inhibitory module (IM). The
ΔN301 protein contains only the ETS domain with the IM. Desjardins et al. demonstrated that
the presence of the N-terminal IDR neither perturbs the structure of the ETS domain nor changes
dynamics of the Ets-1 upon binding to specific DNA, using 1H-15N HSQC spectra and
heteronuclear NOE measurements.
The SRR (residues 244 to 300) of Ets-1 inhibits DNA binding in a phosphorylationdependent manner, by stabilizing the IM and transiently associating with DNA recognition
interface of the ETS domain (74,141-143). The SRR of Ets-1 contains five specific Ser residues
(251, 270, 273, 282, and 285) that are the targets of phosphorylation (36). Likewise, the PEST
domain of PU.1 contains Ser residues (130, 131, 140, and 146) as phosphorylation targets, whose
phosphorylation increases the anionic charge density of the protein and enhances PU.1 binding
activity (62,138,144-149). Transition in the degree of disorder, which is the same trend seen in
the unbound PU.1 PEST domain as shown above, was reported previously for DNA-free Ets-1
SRR using 1H{15N}-NOE measurements (34,35). Thus, neither of these IDRs (the PEST domain
of PU.1 and the SRR of Ets-1) change the structure and dynamics of the ETS domain. Instead,
the PEST domain and the SRR build up anionic charges. Consequently, the PEST domain
increases transcriptionally active PU.1, and the SRR stabilizes autoinhibition.
The SRR of Ets-1 interacts with the ETS domain via the DNA recognition interface in the
absence of DNA, but DNA binding by the ETS domain is favored so that the association of DNA
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and SRR is mutually exclusive (150). The chemical shift perturbations observed in the same
study revealed that the SRR of Ets-1 also interacts with PU.1 via the same sites (H1 and the
wing) that are perturbed by DNA-free dimer formation of PU.1 containing the PEST domain
(138,150). Our heteronuclear NOE measurements revealed that the PEST domain is more
dynamic in the 1:1 complex with site-specific DNA than in the unbound dimer (cf. Fig. 3.5 F and
L). It is presumably because specific DNA binding is favored by the PU.1 ETS domain, and
therefore the association of DNA and the PEST domain by the PU.1 ETS domain is mutually
exclusive, in the same manner as Ets-1 (the ETS domain and the SRR). Consequently, the “free”
PEST domain, which is acidic (pI: 3.5) in contrast to basic ETS domain (pI: 10.5), has chargecharge repulsion with DNA in the 1:1 complex. As a result, the PEST domain becomes more
dynamic than that in the DNA-free dimeric form. By contrast, the PEST domain in the DNA-free
PU.1 dimer interacts with the ETS domain electrostatically from a distance and therefore
stabilizes the homo-dimerization of the ETS domain. Furthermore, such an increase in the
affinity of the 1:1 PU.1/DNA complex probably makes the complex more compact, and therefore
the rotational correlation time of the complex becomes faster. Thus, faster average R1 (ΔN117:
1.97 ± 0.10 as compared to ΔN165: 1.53 ± 0.07) and very similar average R2 (ΔN117: 30.57 ±
1.06 as compared to ΔN165: 29.24 ± 0.65) relaxation rates of the ETS domain of ΔN117 in the
1:1 complex do not directly reflect the molecular weight difference (i.e., between ΔN165 and
ΔN117).
3.6.3

PEST domain facilitates 1:1 binding of the ETS domain with specific DNA

Our recent study revealed that the PEST domain drives DNA-free PU.1 dimer formation
via the ETS domain (138). Considering the PEST domain is acidic (pI: 3.5) and the ETS domain
is highly basic (pI: 10.5), electrostatic interactions of the PEST and ETS domains would greatly
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reduce the charge-charge repulsion arising from the homodimer of the ETS domain. Reinforcing
negative charges in the PEST domain facilitates the DNA-free dimerization of PU.1 ETS
domain, and acidic crowders have the same effect on PU.1 ETS domain in the absence of the
PEST domain. Therefore, the anionic charge of the PEST domain probably gives the driving
force for DNA-free dimerization of the ETS domain.
In the presence of DNA, the highly cationic ETS domain bound with the PEST domain
probably releases it and bind with DNA because phosphate groups of DNA are much more
acidic than the PEST domain. Consequently, upon DNA binding of the ETS domain, the released
PEST domain becomes more dynamic than in the DNA-free homodimer. This is consistent with
our observation by heteronuclear NOE (cf. Fig. 3.5 F and L). Our DNA-binding assays also
revealed that the presence of the PEST domain increases affinity in the 1:1 PU.1/DNA complex.
This is probably because the “free” PEST domain enhances the ETS:DNA interaction.
3.6.4

Dynamic properties of the ETS domains – PU.1 vs. Ets-1

It is important to understand whether or not autoinhibition changes backbone mobility of
the ETS domain in the ETS family. In general, DNA-binding domains of transcription factors are
dynamic (47,48). This feature enables DNA-binding domains to search for specific binding sites
in a majority of nonspecific DNA until it is quenched upon specific DNA binding (47,48). This
feature is probably common for all the ETS domains because DNA-binding interface in the ETS
domains of Ets-1 and ETV6 are conformationally dynamic (33,37). Ets-1 shares the same
binding interface for specific and nonspecific DNA binding (33), probably due to the flexibility
in the DNA-binding interface. However, the flexibility in the ETS domain is likely to
compromise due to the autoinhibitory module (IM) adjacent to the ETS domain. Thus, the ETS
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domain of PU.1 (non-autoinhibited) is probably more flexible than that of Ets-1 (autoinhibited)
in the absence of DNA.
We studied the dynamic properties of PU.1 by amide hydrogen-deuterium exchange
(HDX) experiments. An HDX experiment using the PU.1 ETS domain was done in the absence
of DNA in physiological conditions. However, almost all the crosspeaks in HSQC disappeared
immediately when we prepared the sample in 100% D2O (only in 15 minutes) (Fig. 3.6). In
contrast, successful HDX experiments using unbound Ets-1 have been reported (35,36).
Therefore, the unbound PU.1 protein is probably very flexible and not fixed unless it binds to
DNA specifically. Thus, the backbone dynamics of PU.1 is quite different from that of Ets-1 in
this respect, probably due to the absence of autoinhibition.
3.6.5

Responsible sites of PU.1 ETS domain for PPIs

To examine the structural perturbation in the ETS domain upon specific DNA binding,
we carried out chemical shift perturbation (CSP) analysis of unbound and 1:1 DNA-bound ETS
domain of hPU.1ΔN117. Quite large CSPs were observed for amides in H1, the turn between H2
and H3, and the wing (S3/S4) (Fig. 3.7 A and B); this is consistent with the trend seen in the CSP
analysis of unbound and 1:1 specific DNA-bound Ets-1ΔN301 reported previously (33).
Considering the H2 and H3 also exhibit large CSPs for both PU.1 and Ets-1, we suggest that
PU.1 and Ets-1 bind specific DNAs via the same interface of the ETS domain.
Interestingly enough, H1 and the wing are also the most perturbed sites according to the
CSP analyses of DNA-free dimer formation of PU.1 (138) and the SRR moiety of Ets-1 (a
peptide) binding to PU.1 (150). Furthermore, Met185 alone or the loop between H1 and S1 is
presumably responsible for conformational exchange in the absence of DNA as we discussed
above. Therefore, H1, the loop between H1 and S1, and the wing are presumably responsible for
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ligand binding and protein-protein interactions (PPIs) of PU.1 in the absence of DNA. The four
consecutive charged residues (193DKDK196) of hPU.1 on the loop between S1 and S2 distal to the
DNA-binding site are at the self-dimerization interface of PU.1 ETS domain in the presence of
site-specific DNA as described in Chapter 2. Thus, the site responsible for DNA-free PU.1
homodimerization (H1, the loop between H1 and S1, and the wing) is different from the DNAbound dimeric interface.
3.7

Conclusion
We successfully assigned at least ~90% of HSQC resonances of hPU.1sΔN165, ΔN165,

and ΔN117 proteins both in the absence and presence (1:1 binding) of cognate DNA. This
provided us with opportunities to further analyze the PU.1 protein using NMR such as fast (ps to
ns) time scale spin relaxation experiments. The protein dynamics study using NMR spectroscopy
yielded relaxation and internal dynamics parameters (T1, T2, and heteronuclear 1H{15N}c-NOE)
for unbound and 1:1 DNA-bound PU.1 proteins. Mainly using the NOE values, we demonstrated
that the presence of disordered PEST domain does not change the internal dynamics of the ETS
domain upon 1:1 specific DNA binding. The acidic PEST domain has repulsion with DNA in the
1:1 complex and becomes more dynamic than in the DNA-free PU.1, where the PEST domain
stabilizes the homo-dimerization and transiently associates with the ETS domain. This study can
mark a first step toward the characterization of self-regulatory mechanisms of some ETS family
members that lack autoinhibition.
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Figure 3.1 DOSY and 1H-15N HSQC NMR titrations of hPU.1117-270 by 23- and 16-bp sitespecific DNA.
A, (a) A DOSY NMR titration of hPU.1ΔN117 with 23-bp specific DNA demonstrate two DNAbound states of PU.1 (dimer at DNA:protein = 0.5 and monomer at 1:1). PU.1 dimer is not a 2:2
DNA complex like its homolog Ets-1 protein as indicated by the absence of a single minimum at
DNA:protein = 1:1 when 23-bp DNA was used, as shown in red data points. The DOSY titration
data using mPU.1ΔN167 and 16-bp specific DNA, as described in Chapter 2 (cf. Fig. 2.3), is
shown in blue data points for comparison. (b) As shown in magenta data points, 16-bp DNA was
not long enough for hPU.1ΔN117 protein to form the 1:1 and 2:1 PU.1/DNA complexes in direct
response to the PU.1/DNA molar ratio. B, Uniformly 15N-labeled hPU.1ΔN117 was titrated with
a 23-bp unlabeled specific DNA at the indicated molar ratios. C, (a) An overlay of the HSQC
spectra of 1:1 hPU.1ΔN117 complex with 16-bp HA DNA (red) onto 23-bp HA DNA (green).
Three consecutive residues K245-247 shifted a lot between these two states (circled in blue in
the HSQC spectrum of the 23-bp DNA). (b) Mapping the K245-247 residues (highlighted in red)
on the structure of 1:1 complex (PDB 1PUE). These residues reside at the center of the wing
(S3/S4) (circled in blue), and therefore they are highly perturbed by the DNA length.
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Figure 3.2 Primary sequence of hPU.1 and partial strips of 3D NMR spectra used in the
sequential backbone assignment.
A, Primary sequence of hPU.1117-270. The N- and C-terminal residues of sPU.1 (165-258 aa),
hPU.1ΔN165 (165-270 aa), and hPU.1ΔN117 (117-270 aa) are shown in L-shaped lines. The
five specific amino acids that have characteristic carbon chemical shifts (G, A, S, and T) or have
no 1H attached to its 15N (P) are shown in color and bold (G: blue; A: green; S and T: red; P:
gray). Consecutive residues among these were able to assign directly. Thus, they were used as
starting points for sequential assignments. B, A representative set of strips of 3D NMR spectra
(CACBCONH, HNCACB, and HNCA from left to right) of Q251, F252, S253, and G254
residues of hPU.1ΔN165 in the absence of DNA. Connections of the alpha and beta carbon
signals of each residue are shown in yellow lines. The red square indicates the beta carbon
signals of S253.
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(A) hPU.1 proteins in the absence of DNA
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(B) hPU.1 proteins in 1:1 Complex with cognate DNA
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Figure 3.3 1H-15N HSQC spectra of hPU.1 proteins (sΔN165, ΔN165, and ΔN117) in the
absence of DNA and in the 1:1 complex with cognate DNA, with the resonances assigned.
H-15N HSQC resonances of hPU.1 proteins sΔN165 (top panel), ΔN165 (middle panel), and
ΔN117 (bottom panel) in the absence of DNA (A), and sΔN165 (top panel), ΔN165 (middle
panel), and ΔN117 (bottom panel) in 1:1 complex with cognate DNA (B) were sequentially
assigned using 3D NMR experiments HNCO, HN(CA)CO, HNCA, HNCACB, and
HN(CO)CACB. Note that the resonances of hPU.1sΔN165 in the 1:1 complex with 16-bp sitespecific DNA were assigned by our collaborator Dr. James Aramini.
1
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A

B

Figure 3.4 The presence of the PEST domain does not perturb the PU.1 ETS domain
structurally, and it remains disordered upon DNA binding.
Overlaid HSQC spectra of hPU.1ΔN117 (red) and ΔN165 (blue) in the absence of DNA (A) and
in the 1:1 complex with cognate DNA (B).
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Figure 3.5 Fast (picosecond to nanosecond) time scale backbone dynamics of unbound
and DNA-bound (1:1 complex) PU.1 obtained by 15N spin relaxation measurements.
R1, R2, and heteronuclear 1H{15N}-NOE plots of unbound hPU.1ΔN165 (A-C) and
ΔN117 (D-F) and 1:1 complex of ΔN165 (G-I) and ΔN117 (J-L) with 23-bp specific DNA (5’GCGAATAAGCGGAAGTGAAACCG-3’). The color scheme follows the HSQC in Fig. 3.4.
𝑛𝑜𝑖𝑠𝑒 𝑆𝑎𝑡 2
𝑛𝑜𝑖𝑠𝑒 𝑈𝑛𝑠𝑎𝑡 2
Heteronuclear 1H{15N}-NOE error was derived by |𝑁𝑂𝐸|√{(
) +(
)}
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑆𝑎𝑡

𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑈𝑛𝑠𝑎𝑡

using backgoround noise level of the spectra. Weak HSQC signals of M185 and K245 (M)
resulted in high errors in the spin relaxation measurements. Subtracted heteronuclear NOE
(ΔN165 - ΔN117) of DNA-free PU.1 (N) and 1:1 complex of PU.1 with the same DNA (O) are
also shown.
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Figure 3.6 Amide hydrogen-deuterium exchange (HDX) of the PU.1 ETS domain.
A 1H-15N HSQC spectrum using mPU.1ΔN167 protein as a reference (A). The first 1H-15N
HSQC spectrum of uniformly 15N-labeled mPU.1ΔN167 sample in 100% D2O. Because most of
the PU.1 crosspeaks disappeared immediately after bringing up the PU.1 with 100% D2O and set
up an HSQC experiment (only after ~15 min), slow amide-deuterium 1H exchange rates were not
able to measure using this sample (B). The HSQC spectrum using the same PU.1 sample in
100% D2O after ~1 h (C). 1D 1H NMR of the sample in (A) (top) and (C) (bottom), respectively.
Note that the PU.1 protein in the bottom sample is folded judging from the methyl peaks.
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A

B

Figure 3.7 1H-15N Chemical shift perturbations (CSPs) of unbound and DNA-bound (1:1
complex) PU.1 ETS domain.
A, an overlay of 1:1 specific DNA-bound (green) onto unbound (red) hPU.1ΔN117 HSQC
spectra. B, weighed average of amide (15N and 1H) chemical shift perturbations (CSPs) from
unbound and DNA-bound (1:1 complex with 23-bp specific DNA) PU.1 ETS domain (ΔN117),
derived by Δδ = √{δ1H2 + 0.2 (δ15N)2}, are plotted as a function of residue number in hPU.1.
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Supplemental Table 3.1 Relaxation rates of DNA-free hPU.1ΔN165.
Res.

R1 (1/s)

R2 (1/s)

NOE

168
169
170
171
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
205
206
207
208
209
210
211

3.04 ± 0.18
3.09 ± 0.30
2.86 ± 0.15
2.70 ± 0.12
2.24 ± 0.10
1.88 ± 0.09
2.07 ± 0.01
1.70 ± 0.10
1.61 ± 0.10
1.64 ± 0.04
1.47 ± 0.16
1.46 ± 0.15
1.79 ± 0.21
1.95 ± 0.06
2.13 ± 0.07
2.12 ± 0.09
1.65 ± 0.42
1.77 ± 0.09
2.11 ± 0.06
1.83 ± 0.04
1.96 ± 0.13
2.07 ± 0.01
1.63 ± 0.02
1.74 ± 0.13
2.00 ± 0.07
2.98 ± 0.19
2.52 ± 0.28
1.55 ± 0.06
1.61 ± 0.02
1.87 ± 0.06
1.89 ± 0.04
1.83 ± 0.05
1.97 ± 0.10
2.14 ± 0.12
2.71 ± 0.24
2.81 ± 0.14
2.17 ± 0.04
2.10 ± 0.04
1.58 ± 0.09
1.28 ± 0.15
2.15 ± 0.05

4.67 ± 0.37
5.74 ± 0.33
6.98 ± 0.15
11.03 ± 0.34
9.89 ± 0.26
10.34 ± 0.13
10.63 ± 0.16
10.66 ± 0.39
10.90 ± 0.26
10.50 ± 0.29
9.48 ± 0.16
25.40 ± 1.39
9.88 ± 0.36
10.83 ± 0.47
12.00 ± 0.34
14.22 ± 0.43
20.83 ± 0.48
12.75 ± 0.52
11.27 ± 0.33
9.87 ± 0.30
10.04 ± 0.23
10.63 ± 0.16
9.98 ± 0.24
8.78 ± 0.23
9.22 ± 0.24
10.91 ± 0.29
10.70 ± 0.25
9.73 ± 0.21
10.16 ± 0.61
9.89 ± 0.39
9.10 ± 0.42
9.59 ± 0.28
10.98 ± 0.34
9.79 ± 0.18
11.72 ± 0.47
10.50 ± 0.42
11.10 ± 0.30
10.31 ± 0.26
9.74 ± 0.40
9.10 ± 0.57
10.91 ± 0.30

-0.514 ± 0.099
0.272 ± 0.090
0.465 ± 0.032
0.670 ± 0.046
0.970 ± 0.030
0.892 ± 0.030
0.921 ± 0.022
0.921 ± 0.034
0.802 ± 0.028
0.909 ± 0.020
0.878 ± 0.024
0.970 ± 0.081
1.004 ± 0.092
0.841 ± 0.028
0.870 ± 0.031
0.832 ± 0.025
0.856 ± 0.223
0.959 ± 0.085
0.830 ± 0.023
0.876 ± 0.034
0.917 ± 0.035
0.921 ± 0.022
0.892 ± 0.032
0.861 ± 0.056
0.842 ± 0.032
0.848 ± 0.052
0.839 ± 0.020
0.820 ± 0.028
0.836 ± 0.027
0.875 ± 0.027
0.922 ± 0.037
0.862 ± 0.033
0.877 ± 0.041
0.824 ± 0.032
0.869 ± 0.057
0.781 ± 0.028
0.861 ± 0.024
0.895 ± 0.022
0.820 ± 0.032
0.917 ± 0.025
0.867 ± 0.019
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Res.

R1 (1/s)

R2 (1/s)

NOE

212
213
214
215
216
217
218
219
221
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255

2.03 ± 0.16
1.95 ± 0.07
1.54 ± 0.10
1.71 ± 0.11
2.03 ± 0.14
2.19 ± 0.14
2.63 ± 0.10
2.96 ± 0.24
2.73 ± 0.14
2.61 ± 0.09
1.96 ± 0.03
2.91 ± 0.13
2.40 ± 0.10
1.30 ± 0.12
1.60 ± 0.06
1.98 ± 0.18
1.71 ± 0.11
1.79 ± 0.18
1.82 ± 0.13
1.95 ± 0.13
2.27 ± 0.15
2.09 ± 0.14
1.74 ± 0.06
2.88 ± 0.17
2.18 ± 0.05
1.64 ± 0.06
2.01 ± 0.05
1.64 ± 0.09
1.67 ± 0.06
2.14 ± 0.03
1.76 ± 0.12
2.93 ± 0.39
2.68 ± 0.11
3.10 ± 0.39
3.23 ± 0.37
2.17 ± 0.09
1.89 ± 0.05
1.59 ± 0.09
1.58 ± 0.12
1.89 ± 0.12
3.01 ± 0.20
2.78 ± 0.26

10.89 ± 0.27
9.35 ± 0.24
10.91 ± 0.38
11.17 ± 0.35
9.63 ± 0.30
12.45 ± 0.45
12.52 ± 0.60
11.40 ± 0.33
9.90 ± 0.14
11.22 ± 0.47
11.55 ± 0.40
11.23 ± 0.14
12.15 ± 0.27
10.45 ± 0.35
9.84 ± 0.23
10.39 ± 0.23
11.17 ± 0.35
9.59 ± 0.19
10.54 ± 0.27
9.86 ± 0.50
10.39 ± 0.31
10.40 ± 0.35
10.04 ± 0.17
10.95 ± 0.28
11.76 ± 0.45
9.18 ± 0.28
9.55 ± 0.19
10.13 ± 0.28
8.57 ± 0.29
8.30 ± 0.21
9.37 ± 0.23
11.01 ± 0.58
7.01 ± 0.27
11.27 ± 0.57
10.02 ± 0.36
9.50 ± 0.21
10.45 ± 0.44
9.85 ± 0.32
10.61 ± 0.24
11.04 ± 0.23
10.16 ± 0.54
10.30 ± 0.33

0.906 ± 0.024
0.786 ± 0.024
0.890 ± 0.037
0.848 ± 0.013
0.888 ± 0.026
0.853 ± 0.026
0.718 ± 0.044
0.713 ± 0.043
0.607 ± 0.053
0.649 ± 0.035
0.734 ± 0.033
0.766 ± 0.056
0.783 ± 0.024
0.880 ± 0.032
0.852 ± 0.025
0.879 ± 0.025
0.848 ± 0.013
0.810 ± 0.020
0.808 ± 0.024
0.860 ± 0.022
0.861 ± 0.021
0.708 ± 0.022
0.831 ± 0.025
0.768 ± 0.039
0.746 ± 0.032
0.803 ± 0.029
0.846 ± 0.023
0.885 ± 0.027
0.838 ± 0.038
0.784 ± 0.027
0.869 ± 0.041
0.517 ± 0.151
0.345 ± 0.029
0.684 ± 0.155
0.707 ± 0.097
0.819 ± 0.032
0.919 ± 0.040
0.882 ± 0.039
0.862 ± 0.036
0.876 ± 0.026
0.813 ± 0.043
0.841 ± 0.025
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Res.

R1 (1/s)

R2 (1/s)

NOE

256
257
258
259
260
261
262
263
264
265
266
267
270

1.76 ± 0.03
1.78 ± 0.07
2.39 ± 0.12
2.64 ± 0.08
2.78 ± 0.22
2.95 ± 0.20
3.21 ± 0.13
2.86 ± 0.16
3.13 ± 0.12
3.26 ± 0.23
2.06 ± 0.13
1.73 ± 0.12
1.68 ± 0.07

10.51 ± 0.28
10.48 ± 0.24
9.23 ± 0.36
9.02 ± 0.21
6.93 ± 0.28
5.86 ± 0.18
5.42 ± 0.13
4.94 ± 0.17
4.85 ± 0.13
5.01 ± 0.28
2.63 ± 0.16
2.47 ± 0.03
2.12 ± 0.06

0.853 ± 0.027
0.900 ± 0.029
0.788 ± 0.025
0.701 ± 0.033
0.483 ± 0.080
0.237 ± 0.048
0.261 ± 0.025
-0.053 ± 0.026
0.078 ± 0.022
-0.166 ± 0.049
-1.043 ± 0.160
-1.172 ± 0.114
-1.188 ± 0.032
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Supplemental Table 3.2 Relaxation rates of DNA-free hPU.1ΔN117.
Res.

R1 (1/s)

R2 (1/s)

NOE

118
123
125
127
128
130
131
132
133
134
135
136
137
138
139
140
143
144
145
146
148
150
151
152
153
154
156
158
159
160
162
163
164
165
166
167
170
171
173
174
175

4.50 ± 0.63
3.09 ± 0.28
3.99 ± 0.80
3.04 ± 0.18
2.70 ± 0.14
2.93 ± 0.21
3.58 ± 0.76
3.03 ± 0.23
2.70 ± 0.14
2.79 ± 0.10
2.79 ± 0.15
3.12 ± 0.18
3.01 ± 0.14
2.21 ± 0.07
2.57 ± 0.13
2.56 ± 0.37
2.21 ± 0.07
2.69 ± 0.09
3.02 ± 0.21
3.05 ± 0.23
3.19 ± 0.26
4.11 ± 0.42
3.00 ± 0.22
2.68 ± 0.07
2.58 ± 0.16
2.49 ± 0.06
3.00 ± 0.21
3.13 ± 0.27
2.65 ± 0.10
2.10 ± 0.03
3.16 ± 0.21
3.39 ± 0.29
3.10 ± 0.36
3.60 ± 0.75
0.00 ± 0.00
3.01 ± 0.27
2.65 ± 0.12
2.94 ± 0.19

4.49 ± 1.01
4.82 ± 0.12
4.69 ± 0.27
6.57 ± 0.18
5.03 ± 0.12
5.65 ± 0.18
5.14 ± 0.20
6.24 ± 0.40
5.03 ± 0.12
5.42 ± 0.15
5.91 ± 0.18
5.45 ± 0.19
6.20 ± 0.21
5.69 ± 0.14
5.71 ± 0.12
7.94 ± 0.50
5.69 ± 0.14
6.21 ± 0.15
6.07 ± 0.16
6.58 ± 0.30

-0.717 ± 0.205
-0.410 ± 0.023
-0.396 ± 0.044
-0.318 ± 0.012
-0.067 ± 0.007
-0.110 ± 0.026
0.017 ± 0.059
0.104 ± 0.017
-0.067 ± 0.007
-0.239 ± 0.011
0.146 ± 0.010
0.141 ± 0.015
0.240 ± 0.010
0.168 ± 0.014

1.57 ± 0.20
1.30 ± 0.16

6.30 ± 0.55
6.84 ± 0.16
5.34 ± 0.16
6.71 ± 0.37
5.86 ± 0.15
7.26 ± 0.47
5.75 ± 0.08
5.39 ± 0.15
4.87 ± 0.27
6.09 ± 0.54
6.33 ± 0.26
11.37 ± 1.05
5.29 ± 0.67
7.00 ± 0.90
7.16 ± 0.66
11.53 ± 0.47
4.17 ± 0.15
14.56 ± 0.74
15.14 ± 0.72
15.33 ± 0.95

0.129 ± 0.030
0.168 ± 0.014
0.088 ± 0.013
0.144 ± 0.015
0.318 ± 0.026
0.123 ± 0.020
0.409 ± 0.136
0.194 ± 0.015
0.205 ± 0.009
0.202 ± 0.014
0.144 ± 0.013
0.233 ± 0.012
0.129 ± 0.023
0.163 ± 0.013
0.113 ± 0.013
0.180 ± 0.033
0.332 ± 0.021
0.228 ± 0.060
0.200 ± 0.082
0.247 ± 0.149
0.350 ± 0.030
0.564 ± 0.032
0.451 ± 0.043
0.841 ± 0.068
0.954 ± 0.064
0.676 ± 0.032
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Res.

R1 (1/s)

R2 (1/s)

NOE

176
177
178
179
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
223

0.86 ± 0.19
1.28 ± 0.29
1.39 ± 0.16
1.48 ± 0.20
1.11 ± 0.26
1.49 ± 0.16
1.92 ± 0.14
1.59 ± 0.12
0.00 ± 0.00
1.65 ± 0.92
0.87 ± 0.45
1.47 ± 0.07
1.25 ± 0.25
1.44 ± 0.14
1.21 ± 0.38
1.78 ± 0.52
1.97 ± 0.50
3.40 ± 0.45
1.98 ± 0.18
1.15 ± 0.38
1.43 ± 0.09
1.38 ± 0.12
1.30 ± 0.40
1.21 ± 0.11
1.35 ± 0.35
1.98 ± 0.12
2.00 ± 0.34
2.25 ± 0.32
1.89 ± 0.13
1.87 ± 0.10
1.41 ± 0.24
1.17 ± 0.22
1.43 ± 0.09
2.13 ± 0.12
2.21 ± 0.07
1.99 ± 0.31
1.49 ± 0.11
1.81 ± 0.67
1.52 ± 0.22
2.21 ± 0.49
2.44 ± 0.50
2.68 ± 0.31

15.86 ± 0.63
16.19 ± 0.60
16.20 ± 0.48
14.94 ± 0.68
14.08 ± 0.54
16.29 ± 0.57
16.83 ± 0.82
18.01 ± 0.78
18.48 ± 2.13
15.71 ± 2.03
16.48 ± 0.91
14.41 ± 0.38
17.40 ± 2.22
14.67 ± 0.64
14.96 ± 0.56
12.96 ± 0.37
14.46 ± 0.69
12.72 ± 0.58
15.74 ± 0.18
14.45 ± 0.59
14.65 ± 0.75
15.95 ± 0.39
15.06 ± 0.87
15.14 ± 0.94
15.39 ± 0.66
11.47 ± 0.45
16.28 ± 0.87
15.98 ± 0.64
12.73 ± 1.12
16.38 ± 0.42
15.04 ± 0.36
16.76 ± 0.45
16.92 ± 0.71
14.40 ± 0.54

0.820 ± 0.074
0.829 ± 0.042
0.816 ± 0.041
0.870 ± 0.052
0.937 ± 0.125
0.895 ± 0.054
0.731 ± 0.046
0.644 ± 0.035
0.542 ± 0.163
0.782 ± 0.077
0.770 ± 0.036
0.761 ± 0.057
0.808 ± 0.053
0.845 ± 0.035
0.777 ± 0.049
0.725 ± 0.083
0.703 ± 0.022
0.805 ± 0.083
0.727 ± 0.035
0.752 ± 0.041
0.733 ± 0.046
0.955 ± 0.050
0.811 ± 0.057
0.751 ± 0.054
0.830 ± 0.068
0.376 ± 0.028
0.708 ± 0.077
0.814 ± 0.057
0.617 ± 0.035
0.884 ± 0.043
0.748 ± 0.044
0.750 ± 0.046
0.779 ± 0.043
0.703 ± 0.022

16.33 ± 0.97
17.21 ± 1.00
12.90 ± 0.90
18.03 ± 0.59
17.68 ± 2.39
16.72 ± 1.92
16.37 ± 2.14

0.753 ± 0.071
0.801 ± 0.026
0.834 ± 0.032
0.822 ± 0.056
0.779 ± 0.076
0.615 ± 0.041
0.626 ± 0.057
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Res.

R1 (1/s)

R2 (1/s)

NOE

224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
266
267
270

1.34 ± 0.18
3.39 ± 0.30
2.20 ± 0.09
1.58 ± 0.17
1.47 ± 0.10
1.21 ± 0.18
1.49 ± 0.11
1.41 ± 0.12
1.49 ± 0.14
1.52 ± 0.15
1.83 ± 0.09
1.58 ± 0.31
1.94 ± 0.34
2.02 ± 0.21
1.74 ± 0.22
1.56 ± 0.10
1.53 ± 0.12

17.97 ± 0.89
12.90 ± 0.95
15.86 ± 0.70
15.23 ± 0.61
15.67 ± 0.70
16.48 ± 1.71
16.92 ± 0.79
14.56 ± 0.28
16.02 ± 0.59
15.16 ± 1.75
14.61 ± 0.53
15.33 ± 0.24
13.72 ± 0.88
15.63 ± 0.38
15.10 ± 0.79
13.52 ± 0.45
15.09 ± 0.41
16.79 ± 0.72
13.60 ± 0.39
12.57 ± 0.28
14.19 ± 0.76
9.05 ± 1.54
9.69 ± 0.10
12.46 ± 0.73
14.30 ± 0.37
12.26 ± 0.43
15.56 ± 0.89
16.19 ± 0.82
13.80 ± 1.87
12.59 ± 0.60
13.81 ± 0.58
16.11 ± 0.76
15.38 ± 0.28
14.20 ± 0.55
12.36 ± 0.31
8.69 ± 0.73
5.34 ± 0.16
5.95 ± 0.20
5.17 ± 0.20
5.26 ± 0.12
3.08 ± 0.15
2.62 ± 0.07
2.30 ± 0.04

0.709 ± 0.061
0.801 ± 0.109
0.723 ± 0.043
0.826 ± 0.042
0.748 ± 0.053
0.814 ± 0.048
0.801 ± 0.026
0.843 ± 0.045
0.831 ± 0.053
0.568 ± 0.025
0.790 ± 0.038
0.692 ± 0.026
0.651 ± 0.028
0.773 ± 0.032
0.664 ± 0.043
0.727 ± 0.043
0.703 ± 0.043
0.778 ± 0.045
0.817 ± 0.056
0.756 ± 0.045
0.794 ± 0.067
0.792 ± 0.190

1.50 ± 0.38
1.48 ± 0.18
1.67 ± 0.27
2.60 ± 1.62
2.53 ± 0.30
3.59 ± 0.92
1.26 ± 0.25
1.31 ± 0.18
1.31 ± 0.18
1.72 ± 0.19
2.63 ± 0.30
2.47 ± 0.25
1.65 ± 0.09
1.31 ± 0.30
1.76 ± 0.15
2.53 ± 0.21
3.29 ± 0.37
2.68 ± 0.07
3.07 ± 0.22
3.09 ± 0.17
2.99 ± 0.16
2.05 ± 0.16
1.68 ± 0.14
1.72 ± 0.06

0.674 ± 0.127
0.722 ± 0.042
0.818 ± 0.060
0.732 ± 0.056
0.777 ± 0.062
0.735 ± 0.044
0.859 ± 0.075
0.680 ± 0.040
0.836 ± 0.040
0.692 ± 0.026
0.775 ± 0.038
0.587 ± 0.033
0.363 ± 0.048
0.205 ± 0.009
0.080 ± 0.014
-0.095 ± 0.011
0.150 ± 0.013
-0.492 ± 0.098
-0.462 ± 0.060
-0.669 ± 0.018
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Supplemental Table 3.3 Relaxation rates of 1:1 DNA-bound hPU.1ΔN165.
Res.

R1 (1/s)

R2 (1/s)

NOE

167
168
169
170
171
172
173
174
175
177
178
179
180
181
182
183
184
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
204
205
206
208
209
210
211

2.35 ± 0.36
2.94 ± 0.19
2.87 ± 0.23
2.95 ± 0.16
1.63 ± 0.70
1.25 ± 0.66
1.59 ± 1.35
0.80 ± 0.44
1.92 ± 0.36
1.29 ± 0.42
3.31 ± 0.73
0.74 ± 0.21
1.29 ± 0.74
1.10 ± 0.27
0.73 ± 0.30

16.70 ± 1.24
9.17 ± 0.85
10.48 ± 1.38
9.13 ± 0.97
30.05 ± 2.55
22.14 ± 3.54
29.85 ± 1.57
35.22 ± 3.89
29.21 ± 4.22
33.53 ± 1.81
32.39 ± 2.72
31.51 ± 1.91
43.76 ± 4.01
17.84 ± 1.30
30.92 ± 1.80
29.91 ± 3.01
33.45 ± 2.09
31.17 ± 2.29
34.93 ± 2.27
34.77 ± 2.33
29.90 ± 2.31
31.51 ± 1.91
29.55 ± 2.27
26.59 ± 5.20
30.05 ± 2.03
29.97 ± 3.07
36.29 ± 3.09
30.43 ± 2.90
30.25 ± 2.67
32.76 ± 2.21
28.50 ± 2.05
28.59 ± 1.80
27.31 ± 1.82
28.98 ± 4.69
29.16 ± 2.37
24.31 ± 2.57
19.17 ± 2.59
17.19 ± 4.28
38.35 ± 2.67
28.58 ± 2.00
35.27 ± 3.41

-0.136 ± 0.035
0.163 ± 0.008
0.114 ± 0.009
0.195 ± 0.020
0.885 ± 0.071
0.818 ± 0.128
0.894 ± 0.090
0.894 ± 0.079
0.732 ± 0.058
0.859 ± 0.052
0.789 ± 0.060
0.889 ± 0.033
1.023 ± 0.189
0.770 ± 0.138
0.838 ± 0.062
0.811 ± 0.066
0.680 ± 0.048
0.755 ± 0.072
0.894 ± 0.052
0.977 ± 0.103
1.088 ± 0.078
0.889 ± 0.033
0.948 ± 0.077
0.637 ± 0.137
0.689 ± 0.050
0.983 ± 0.147
0.936 ± 0.062
0.787 ± 0.065
0.780 ± 0.045
0.952 ± 0.059
0.947 ± 0.081
0.819 ± 0.038
0.880 ± 0.090
0.874 ± 0.121
0.688 ± 0.073
0.787 ± 0.075
0.688 ± 0.088
0.833 ± 0.061
0.655 ± 0.089
0.727 ± 0.067
0.733 ± 0.062

1.10 ± 0.35
1.02 ± 0.30
1.01 ± 0.26
0.86 ± 0.13
1.52 ± 0.47
1.08 ± 0.21
0.74 ± 0.17
1.79 ± 0.30
0.76 ± 0.61
1.17 ± 0.56
0.92 ± 0.37
1.16 ± 0.35
1.27 ± 0.43
1.29 ± 0.41
1.39 ± 0.61
1.76 ± 0.40
1.97 ± 0.53
1.03 ± 0.46
3.05 ± 0.52
1.08 ± 0.14
1.46 ± 0.31
1.21 ± 0.36
1.13 ± 0.27
1.56 ± 0.36
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Res.

R1 (1/s)

R2 (1/s)

NOE

212
213
214
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255

1.89 ± 0.46
1.04 ± 0.56
1.89 ± 1.05
1.77 ± 0.11
1.35 ± 0.20
1.26 ± 0.30
1.76 ± 0.40
1.29 ± 0.23
1.50 ± 0.37
2.24 ± 0.69

36.99 ± 4.08
36.93 ± 4.49
33.81 ± 1.20
33.50 ± 5.49
31.39 ± 2.56
35.78 ± 3.17
28.59 ± 1.80
31.24 ± 2.22
27.25 ± 3.57
30.29 ± 3.33
25.21 ± 2.51
27.63 ± 2.18
31.42 ± 2.49
33.24 ± 2.24
29.53 ± 2.09
33.68 ± 4.06
31.59 ± 2.22
30.05 ± 2.55
27.81 ± 3.04
30.84 ± 3.20
32.37 ± 1.67
33.21 ± 2.25
33.07 ± 2.69
29.80 ± 1.35
29.65 ± 2.39
25.25 ± 1.76
31.95 ± 1.82
29.03 ± 2.76
24.10 ± 1.98
25.73 ± 1.98
22.04 ± 2.61
31.03 ± 2.89
32.48 ± 1.85
33.81 ± 2.73
29.68 ± 2.70
16.34 ± 1.48
25.60 ± 3.13
28.14 ± 3.53
25.69 ± 4.02
33.45 ± 3.60
29.33 ± 4.35
33.68 ± 1.92

0.775 ± 0.067
0.685 ± 0.050
0.834 ± 0.155
0.871 ± 0.080
0.900 ± 0.072
0.899 ± 0.064
0.819 ± 0.038
0.687 ± 0.062
0.651 ± 0.079
0.740 ± 0.101
0.863 ± 0.101
0.888 ± 0.112
0.860 ± 0.052
0.830 ± 0.085
0.822 ± 0.072
0.943 ± 0.063
0.879 ± 0.072
0.885 ± 0.071
0.713 ± 0.063
0.885 ± 0.090
0.785 ± 0.049
0.817 ± 0.056
0.760 ± 0.045
0.502 ± 0.033
0.801 ± 0.056
0.684 ± 0.057
0.889 ± 0.070
0.845 ± 0.065
0.681 ± 0.087
0.827 ± 0.082
1.189 ± 0.183
0.836 ± 0.067
0.601 ± 0.054
0.675 ± 0.089
1.080 ± 0.183
0.506 ± 0.032
1.006 ± 0.109
0.744 ± 0.069
0.709 ± 0.084
0.849 ± 0.083
1.012 ± 0.096
0.839 ± 0.056

0.93 ± 0.45
1.59 ± 0.14
2.13 ± 0.74
1.25 ± 0.89
1.75 ± 0.74
1.30 ± 0.58
1.63 ± 0.70
1.64 ± 0.57
1.21 ± 0.31
1.87 ± 0.50
1.54 ± 0.46
0.54 ± 0.24
1.13 ± 0.21
1.28 ± 0.52
0.95 ± 0.38
1.74 ± 0.20
2.12 ± 0.58
2.21 ± 0.44
1.53 ± 0.25
2.27 ± 0.69
0.96 ± 0.26
1.16 ± 0.48
1.31 ± 0.34
1.67 ± 0.28
1.56 ± 0.43
2.30 ± 0.21
1.63 ± 0.80
1.66 ± 0.21
3.04 ± 0.74
1.91 ± 0.54
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Res.

R1 (1/s)

R2 (1/s)

NOE

256
257
258
259
260
261
262
263
264
266
267
270

1.22 ± 0.12

33.47 ± 2.85
30.84 ± 2.78
29.65 ± 2.21
25.95 ± 2.65
14.33 ± 1.04
13.00 ± 0.98
10.62 ± 0.91
9.09 ± 0.83
8.67 ± 0.79
4.75 ± 0.52
4.21 ± 0.50
3.53 ± 0.45

0.763 ± 0.062
0.934 ± 0.084
0.826 ± 0.049
0.640 ± 0.028
0.392 ± 0.024
0.293 ± 0.012
0.278 ± 0.008
0.117 ± 0.007
0.121 ± 0.006
-0.717 ± 0.074
-0.377 ± 0.036
-0.868 ± 0.011

1.13 ± 0.39
2.40 ± 0.27
2.96 ± 0.45
2.97 ± 0.31
2.79 ± 0.21
2.88 ± 0.16
2.83 ± 0.15
1.59 ± 0.32
1.51 ± 0.06
1.57 ± 0.08
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Supplemental Table 3.4 Relaxation rates of 1:1 DNA-bound hPU.1ΔN117.
Res.

R1 (1/s)

R2 (1/s)

NOE

123
125
127
128
130
131
132
134
135
136
137
138
139
140
143
144
145
146
148
150
151
152
153
154
156
158
159
160
162
163
164
165
166
167
171
172
173
174
176
177
178

3.30 ± 0.21
3.40 ± 0.36
2.89 ± 0.15
2.48 ± 0.11
3.19 ± 0.22
3.38 ± 0.29
2.65 ± 0.12
2.23 ± 0.09
2.40 ± 0.09
2.68 ± 0.14
2.48 ± 0.11
1.78 ± 0.06
3.13 ± 0.19
3.08 ± 0.22
1.78 ± 0.06
2.59 ± 0.11
2.16 ± 0.09
3.13 ± 0.18
2.68 ± 0.14
3.17 ± 0.21
2.66 ± 0.14
2.30 ± 0.09
2.07 ± 0.08
2.01 ± 0.05
2.30 ± 0.09
2.77 ± 0.18
1.99 ± 0.07
1.70 ± 0.04
2.53 ± 0.31
2.70 ± 0.17
3.21 ± 0.26
3.08 ± 0.27
3.08 ± 0.21
2.77 ± 0.18
1.35 ± 0.78

5.66 ± 0.39
5.66 ± 0.39
3.61 ± 0.35
4.03 ± 0.27
5.38 ± 0.30
5.91 ± 0.36
4.46 ± 0.43
3.23 ± 0.38
3.71 ± 0.36
3.73 ± 0.37
4.03 ± 0.27
3.09 ± 0.25
4.71 ± 0.44
5.35 ± 0.30
3.09 ± 0.25
4.02 ± 0.31
2.76 ± 0.32
5.88 ± 0.72
3.49 ± 0.27
4.90 ± 0.31
5.34 ± 0.58
4.57 ± 0.29
3.27 ± 0.27
3.69 ± 0.29
4.57 ± 0.29
5.32 ± 0.41
4.20 ± 0.34
4.23 ± 0.34
5.87 ± 0.40
6.01 ± 0.39
6.86 ± 0.47
6.46 ± 0.42
8.54 ± 0.60
6.99 ± 0.97
25.78 ± 5.03

-0.560 ± 0.010
-0.638 ± 0.015
-0.576 ± 0.006
-0.269 ± 0.002
-0.364 ± 0.007
-0.253 ± 0.010
-0.241 ± 0.003
-0.448 ± 0.005
-0.228 ± 0.004
-0.440 ± 0.004
-0.269 ± 0.002
-0.323 ± 0.004
-0.201 ± 0.007
-0.208 ± 0.008
-0.323 ± 0.004
-0.389 ± 0.006
-0.216 ± 0.005
-0.352 ± 0.007
-0.440 ± 0.004
-0.299 ± 0.042
-0.388 ± 0.006
-0.384 ± 0.003
-0.296 ± 0.005
-0.403 ± 0.006
-0.384 ± 0.003
-0.117 ± 0.006
-0.120 ± 0.006
-0.129 ± 0.006
-0.008 ± 0.045
0.101 ± 0.007
-0.113 ± 0.010
0.047 ± 0.010
0.141 ± 0.010
0.122 ± 0.010
1.197 ± 0.175
0.936 ± 0.251
1.087 ± 0.202
0.935 ± 0.144
0.925 ± 0.155
1.004 ± 0.100
0.781 ± 0.088

1.80 ± 0.83
1.19 ± 0.14
2.24 ± 1.02
1.63 ± 0.54

43.78 ± 5.86
20.22 ± 3.79
24.47 ± 4.46
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Res.

R1 (1/s)

R2 (1/s)

NOE

179
180
181
182
183
184
186
187
188
190
191
192
193
194
195
196
197
198
199
200
201
202
204
205
208
209
210
211
212
214
217
218
219
220
221
222
223
224
225
226
227
228

1.28 ± 0.51

32.24 ± 6.39

4.06 ± 1.20
1.41 ± 0.82
0.86 ± 0.87
0.81 ± 0.22
0.93 ± 0.79
1.56 ± 0.46
1.14 ± 0.56
1.28 ± 0.51
0.98 ± 0.56

25.21 ± 6.71
32.44 ± 6.31
25.42 ± 4.48
22.89 ± 3.99
27.11 ± 4.12

1.48 ± 0.32
2.62 ± 0.70
1.73 ± 0.40
1.55 ± 0.99
2.67 ± 0.35
0.98 ± 0.23
1.60 ± 0.77
1.31 ± 0.49
1.30 ± 0.47
1.57 ± 0.14
2.90 ± 0.30
1.74 ± 0.30
0.90 ± 0.43
2.84 ± 0.62
2.61 ± 0.16
2.53 ± 0.67
3.90 ± 0.83
1.12 ± 0.69
2.27 ± 0.92
1.45 ± 0.78
1.08 ± 0.50
1.31 ± 0.49
1.58 ± 0.56
3.12 ± 0.45
1.81 ± 1.28

31.38 ± 3.07

0.915 ± 0.057
1.015 ± 0.228
1.075 ± 0.216
0.984 ± 0.094
0.891 ± 0.117
0.614 ± 0.057
1.251 ± 0.185
0.878 ± 0.087
0.761 ± 0.116
0.915 ± 0.057
0.764 ± 0.086
0.653 ± 0.163
0.843 ± 0.087
0.948 ± 0.168
0.801 ± 0.074
0.768 ± 0.095
1.014 ± 0.105
0.892 ± 0.079
0.952 ± 0.127
0.645 ± 0.056
1.094 ± 0.205
0.675 ± 0.021
0.974 ± 0.139
0.825 ± 0.108
0.734 ± 0.084
0.827 ± 0.182
0.768 ± 0.150
0.849 ± 0.095
1.000 ± 0.136
0.521 ± 0.155
1.494 ± 0.218
0.800 ± 0.102
0.967 ± 0.096
0.645 ± 0.056
0.812 ± 0.106
0.466 ± 0.053
0.961 ± 0.179
0.758 ± 0.162
0.819 ± 0.160
0.672 ± 0.070
0.642 ± 0.110
1.051 ± 0.159

4.98 ± 0.53
2.16 ± 0.67
2.04 ± 0.80

19.71 ± 2.96
32.24 ± 6.39
33.79 ± 5.29

29.23 ± 4.82
38.90 ± 5.65
30.78 ± 4.80
29.77 ± 4.05
28.49 ± 4.78
31.17 ± 2.69
30.83 ± 6.52
18.35 ± 5.72
24.93 ± 3.53
25.50 ± 7.71
40.53 ± 6.16

40.51 ± 6.02
29.88 ± 2.57
33.38 ± 4.56
31.53 ± 6.68
31.17 ± 2.69
32.20 ± 3.85
25.20 ± 4.93

37.63 ± 5.54
21.65 ± 3.95
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Res.

R1 (1/s)

R2 (1/s)

NOE

229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
254
255
256
257
258
259
260
261
262
263
264
266
267
270

2.99 ± 0.47
2.87 ± 0.38
1.35 ± 0.78
2.86 ± 0.53
2.80 ± 0.50
2.76 ± 0.44
1.72 ± 0.60
1.55 ± 0.84
1.31 ± 0.27
1.67 ± 0.65
2.31 ± 0.81
1.76 ± 0.46
1.90 ± 0.13
1.78 ± 0.93
2.72 ± 0.30
2.02 ± 1.38
1.39 ± 0.74
1.24 ± 0.80
2.19 ± 0.53

51.03 ± 10.17
47.02 ± 3.32
30.56 ± 3.67
26.22 ± 8.18

0.706 ± 0.087
0.877 ± 0.105
1.197 ± 0.175
0.573 ± 0.072
0.541 ± 0.074
0.448 ± 0.069
0.750 ± 0.081
0.674 ± 0.067
0.504 ± 0.048
0.709 ± 0.076
0.698 ± 0.086
0.927 ± 0.114
0.773 ± 0.092
0.900 ± 0.154
0.681 ± 0.085
0.844 ± 0.199
0.779 ± 0.093
0.561 ± 0.085
0.543 ± 0.139
0.988 ± 0.220
0.795 ± 0.108
0.967 ± 0.149
0.875 ± 0.145
1.280 ± 0.253
0.738 ± 0.131
0.795 ± 0.041
0.598 ± 0.070
0.630 ± 0.083
0.720 ± 0.063
0.702 ± 0.040
0.271 ± 0.019
0.293 ± 0.013
0.207 ± 0.008
-0.157 ± 0.005
0.178 ± 0.006
-0.434 ± 0.062
-0.318 ± 0.037
-0.731 ± 0.010

3.01 ± 1.02
1.30 ± 0.33
1.99 ± 0.91
2.10 ± 0.62
3.55 ± 1.43
1.89 ± 0.13
1.72 ± 0.54
1.26 ± 0.33
1.17 ± 0.46
1.90 ± 0.22
2.78 ± 0.32
3.35 ± 0.43
2.68 ± 0.11
2.91 ± 0.17
2.55 ± 0.13
1.35 ± 0.26
1.59 ± 0.08
1.61 ± 0.06

41.05 ± 5.12
31.87 ± 4.05
36.55 ± 4.89
27.89 ± 4.11
26.74 ± 5.06
27.35 ± 2.49
39.32 ± 5.17
32.00 ± 2.46
26.25 ± 2.78
31.61 ± 1.55
22.85 ± 1.85
42.52 ± 4.09
39.22 ± 0.80
31.74 ± 2.52
36.57 ± 2.36
26.35 ± 3.62
36.86 ± 3.69
26.89 ± 4.87
35.99 ± 3.06
42.87 ± 4.19
38.22 ± 3.25
33.51 ± 3.81
37.31 ± 4.69
24.19 ± 3.24
10.52 ± 0.95
12.73 ± 1.35
7.88 ± 0.73
5.53 ± 0.56
7.04 ± 0.42
6.12 ± 0.26
3.19 ± 0.24
2.64 ± 0.16
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4

CONCLUSIONS AND FUTURE DIRECTIONS

The ETS family of transcription factors has a so-called ETS domain on which sitespecific DNA is bound. The ETS domains are structurally homologous but their primary
sequences are divergent; for example, two ETS family members PU.1 and Ets-1 share only 30%
sequence homology. PU.1 is an essential transcription factor and its main biological role is the
development of hematopoietic stem cells (HSCs) in the immune system (15). PU.1 is a central
transcriptional regulator of differentiation of HSCs into lymphocytes and myelocytes, B and T
cell development, and maintenance of HSCs (16). This function spans from early to late stages of
progression in a lineage- and cell type-specific manner; thus, it controls proliferation, terminal
differentiation, and maintenance of HSCs (17). Therefore, PU.1 is a key transcriptional regulator
within the hematopoietic system and plays critical roles in both the innate and adaptive immune
systems by controlling cell differentiation.
The biological activity of PU.1 is primarily controlled by up- and down-regulation of its
expression. However, because the metabolic half-life of PU.1 spans the entire cell cycle (~50 h)
(103), downregulation of its expression alone is probably not sufficient for PU.1 regulation.
Therefore, PU.1 activity during its lifetime in the cell needs to be regulated as well. Only a few
inhibitory mechanisms are known for PU.1 other than down-regulated expression. The most
understood one involves the nature of PU.1 itself forming a heterodimer with other protein
partners, such as GATA-1 (29).
Autoinhibition is a regulatory mechanism of protein activity, whereby inhibitory module
or domain of a protein interacts with another part of the protein so that it works for negative
regulation (30). Protein expression is known to be regulated via autoinhibition. For example,
autoinhibitory modules are removed by alternative splicing or proteolysis. Post-translational
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modifications (PTM) or protein-protein interactions (PPI) in response to cellular signaling can
relieve or reinforce autoinhibition and enable the protein to control downstream events (31). For
ETS transcription factors, autoinhibition has been described as a key regulatory mechanism at
the protein/DNA level (30). Autoinhibition in ETS family has a common mechanism in which
autoinhibitory elements, typically helices (α- or 310-helix), adjacent to the ETS domain, make
DNA binding unfavorable. Most of the 28 paralogs of ETS family in humans have been found to
possess autoinhibition, while PU.1 is one of a few members that are not autoinhibited (31).
In addition to transcriptionally active 1:1 protein/DNA complex, homodimerization of
many ETS family members, including Ets-1, Elk-1, ETV1, ETV6, FEV, ERG, and PU.1, has
been reported (66-70). Interestingly, all these ETS domain homodimers are 2:2 protein/DNA
complex except for a 2:1 protein/DNA complex of Ets-1 in a non-reducing environment, where
two Cys residues from each subunit are likely to form a disulfide bond (71). For example,
positively co-operative binding of Ets-1 at 2:2 protein/DNA stoichiometry is observed at
repeated (palindromic) specific DNA sites such as stromelysin-1 promoter (72). Such a
positively cooperative DNA binding of Ets-1 is known to counteract to its autoinhibition (73).
Three homodimeric structures of Ets-1 have been determined by crystallization (PDB: 2NNY,
3MFK, and 3RI4) so far (72,74,75). In the case of Elk-1, homodimerization mediated by its ETS
domain gives Elk-1 cytoplasmic stability to resist proteasomal degradation as well as localization
to the nucleus (68). PU.1 in the nucleus forms DNA-free homodimer(s) but is monomeric upon
specific DNA binding (68). Thus, PU.1 homodimerization mediated by the ETS domain is
biologically relevant. This also raises a new question of whether PU.1 can dimerize in the
presence of DNA.
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Before the present study was undertaken, our group had observed the potential for the
ETS domain of PU.1 to dimerize at a single specific site by ITC titration experiments (76). We
observed two distinct DNA binding modes (1:1 and 2:1 protein:DNA ratio) for PU.1 protein.
Also, the negative to positive transition in the reverse titration (namely, adding DNA to PU.1) of
ITC implied that a 2:1 (PU.1:DNA) complex is formed in a negatively cooperative manner. The
free energy of each of the four states of PU.1 (i.e. monomeric and dimeric PU.1 in the absence or
presence of site-specific DNA) under standard state conditions revealed that the free energy (G°)
gradient of the PU.1 ETS domain is described as unbound monomer > PU.1 dimer in the absence
of DNA > 2:1 DNA-bound complex > 1:1 DNA-bound complex.
In the present study (cf. Chapter 2 of this dissertation), we established a DNA-binding
model of PU.1 using diffusion-ordered NMR spectroscopy (DOSY). Namely, the ETS domain of
PU.1 dimerizes at a single cognate site in a negatively cooperative manner, unlike its autoinhibited family member Ets-1. We also detected a potential interface of DNA-bound PU.1
dimer by using heteronuclear single quantum correlation (HSQC) NMR. We detected four
consecutive charged residues (namely, 193DKDK196 in hPU.1) on the loop between β-sheets S1
and S2 at the potential interface of DNA-bound dimer of PU.1, by overlaying the HSQC spectra.
To assess the effect of electrostatic interactions on PU.1 dimerization in complex with DNA, we
generated 193NINI196 mutant designed to remove the charges but maintain similar side-chain
structures. This mutation abolished site-specific 2:1 PU.1/DNA binding. Furthermore, the DNA
contact interface of the 2:1 PU.1/DNA complex made extended contacts with the DNA
compared to the 1:1 complex. Taken together, the 2:1 PU.1/DNA complex is presumably a
transcriptionally inactive form, and its formation is potentially a self-regulatory mechanism of
PU.1 at the protein-DNA level, instead of auto-inhibition for other ETS proteins.
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Expression levels of PU.1 in the cells are as high as those of housekeeping genes (133).
Moreover, the estimated half-life of PU.1 in the cells is long enough as the lifespan (~50 hours)
of the cells (cf. Chapter 2). Therefore, we proposed that excess PU.1 proteins are sequestered to
form DNA-bound PU.1 dimers, as potentially a negative feedback mechanism for PU.1 activity
(cf. Chapter 2). Our recent study demonstrated it using mammalian cells (138). We established a
reporter gene system in HEK293 cells to measure PU.1 transactivation levels using tandem
copies of specific ETS binding site (EBS) spaced by 20 bp. Since PU.1 is not expressed in
HEK293 cells, the reporter is not activated unless we induce a plasmid encoding full-length PU.1
that yields EGFP fluorescence. The fluorescence signals of PU.1 transactivation levels showed a
bell-shaped response to the dose of the PU.1 plasmid. This suggests that excess PU.1 was used
for negative feedback in the cells. Therefore, this study demonstrated that the formation of a 2:1
PU.1/DNA complex using excess PU.1 is a self-regulatory mechanism.
Our recent study also revealed the roles of IDRs on DNA-free PU.1 homodimerization,
which was previously observed in vivo by Evans et al. (68,138). We found the PU.1 dimers in
the absence and presence of DNA antagonize to each other, and the IDRs flanking the ETS
domain (i.e., N-terminal PEST domain and C-terminal 12 residues) play key roles for this
phenomenon (138). We also found that the presence of IDR modifies DNA recognition by the
ETS domain of PU.1. The N-terminal PEST domain, which is intrinsically disordered, increases
the affinity of 1:1 DNA complex but reduces that of 2:1 PU.1/DNA complex (138). On the other
hand, the absence of C-terminal IDR does not affect DNA recognition of the ETS domain, but
PU.1 is unable to form the DNA-free dimer without it (138).
In the present study (cf. Chapter 3 of this dissertation), we tracked translational diffusion
constants in a titration with 23- and 16-bp site-specific DNA by DOSY NMR in the same way as
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described in Chapter 2. The result indicated that the PU.1 ETS domain retains its ability to form
a DNA-bound homodimer in a negatively cooperative manner, even in the presence of the Nterminal IDR (the PEST domain) flanking the ETS domain (namely, hPU.1ΔN117) (cf. Fig. 3.1
A). This result is consistent with our observation for the PU.1 ETS domain in the absence of the
PEST domain (namely, mPU.1ΔN167) with 16-bp specific DNA (cf. Fig. S 2.3). We also
observed 23-bp specific DNA is long enough, but 16-bp is not, for ΔN117 to form the 1:1 and
2:1 complexes in direct response to the PU.1/DNA molar ratios, presumably because the three
positively charged residues (K245-247) in the “wing” are structurally perturbed due to chargecharge repulsion with phosphate groups of DNA if the DNA is short (cf. Fig. 3.1 C).
We also tested whether or not the PEST domain changes the internal dynamics of the
ETS domain using NMR to study how the PEST domain modifies DNA recognition of PU.1. We
successfully assigned ~90% or more HSQC resonances of hPU.1sΔN165, ΔN165, and ΔN117,
both in the absence and presence (i.e., 1:1 binding) of cognate DNA. The backbone assignments
provided us with opportunities to perform measurements of 15N relaxation parameters (namely,
spin-lattice (R1) and spin-spin (R2) relaxation rate and the steady-state heteronuclear 1H{15N}NOE) for both DNA-free and 1:1 DNA-bound PU.1 proteins. The chemical shifts of the assigned
HSQC resonances and the spin relaxation measurements suggest that the PEST domain remains
disordered but becomes more dynamic upon 1:1 specific DNA binding of PU.1. The chemical
shifts of the assigned HSQC resonances also suggest that the PEST domain does not structurally
perturb the ETS domain upon specific DNA binding. Using the 15N relaxation parameters, we
observed the presence of the PEST domain does not change the internal dynamics of the ETS
domain upon 1:1 specific DNA binding. Taken together, we propose a role of the disordered
PEST domain on 1:1 specific DNA binding of the PU.1 ETS domain. In the presence of DNA,
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the highly cationic ETS domain bound with the basic PEST domain probably releases it and
binds with DNA instead. The released PEST domain upon DNA binding of the ETS domain
becomes more dynamic than in the DNA-free form. As a result, the presence of the PEST
domain increases affinity in the 1:1 PU.1/DNA complex because the “free” PEST domain
presumably enhances the ETS:DNA interaction.
I propose future directions and studies as described below, on the basis of PU.1 studies
done in this dissertation. It is reasonable to assume that the interfaces in PPIs have been evolved
to optimize their functional requirement (44). In particular, weak and nonspecific interactions at
the interfaces have been adjusted properly to survive against selective pressure. In the ETS
family, autoinhibition has been lost through evolution: namely, PU.1 is evolutionary the newest
and not autoinhibited. Therefore, it would be interesting to study the relationship between
quaternary structures (or properties in dimeric interfaces) and the efficiency of self-regulation
(i.e., inhibition) through dimerization in vivo in the ETS family. If the optimization of the
physics of association at the dimeric interface has evolved by selective pressure (namely, in
inverse proportion to autoinhibition), self-regulation of the protein through dimerization has
probably been achieved most effectively in PU.1 among the ETS family members.
We will be able to do NMR experiments further to characterize the DNA-free PU.1
dimer. In particular, relaxation dispersion NMR to detect motions in the intermediate (i.e.,
microsecond to millisecond) time scale will be very useful. A conformational exchange rate
constant Rex obtained by this experiment explains the chemical exchange processes that
contribute to the decay in the transverse magnetization (R2). Large Rex values generally are
derived from line broadening due to chemical (conformational) exchange processes between two
states typically in the microsecond to millisecond time scale. Interpretation of the Rex constant is
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somewhat complicated because this parameter includes exchange rate, chemical shift difference,
and fractional populations at the exchange sites. Nevertheless, large Rex values suggest that
dynamic exchange occurs at the corresponding residues in the microsecond to millisecond time
scale. As discussed above, we have detected the PU.1 residues that reflect structural perturbation
between two states (DNA-free monomer and dimer) using chemical shift perturbations (CSPs)
(138). Also, as discussed in Chapter 3, we have detected the PU.1 residues that are dynamic in
the fast (i.e., picosecond to nanosecond) time scale, using heteronuclear NOE in the absence of
DNA: These PU.1 residues are presumably responsible for DNA-free dimer formation.
Therefore, once Rex values are obtained for a DNA-free PU.1 dimer sample, it helps us further
characterize the dynamic properties of PU.1 and detect the residues that are responsible for the
dimerization.
To further characterize the interface of the DNA-bound dimer of PU.1, we will be able to
test 193AAAA196 and 193NANA196 mutant to study the effects of hydrophobicity in the
corresponding region on the PPI in the 2:1 DNA-bound dimer. Even though the 193NINI196
mutant was designed to abrogate charges but maintain similar side-chain structures and
secondary structure propensities to WT protein, the 193NINI196 surface is much more
hydrophobic than that of WT since Ile is one of the most hydrophobic amino acids. Therefore, by
using the above mutants, we can estimate the contribution from the hydrophobicity of the side
chain (or hydrophobic interactions introduced by the Ile side chain) to affect the 2:1 binding. If
the 193NANA196 mutant does not abolish the 2:1 binding but the 193AAAA196 mutant does, then
we could estimate the effect of hydrophilicity of the Asp residues in this region for the 2:1
complex formation. We could subsequently test if hydrophilicity is more important than
electrostatic interactions for this protein-protein interaction.
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If we can detect other component(s) of the dimeric interface in the 2:1 PU.1/DNA
complex besides the 193DKDK196 site, then such a component would be very useful to
characterize the DNA-bound PU.1 dimer. One of the ideas to test this is to generate “193NINI196 +
R230A/R233A” mutant and to conduct the same DNA binding experiment like the one using the
R230A/R233A mutant (138), as described above. Thus, we are probably able to designate the
binding order: WT PU.1 always binds to DNA and the mutant binds to the 1:1 PU.1/DNA
complex. If the mutant forms a 2:1 complex without forming a 1:1 complex, then it provides us
with proof that the presence of the other dimeric interface. Furthermore, capturing the 2:1
complex in an HSQC spectrum would also be very useful to characterize the DNA-bound PU.1
dimer. We will be able to reach this goal by making the 1:1 PU.1/DNA complex first using
unlabeled PU.1 and subsequently by adding the equivalent amount of 15N-labeled R230A/R233A
mutant. Under the conditions, each monomeric components of the DNA-bound PU.1 dimer are
not probably interchangeable because the mutant PU.1 cannot bind DNA. Therefore, the
crosspeaks of the 2:1 complex will be visible, and therefore we should be able to see the
crosspeaks of the 2:1 complex. If this experiment works, then we could plan to label WT PU.1
by 15N and do the same experiment. Then, we will be able to do spin relaxation measurements. If
we successfully obtain Rex rates for PU.1 residues, we can detect the residues responsible for
dimerization.
Moreover, we could try to determine the crystal structure of the 2:1 PU.1/DNA complex.
We will need to use the PU.1 protein without IDRs (s∆N165) for the study because the presence
of intrinsically disordered regions makes protein crystallization difficult and also does not
facilitate the DNA-bound dimer formation. Our data show that the two monomers of PU.1 in this
complex are interconvertible (cf. Fig. 2.3 B). Namely, PU.1 in the 2:1 complex is highly
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dynamic, and crystallization may be difficult. If the 2:1 complex using WT PU.1 is not
crystallized by any means, then the R230A/R233A mutant can be analyzed by NMR. If we mix
WT PU.1, R230A/R233A mutant, and specific DNA at 1:1:1 molar ratio, then we will obtain a
2:1 PU.1/DNA complex. It is reasonable to assume that well-dispersed HSQC crosspeaks of
PU.1 in the 2:1 complex will be obtained because the interconversion of the two PU.1 monomers
is disturbed in this experiment, as discussed above.
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APPENDICES
Appendix A: Introduction
PU.1 expression levels in the cells are as high as those of housekeeping genes (133), and
the estimated PU.1 half-life in the cells is as long as the lifespan of the cells (~50 hours) (cf.
Chapter 2). Thus, excess DNA-free PU.1 should be sequestered by forming a presumably
inactive 2:1 PU.1/DNA complex, as a negative feedback mechanism for PU.1. Our mammalian
cell study recently provided us with proof that excess PU.1 was used for negative feedback in the
cells (138). Therefore, our recent study demonstrated that the formation of 2:1 PU.1/DNA
complex with excess PU.1 is by a negative feedback mechanism for PU.1.
As we directly demonstrated using the diffusion coefficients of PU.1 by titration with
site-specific DNA (> 10-bp), the DNA-bound PU.1 dimer is not a 2:2 complex (Fig. S 2.3). The
2:2 ETS/DNA complex is often seen in the ETS family (66-70). This finding also suggests that
the DNA-bound dimer of PU.1 ETS domain is not formed by simple electrostatic interactions
between two PU.1 molecules using the charges of 193DKDK196 side-chains. If the 193DKDK196
sites of two PU.1 molecules interact to form a DNA-bound dimer, a 2:2 complex should
eventually be formed because the DNA-binding surface (namely, the surface opposite to the
193

DKDK196 site) is available for both monomers of PU.1. Thus, the DNA-bound dimer of PU.1

ETS domain is asymmetric (i.e., not a “head-to-head” binding), and the dimeric interface
consists of the 193DKDK196 site and another site of the ETS domain. A mutant study in our recent
report confirmed the asymmetric configuration of the DNA-bound PU.1 dimer (138). We
mutated two Arg residues to Ala (R230A/R233A) in the DNA-recognition helix H3 and
confirmed this mutant alone does not bind to site-specific DNA. In the presence of a negligible
concentration of WT PU.1, this mutant PU.1 only formed a 2:1 PU.1/DNA complex upon
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specific DNA binding, at similar binding affinity to WT protein. In this assay, the sub-saturating
concentration of WT PU.1 was used to form a 1:1 WT PU.1/DNA complex, where the mutant
PU.1 protein was added to form a heterodimeric PU.1 dimer in complex with DNA.
Moreover, nonspecific DNA binding by PU.1 ETS domain is quite different from specific
binding (cf. supplemental Fig. S2.3 C). In a DOSY titration of PU.1 with 16-bp nonspecific
DNA, only an inflection point was observed at a DNA/PU.1 ratio of ~0.5, and it had a stable
diffusion coefficient at a higher molar ratio. Thus, nonspecific DNA binding of PU.1 yields only
a DNA-bound dimer, which is distinct from the DNA-bound dimer with specific DNA, judging
from the diffusion coefficients. In the present study, we further characterized the nonspecific
DNA binding of PU.1. The results provide us with a comparison of PU.1 with Ets-1.
Appendix B: Materials and methods
Proteins. DNA fragments of mutant PU.1 ETS domain (i.e., mPU.1∆N167) were
obtained by PCR amplification and subcloned directly into the NcoI/HindIII sites of pET28b
vector. All the constructs were verified by Sanger sequencing (Macrogen). The protein samples
(namely, wildtype hPU.1∆N165, mutant mPU.1∆N167, and Ets-1∆N280) were expressed and
purified in the same way as described in Chapters 2 and 3.
Nucleic acids. 16-bp nonspecific DNA (5’-GCAAGCGAGAGTGAGC- 3’) was
purchased from Integrated DNA Technologies as synthetic DNA oligos and annealed as
described in Chapter 2. Fluorescent DNA probes were constructed by annealing a Cy3-labeled
oligo with excess unlabeled complementary strand, as described in Chapter 2.
NMR spectroscopy. Uniformly 15N-labeled mPU.1∆N167 (0.75 mM) or Ets-1∆N280
(~0.3 mM) was dialyzed with 16-bp nonspecific DNA (~2 mM) in separate dialysis tubings
against 22 mM MES, pH 6.5, 55 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, and 5 mM DTT, and
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D2O was added at a final concentration of 10%. Note that the DNA was titrated into protein to
achieve the desired DNA/protein ratios. 1H-15N correlated measurements were made using a
phase-sensitive, double inept transfer with a GARP decoupling sequence, and solvent
suppression (hsqcf3gpph19). Spectra were acquired with 1024 × 144 data points and zero-filled
to 4096 × 4096.
Fluorescence polarization titrations. DNA binding experiments by fluorescence
anisotropy measurements of a Cy3-labeled DNA probe were performed as described
(111,113,151). Briefly, graded concentrations of WT hPU.1ΔN165 or mutants were incubated to
equilibrium with a Cy3-labeled 23-bp DNA duplex oligo harboring the high-affinity PU.1 target
site 5’-AGCGGAAGTG-3’. The binding assay samples were made in 10 mM Tris-HCl (pH 7.4)
buffer with 0.15 M total [Na+], and 0.1 mg/mL BSA.
Circular dichroism spectroscopy. Purified PU.1 proteins at graded concentrations were
scanned for far-UV (200 to 250 nm) spectra in 10 mM NaH2PO4/Na2HPO4 (pH 7.4), 50 mM
total [Na+] at 25°C using a Jasco J-810 instrument.
Appendix C: Results and discussion
Appendix C.1: Asymmetric configuration of the PU.1 dimer in the presence of DNA
In Chapter 2, we observed ~80% of the HSQC crosspeaks of the DNA-bound PU.1 dimer
disappeared (cf. Fig. 2.3 B). We presumed that it was due to the conformational exchange of
PU.1, but not due to disorder. To confirm it, we assigned the 1H-15N resonances of PU.1 ETS
domain in complex with nonspecific DNA because most (>90%) of the crosspeaks also
disappeared in a titration of mPU.1∆N167 protein with 16-bp nonspecific DNA at protein:DNA
molar ratio of 1:0.5 and more (Appendix Fig. 1 A). By overlaying the HSQC spectrum at 1:0.5
molar ratio with that of fully-assigned unbound PU.1 resonances shown in Chapter 3 (cf. Fig.
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3.3), we were able to assign the remaining resonances. The assigned peaks were only in the N(before K171) and C-terminal (after G262) loops (Appendix Fig. 1 B-C). Thus, all the PU.1 ETS
domain residues in the structured region disappeared upon nonspecific DNA binding, while the
residues in the intrinsically disordered regions did not. This indicates that the HSQC peak
disappearance of PU.1 upon DNA binding is due to conformational exchange, but not disorder of
the protein. This confirmed our idea that chemical exchange is the reason for the HSQC
crosspeak disappearance in the 2:1 complex of PU.1 with site-specific DNA (cf. Fig. 2.3 B).
To further characterize the DNA-bound dimer that was studied in Chapter2, secondary
structures of PU.1 in the DNA-bound dimer were examined using CD spectroscopy. Negligible
changes in the secondary structure content were observed in the titration of PU.1 ETS domain
with cognate DNA (Appendix Fig. 2). DNA-free (PDB: 5W3G) and 1:1 DNA-bound (PDB:
1PUE) PU.1 structures are similar, as seen by solved structures (cf. Fig. 1.5). Thus, the CD data
above indicate that the DNA-bound PU.1 dimer consists of a DNA-free and a 1:1 DNA-bound
monomer. Namely, the structures of the PU.1 subunits (i.e., PU.1 monomers) in the DNA-bound
dimer are probably similar to each of the solved structures (i.e., PDB: 5W3G and 1PUE).
Furthermore, each subunit of the DNA-bound PU.1 dimer presumably interconverts with each
other. Therefore, this data provided us with proof that the disappeared HSQC crosspeaks of the
DNA-bound dimer (cf. Fig. 2.3 B) are due to conformational exchange between the two states of
PU.1.
In sharp contrast, the CD spectra of the DNA-free PU.1 dimer exhibits completely
different secondary structures content due to a great contribution by random coils, compared to
the DNA-bound dimer (138). The DNA-bound PU.1 dimer is therefore conformationally distinct
from the DNA-free dimer. Our group also found that the DNA-bound dimer is asymmetric, as
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described above (138). Thus, we tested whether the DNA-free dimer is symmetric or not. We
generated a mutant that is suitable to discuss this, namely the 193DKCDK197’ mutant. This mutant
is obligated to form a dimer of head-to-head ETS domains using the crosslink between the
inserted Cys residues in non-reducing conditions. The CD spectrum of the 193DKCDK197’ dimer
(Appendix Fig. 3 A) is utterly different from that of WT PU.1 monomer, whereas it is similar to
that of DNA-free PU.1 dimer (WT ΔN165 at ~800 μM at 50 mM salt concentration) which we
reported recently (138). Therefore, the DNA-free dimer of PU.1 is suggested to be symmetric, in
contrast with the DNA-bound dimer. The 193DKCDK197’ PU.1 dimer binds to cognate DNA
>100-fold weakly than WT (Appendix Fig. 3 B), which further suggests that the DNA-free and bound PU.1 dimers are conformationally distinct.
Appendix C.2: Electrostatic components responsible for DNA-bound PU.1
dimerization
The 193NINI196 (in hPU.1) mutant study indicated that electrostatic interactions via the
side-chain charges of 193DKDK196 are important for PU.1 to form the 2:1 complex, as described
in Chapter 2 (cf. Fig. 2.5 H). Therefore, we introduced more mutations at this site to further study
which electrostatic components are responsible for DNA-bound PU.1 dimer formation. We used
three mutants 193AKAK196, 193DADA196, and 193TGDG196. The first two mutants were designed
to remove either all the positive or negative charges. The third mutant was designed from the
same site (357TGDG360) of Ets-1, which is a close structural homolog of PU.1 but does not form a
2:1 complex with DNA in non-reducing conditions. DNA binding assays of fluorescence
anisotropy using these mutants showed none of these mutants abolished the 2:1 DNA binding
(Appendix Fig. 4 A (a)-(d) and Appendix Table 1). 193DADA196 mutation did not change in
binding affinity of the 1:1 and 2:1 complex. In sharp contrast, 193AKAK196 and 193TGDG196
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mutations made the binding affinities of both 1:1 and 2:1 complex lower than that of WT.
Namely, for 193AKAK196 mutation, KD1 was ~3-fold and KD2 was ~8-fold lower. For 193TGDG196
mutation, KD1 was ~4-fold and KD2 was ~12-fold lower. Furthermore, 193NINI196 mutation (i.e.,
abrogating all the charges from the 193DKDK196 site) abolished the 2:1 binding (cf. Fig. 2.5 H).
Taken together, PU.1 forms the 2:1 complex with a similar dissociation constant to WT even if
the cationic charge is completely lost from the 193DKDK196 site. In contrast, losing at least one
Asp residue from the 193DKDK196 site compromises the 2:1 binding. Thus, anionic charge in the
193

DKDK196 site is important for the 2:1 complex formation. The CD signals of the mutants

suggest that 193DADA196 and 193AKAK196 mutation do not change the structure of PU.1, but
193

TGDG196 mutation causes a significant change in the structure (Appendix Fig. 4 B). Thus,

193

TGDG196 mutation not only abrogates three of four charged residues but also it changes PU.1

structure significantly. This may be the reason why removing one Asp residue by the
193

TGDG196 mutation compromises the 2:1 binding more than removing two Asp residues by the

193

AKAK196 mutation.
As a potential major driving force for the PU.1 self-association other than electrostatic

interactions, the hydrophilicity of the 193DKDK196 surface may be important for the association
of two PU.1 molecules if water-mediated contact drives the association at the interface of PPI. In
general, hydration greatly contributes to protein packing and association in general, thus water
molecules play important roles in PPIs (152). The reliability of information about solvent
molecules depends on the resolution in crystallographic structures. There are on average 1.0
interfacial water molecules per 100 Å2, discovered from an analysis of a dataset of homo- protein
complexes (<2.6 Å resolution) (153). The majority of these water molecules make hydrogen
bonds with both partners of the association (154). It has been proposed that PPIs involve similar

138

levels of water-mediated contacts to direct contacts (154). Some interfacial water molecules are
conserved among structurally homologous protein complexes, according to high-resolution
crystal structures (152). Some amino acids of one protein at a PPI interface make both direct and
water-mediated contacts with the other protein partner. Water-mediated contacts have been
demonstrated to contribute to the energy of interaction (155). Thus, interfacial water molecules
could facilitate interactions and recognition between protein partners in PPIs.
Appendix C.3: Nonspecific DNA binding of Ets-1 primarily perturbs the autoinhibitory
module and H3
In striking contrast to the titration of PU.1 with nonspecific DNA as described above (cf.
Appendix fig. 1 A), the 1H-15N HSQC crosspeaks of Ets-1∆N280 do not disappear upon
nonspecific DNA binding (Appendix Fig. 5 A(a)). Using the DNA-free and -bound Ets-1
backbone assignments reported previously (33,36), we were able to assign the HSQC resonances
of both unbound Ets-1∆N280 and its complex with 16-bp nonspecific DNA (at 1:1 Ets-1/DNA
molar ratio) (Appendix Fig. 5 A(b)). Then, 1H-15N CSPs were calculated from the assigned
HSQC resonances (Appendix Fig. 5 B). The CSPs as a whole are small, suggesting that
nonspecific DNA binding marginally changes the structure of Ets-1, consistent with the literature
(33). The residues that have large CSPs were mainly in HI-2, H3, H4, and H5. This indicates that
nonspecific DNA binding of Ets-1 primarily perturbs the autoinhibitory module and H3, which is
also consistent with the literature (33).
Our study of Ets-1 binding with nonspecific DNA confirmed the trend seen in the Ets-1
complex with nonspecific DNA, reported by Desjardins et al. (33). They previously reported that
HI-1 and HI-2 of Ets-1 become predominantly unfolded, yet the protein is still ordered upon
DNA binding, regardless of specific or nonspecific binding (33). Their NMR studies
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demonstrated that nonspecific DNA binding of Ets-1 also contrasts with specific DNA binding,
in that the structural and dynamic changes for Ets-1 are much larger with specific DNA than with
nonspecific DNA (33). Their amide chemical shift perturbation mapping showed that dynamic
electrostatic interactions drive association of Ets-1 with both specific and nonspecific DNA,
through the same canonical interface of the ETS domain, whereas the formation of well-ordered
complexes is driven by hydrogen bonding, with specific DNA (33).
For transcription factors in general, DNA-binding domains are dynamic to search for
specific binding sites in a majority of nonspecific DNA until the DNA-scanning is quenched
upon specific DNA binding (47,48). DNA-binding interface in the ETS domains of Ets-1 and
ETV6 has also been demonstrated to be conformationally dynamic (33,37), and this feature is
probably common for all the ETS domains. Such flexibility in the DNA-binding interface also
explains why Ets-1 protein shares the same binding interface for specific and nonspecific DNA
binding (33). However, the autoinhibitory module adjacent to the ETS domain is likely to
compromise the flexibility in the ETS domain (or the DNA-binding interface), suggesting that
the ETS domain of PU.1 (non-autoinhibited) is more flexible than that of Ets-1 (autoinhibited).
Because of the flexibility of the ETS domain of PU.1, HSQC resonances of the ETS domain in
complex with nonspecific DNA disappeared, in contrast to nonspecific DNA binding of Ets-1
(cf. Both Ets-1 (33) and PU.1 form a dimer with nonspecific DNA.) (cf. Fig. S2.3 C, Appendix
Fig. 1 A, and Appendix Fig. 5 A(b)).
Appendix D: Conclusion
We observed the HSQC resonances of all the PU.1 ETS domain residues in the structured
region (i.e., ETS domain) disappeared upon nonspecific DNA binding in a titration of PU.1 with
nonspecific DNA, while the residues in the disordered regions did not. Thus, the HSQC peak
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disappearance of PU.1 upon DNA binding was confirmed to be due to conformational exchange,
but not disorder of the protein. We also studied which electrostatic components at the dimeric
interface (193DKDK196) are responsible for DNA-bound PU.1 dimer formation. Anionic charge,
but not cationic, in the 193DKDK196 site is important for the 2:1 complex formation. The DNAfree PU.1 dimer (symmetric) and DNA-bound one (asymmetric) are conformationally distinct.
Furthermore, we observed HSQC resonances of the PU.1 ETS domain in complex with
nonspecific DNA disappeared, in contrast to nonspecific DNA binding of Ets-1, because of the
flexibility of the ETS domain of PU.1. Even though nonspecific DNA binding of Ets-1
marginally changes the structure of Ets-1, it primarily perturbs the autoinhibitory module and
H3, through the same binding interface as for specific DNA binding.
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Appendix Table 1 Dissociation constants of WT and mutants of PU.1 ETS domain from
fluorescent anisotropy at 150 mM total [Na+].
Dissociation constants of WT and mutants of PU.1 ETS domain at 150 mM total [Na+] were
obtained using fluorescent anisotropy. Note that the dissociation constant for the 193DKCDK197’
dimer was obtained by Ms. Suela Xhani.

KD1, M

KD2, M

WT

(1.1 ± 0.5) × 10-8

(1.6 ± 1.0) × 10-6

193

AKAK196 mutant

(3.2 ± 1.4) × 10-8

(1.2 ± 1.3) × 10-5

193

DADA196 mutant

(7.9 ± 1.7) × 10-9

(1.1 ± 0.7) × 10-6

193

TGDG196 mutant

(4.5 ± 1.3) × 10-8

(2.0 ± 2.5) × 10-5

193

DKCDK197’ mutant (dimer)

(3.1 ± 0.9) × 10-6
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A

B

C

Appendix Figure 1 Assigned HSQC resonances revealed that the ETS domain of PU.1 in
complex with nonspecific DNA is exchange-broadened, but not disordered.
A, 1H-15N HSQC titration of mPU.1ΔN167 with 16-bp nonspecific DNA. B, assigned HSQC
resonances of PU.1 in complex with 16-bp nonspecific DNA at 1:1 PU.1/DNA molar ratio. C,
assigned HSQC resonances were mapped on the PU.1 structure (PDB: 5W3G). The assigned
PU.1 residues are only in the N- and C-terminal disordered regions.
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Appendix Figure 2 Far-UV CD spectra of the DNA-bound mPU.1ΔN167 upon
subtracting the spectrum of the DNA acquired under identical conditions.
Far-UV CD spectra of the DNA-bound mPU.1ΔN167 in the unbound (black), 2:1 DNA-bound
(blue), and 1:1 DNA-bound (red) form, upon subtracting the spectrum of the DNA acquired
under identical conditions (75 μM, 0.15 M [Na+]). The CD-detected structure of PU.1 showed
negligible changes upon titration by DNA.
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Appendix Figure 3 The 193DKCDK197’ dimer of hPU.1ΔN165, mimicking the symmetric
DNA-free dimer of PU.1 ETS domain, is conformationally distinct from the asymmetric DNAbound PU.1 dimer.
CD spectrum of WT ΔN165 (blue) and the 193DKCDK197’ dimer (green) (~400 μM proteins at
0.05 M [Na+]) (A). The 193DKCDK197’ dimer is not conformationally similar to DNA-bound
PU.1 dimer but resembles the DNA-free dimer (138). Fluorescence anisotropy of cognate DNA
binding by WT hPU.1ΔN165 (blue) and the 193DKCDK197’ mutant (green) (B). Note that the CD
measurements and the DNA binding assay using 193DKCDK197’ were conducted by Ms. Suela
Xhani.
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Appendix Figure 4 Fluorescence anisotropy of cognate DNA binding by WT
hPU.1ΔN165, 193AKAK196, 193DADA196, and 193TGDG196 mutants, and CD spectra of these PU.1
proteins.
A, DNA binding assays of fluorescence anisotropy using (a) wild-type hPU.1ΔN165 and three
PU.1 ETS domain mutants (b) 193AKAK196, (c) 193DADA196, and (d) 193TGDG196 with a 23-bp
cognate DNA. The 193AKAK196 and 193DADA196 mutants were designed to remove either all the
positive or negative charges from the wild-type sequence (193DKDK196). The 193TGDG196 mutant
was designed from the same site (357TGDG360) of Ets-1. B, Far-UV CD spectra of DNA-free
PU.1 WT (black), 193AKAK196 (blue), 193DADA196 (red), and 193TGDG196 (magenta) at 150 μM
and 0.15 M [Na+]. The CD-detected structures of 193AKAK196 and 193DADA196 showed
negligible changes, but 193TGDG196 showed significant changes, in comparison with WT.
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Appendix Figure 5 Nonspecific DNA binding of Ets-1 primarily perturbs H3 and the
autoinhibitory module.
A, 1H-15N HSQC resonances of (a) unbound and (b) 1:1 nonspecific DNA-bound Ets-1ΔN280.
Resonances were assigned based on previous reports on Ets-1 (33,36). B, weighed average of
amide (15N and 1H) chemical shift perturbations (CSPs) from unbound and 1:1 nonspecific
DNA-bound Ets-1ΔN280, derived by Δδ = √{δ1H2 + 0.2 (δ15N)2}, are plotted as a function of
residue number.

